
<html lang="en"     class="pb-page"  data-request-id="823bcaaf-a0c4-41cb-a01d-f15c0bb0b637"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.6b00213;issue:issue:10.1021/jmcmar.2016.59.issue-7;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="2,4,6-Triaminopyrimidine as a Novel Hinge Binder in a Series of PI3Kδ Selective Inhibitors" /></meta><meta name="dc.Creator" content="Leena  Patel" /></meta><meta name="dc.Creator" content="Jayaraman  Chandrasekhar" /></meta><meta name="dc.Creator" content="Jerry  Evarts" /></meta><meta name="dc.Creator" content="Aaron C.  Haran" /></meta><meta name="dc.Creator" content="Carmen  Ip" /></meta><meta name="dc.Creator" content="Joshua A.  Kaplan" /></meta><meta name="dc.Creator" content="Musong  Kim" /></meta><meta name="dc.Creator" content="David  Koditek" /></meta><meta name="dc.Creator" content="Latesh  Lad" /></meta><meta name="dc.Creator" content="Eve-Irene  Lepist" /></meta><meta name="dc.Creator" content="Mary E.  McGrath" /></meta><meta name="dc.Creator" content="Nikolai  Novikov" /></meta><meta name="dc.Creator" content="Stephane  Perreault" /></meta><meta name="dc.Creator" content="Kamal D.  Puri" /></meta><meta name="dc.Creator" content="John R.  Somoza" /></meta><meta name="dc.Creator" content="Bart H.  Steiner" /></meta><meta name="dc.Creator" content="Kirk L.  Stevens" /></meta><meta name="dc.Creator" content="Joseph  Therrien" /></meta><meta name="dc.Creator" content="Jennifer  Treiberg" /></meta><meta name="dc.Creator" content="Armando G.  Villaseñor" /></meta><meta name="dc.Creator" content="Arthur  Yeung" /></meta><meta name="dc.Creator" content="Gary  Phillips" /></meta><meta name="dc.Description" content="Inhibition of phosphoinositide 3-kinase δ (PI3Kδ) is an appealing target for several hematological malignancies and inflammatory diseases. Herein, we describe the discovery and optimization of a se..." /></meta><meta name="Description" content="Inhibition of phosphoinositide 3-kinase δ (PI3Kδ) is an appealing target for several hematological malignancies and inflammatory diseases. Herein, we describe the discovery and optimization of a se..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 29, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00213" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00213" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00213" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00213" /></link>
        
    
    

<title>2,4,6-Triaminopyrimidine as a Novel Hinge Binder in a Series of PI3Kδ Selective Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00213" /></meta><meta property="og:title" content="2,4,6-Triaminopyrimidine as a Novel Hinge Binder in a Series of PI3Kδ Selective Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0022.jpeg" /></meta><meta property="og:description" content="Inhibition of phosphoinositide 3-kinase δ (PI3Kδ) is an appealing target for several hematological malignancies and inflammatory diseases. Herein, we describe the discovery and optimization of a series of propeller shaped PI3Kδ inhibitors comprising a novel triaminopyrimidine hinge binder. Combinations of electronic and structural strategies were employed to mitigate aldehyde oxidase mediated metabolism. This medicinal chemistry effort culminated in the identification of 52, a potent and highly selective inhibitor of PI3Kδ that demonstrates efficacy in a rat model of arthritis." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00213"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00213">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00213&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00213&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00213&amp;href=/doi/10.1021/acs.jmedchem.6b00213" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 3532-3548</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00189" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b00276" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">2,4,6-Triaminopyrimidine as a Novel Hinge Binder in a Series of PI3Kδ Selective Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Leena++Patel">Leena Patel</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jayaraman++Chandrasekhar">Jayaraman Chandrasekhar</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jerry++Evarts">Jerry Evarts</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aaron+C.++Haran">Aaron C. Haran</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carmen++Ip">Carmen Ip</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joshua+A.++Kaplan">Joshua A. Kaplan</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Musong++Kim">Musong Kim</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++Koditek">David Koditek</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Latesh++Lad">Latesh Lad</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eve-Irene++Lepist">Eve-Irene Lepist</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mary+E.++McGrath">Mary E. McGrath</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nikolai++Novikov">Nikolai Novikov</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephane++Perreault">Stephane Perreault</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kamal+D.++Puri">Kamal D. Puri</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+R.++Somoza">John R. Somoza</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bart+H.++Steiner">Bart H. Steiner</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kirk+L.++Stevens">Kirk L. Stevens</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph++Therrien">Joseph Therrien</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jennifer++Treiberg">Jennifer Treiberg</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Armando+G.++Villase%C3%B1or">Armando G. Villaseñor</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Arthur++Yeung">Arthur Yeung</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gary++Phillips">Gary Phillips</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Gilead Sciences, Inc., 199 E Blaine Street, Seattle, Washington 98102, United States</span></div><div class="aff-info" id="aff2"><span class="aff-text">Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div><div class="corresp-info"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#7b171e1e151a550b1a0f1e173b1c12171e1a1f55181416"><span class="__cf_email__" data-cfemail="81ede4e4efe0aff1e0f5e4edc1e6e8ede4e0e5afe2eeec">[email protected]</span></a>. Phone: (206) 832-2058.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00213&amp;href=/doi/10.1021%2Facs.jmedchem.6b00213" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 3532–3548</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 16, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>9 February 2016</li><li><span class="item_label"><b>Published</b> online</span>29 March 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 April 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00213" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00213</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3532%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DLeena%2BPatel%252C%2BJayaraman%2BChandrasekhar%252C%2BJerry%2BEvarts%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D7%26contentID%3Dacs.jmedchem.6b00213%26title%3D2%252C4%252C6-Triaminopyrimidine%2Bas%2Ba%2BNovel%2BHinge%2BBinder%2Bin%2Ba%2BSeries%2Bof%2BPI3K%25CE%25B4%2BSelective%2BInhibitors%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3548%26publicationDate%3DApril%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00213"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3070</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">36</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00213" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;2,4,6-Triaminopyrimidine as a Novel Hinge Binder in a Series of PI3Kδ Selective Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Leena&quot;,&quot;last_name&quot;:&quot;Patel&quot;},{&quot;first_name&quot;:&quot;Jayaraman&quot;,&quot;last_name&quot;:&quot;Chandrasekhar&quot;},{&quot;first_name&quot;:&quot;Jerry&quot;,&quot;last_name&quot;:&quot;Evarts&quot;},{&quot;first_name&quot;:&quot;Aaron&quot;,&quot;last_name&quot;:&quot;C. Haran&quot;},{&quot;first_name&quot;:&quot;Carmen&quot;,&quot;last_name&quot;:&quot;Ip&quot;},{&quot;first_name&quot;:&quot;Joshua&quot;,&quot;last_name&quot;:&quot;A. Kaplan&quot;},{&quot;first_name&quot;:&quot;Musong&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Koditek&quot;},{&quot;first_name&quot;:&quot;Latesh&quot;,&quot;last_name&quot;:&quot;Lad&quot;},{&quot;first_name&quot;:&quot;Eve-Irene&quot;,&quot;last_name&quot;:&quot;Lepist&quot;},{&quot;first_name&quot;:&quot;Mary&quot;,&quot;last_name&quot;:&quot;E. McGrath&quot;},{&quot;first_name&quot;:&quot;Nikolai&quot;,&quot;last_name&quot;:&quot;Novikov&quot;},{&quot;first_name&quot;:&quot;Stephane&quot;,&quot;last_name&quot;:&quot;Perreault&quot;},{&quot;first_name&quot;:&quot;Kamal&quot;,&quot;last_name&quot;:&quot;D. Puri&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;R. Somoza&quot;},{&quot;first_name&quot;:&quot;Bart&quot;,&quot;last_name&quot;:&quot;H. Steiner&quot;},{&quot;first_name&quot;:&quot;Kirk&quot;,&quot;last_name&quot;:&quot;L. Stevens&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;Therrien&quot;},{&quot;first_name&quot;:&quot;Jennifer&quot;,&quot;last_name&quot;:&quot;Treiberg&quot;},{&quot;first_name&quot;:&quot;Armando&quot;,&quot;last_name&quot;:&quot;G. Villaseñor&quot;},{&quot;first_name&quot;:&quot;Arthur&quot;,&quot;last_name&quot;:&quot;Yeung&quot;},{&quot;first_name&quot;:&quot;Gary&quot;,&quot;last_name&quot;:&quot;Phillips&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;29&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;3532-3548&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00213&quot;},&quot;abstract&quot;:&quot;Inhibition of phosphoinositide 3-kinase δ (PI3Kδ) is an appealing target for several hematological malignancies and inflammatory diseases. Herein, we describe the discovery and optimization of a series of propeller shaped PI3Kδ inhibitors comprising a novel triaminopyrimidine hinge binder. Combinations of electronic and structural strategies were employed to mitigate aldehyde oxidase mediated metabolism. This medicinal chemistry effort culminated in the identification of 52, a potent and highly selective inhibitor of PI3Kδ that demonstrates efficacy in a rat model of arthritis.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00213&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00213" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00213&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00213" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00213&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00213" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00213&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00213&amp;href=/doi/10.1021/acs.jmedchem.6b00213" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00213" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00213" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00213%26sid%3Dliteratum%253Aachs%26pmid%3D26980109%26genre%3Darticle%26aulast%3DPatel%26date%3D2016%26atitle%3D2%252C4%252C6-Triaminopyrimidine%2Bas%2Ba%2BNovel%2BHinge%2BBinder%2Bin%2Ba%2BSeries%2Bof%2BPI3K%25CE%25B4%2BSelective%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D7%26spage%3D3532%26epage%3D3548%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=292143" title="Metabolism">Metabolism</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/jmcmar.2016.59.issue-7/20160414-01/jmcmar.2016.59.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0022.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00213&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Inhibition of phosphoinositide 3-kinase δ (PI3Kδ) is an appealing target for several hematological malignancies and inflammatory diseases. Herein, we describe the discovery and optimization of a series of propeller shaped PI3Kδ inhibitors comprising a novel triaminopyrimidine hinge binder. Combinations of electronic and structural strategies were employed to mitigate aldehyde oxidase mediated metabolism. This medicinal chemistry effort culminated in the identification of <b>52</b>, a potent and highly selective inhibitor of PI3Kδ that demonstrates efficacy in a rat model of arthritis.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86721" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86721" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Phosphoinositide 3-kinase δ (PI3Kδ) is critical to the etiology of a number of diseases involving B-cell function.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Activation at the cell surface results in PI3Kδ catalyzing the intracellular phosphorylation of phosphatidylinositol 4,5-bisphosphate (PIP2) to the second messenger phosphatidylinositol 3,4,5-trisphosphate (PIP3). PIP3 recruits cytosolic signaling enzymes such as Akt that contain pleckstrin homology (PH) domains to the plasma membrane, triggering cell survival, growth, and metabolism.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">PI3Kδ is predominantly expressed in hematopoietic cells,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and inhibition of PI3Kδ has been shown to be beneficial for the treatment of hematological malignancies where the PI3K/Akt pathway is hyperactive.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_p">Aberrant signaling in B-cells is also found in a number of inflammatory diseases. PI3Kδ is highly expressed in rheumatoid arthritis (RA) synovium,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and inhibition of PI3Kδ can reduce both B-cell and T-cell production of inflammatory cytokines that may ameliorate the production of autoantibodies. In models of RA, PI3Kδ inhibitors have demonstrated efficacy with respect to inflammation<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and reduced bone and cartilage erosion. In allergic asthma, PI3Kδ has been shown to be overactive in mast cells,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> neutrophils,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> T-cells,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> eosinophils, and B-cells.</div><div class="NLM_p">Zydelig (idelalisib), previously called GS-1101 or CAL-101 (<b>1</b>) (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>a), is a first-in-class, oral, potent, and selective inhibitor of PI3Kδ. Zydelig is dosed twice daily and is approved for use in patients with relapsed chronic lymphocytic leukemia (CLL), follicular lymphoma (FL), and small lymphocytic lymphoma (SLL).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p">As revealed by the crystal structure (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>b), idelalisib (<b>1)</b> binds to the ATP site of the p110δ catalytic subunit of PI3Kδ with the purine forming two hydrogen bonds with hinge residues Val828 and Glu826.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The fluoroquinazolinone ring assumes a perpendicular conformation to the hinge binder and is embedded in a specificity pocket between Trp760 and Met752 that is closed in the apo structure of the enzyme.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The phenyl ring lies perpendicular to the quinazolinone and protrudes out of the ATP-binding pocket into an area known as hydrophobic region II (H2). The improved PI3Kδ selectivity of propeller shaped compounds such as idelalisib is presumably due to a lower energy requirement by PI3Kδ for the formation of the specificity pocket relative to the PI3Kα, PI3Kβ, and PI3Kγ isoforms.<a onclick="showRef(event, 'cit11b'); return false;" href="javascript:void(0);" class="ref cit11b">(11b)</a> This previously described binding mode<a onclick="showRef(event, 'cit11a'); return false;" href="javascript:void(0);" class="ref cit11a">(11a)</a> is also adopted by several compounds that have been evaluated in clinical studies (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). Duvelisib, a δ-weighted δ/γ inhibitor, has demonstrated efficacy in B-cell and T-cell lymphomas.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> AMG-319<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and TGR-1202 also inhibit the PI3Kδ isoform and have been tested in phase I clinical trials in CLL and non-Hodgkin lymphoma (NHL) patients.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">In this manuscript, we describe our efforts toward identifying potent, highly selective, and metabolically stable PI3Kδ inhibitors, suitable for the treatment of hematological malignancies and/or inflammatory diseases at a low, once-daily oral dose.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0024.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (a) Structure of idelalisib<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> (<b>1</b>). (b) 2.4 Å X-ray crystal structure of <b>1</b> bound in the PI3Kδ ATP-binding site (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4XE0">4XE0</a>). Idelalisib (<b>1</b>) binds in a propeller shape with the quinazolinone ring occupying an induced specificity pocket formed by Trp760 and Met752. The N3 of the purine hinge binder interacts with the backbone NH of Val828, while the N9 forms short contacts with the backbone carbonyl of Glu826. Blue dashed lines show hydrogen bond contacts between the inhibitor and protein. The Asn836 and Asp832 residues differ among the PI3K isoforms. For clarity, all other residues have been removed.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00213&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0025.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. PI3Kδ inhibitors in clinical trials.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00213&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48612" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48612" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> General Synthetic Route to Novel Quinazolinone Compounds</h3><div class="NLM_p">Analogs were synthesized following the general synthetic route shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The quinazolinone core <b>6</b> was constructed via a one-pot, two-step dehydrative cyclization. Oxazinone intermediate <b>4</b> was prepared by treatment of anthranilic acid <b>2</b>, with protected amino acid <b>3</b> in the presence of diphenyl phosphite and pyridine. Subsequent addition of aniline <b>5</b> to the reaction mixture resulted in the formation of the quinazolinone core <b>6.</b> Deprotection of <b>6</b> with TFA afforded the primary amine intermediate <b>7</b> in high yield. Incorporation of the hinge binder motif was attained by nucleophilic displacement of substituted haloheterocycles <b>8</b> in the presence of Hünig’s base at high temperatures, either thermally or under microwave irradiation.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0009.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00213&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) pyridine, HOP(OPh)<sub>2</sub>, 50 °C, 2 h, 100%; (ii) 50 °C 3–12 h, 50–100%; (iii) CF<sub>3</sub>COOH, CH<sub>2</sub>Cl<sub>2</sub>, rt, 0.5–4 h, 80–100%; (iv) <i>i</i>-Pr<sub>2</sub>NEt, IPA, 120 °C, microwave or thermal, 8–14 h, 30–95%.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Preparation of Acetylene-Containing Compounds</h3><div class="NLM_p">An alternative series of pyrimidines targeting the affinity pocket was synthesized according to the sequence described in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Ethynyltrimethylsilane was functionalized via a Sonagashira coupling with the corresponding aryl or heteroaryl bromide <b>10</b>. Subsequent deprotection of the silyl protected alkynes afforded compounds of the corresponding terminal alkyne <b>11</b>. The synthesis was concluded through a second Sonagashira coupling of <b>11</b> with intermediate <b>12</b> (synthesized according to the procedure described in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) to afford final compounds of the general structure <b>13</b> in good yields.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0010.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00213&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, CuI, Et<sub>3</sub>N, toluene, 80 °C, 3 h, 65–80%; (ii) TBAF, THF; (iii) Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, CuI, Et<sub>3</sub>N, DMF, 90 °C, 3 h, 60–80%.</p></p></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72041" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72041" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">To achieve our goal, we set ourselves a target profile of selectivity greater than 150-fold for PI3Kδ over PI3Kα, PI3Kβ, and PI3Kγ. This would allow EC<sub>90</sub> coverage of PI3Kδ at trough concentrations without compromising isoform selectivity. Additionally, a low in vitro human predicted clearance of 0.2 L/h/kg or less was desired for a once-daily dosing regimen. Compound <b>14</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) served as an attractive starting point due to its PI3Kδ biochemical potency (PI3Kδ IC<sub>50</sub> = 1 nM). In an effort to optimize metabolic stability we first focused on replacing the purine ring which is the primary site of metabolism for <b>1</b>.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> We designed compound <b>15</b> to retain the N3 pyrimidine nitrogen and the 4-amino moiety, both of which were believed to be essential for potency. Unfortunately, this structural modification led to a 100-fold loss in PI3Kδ potency relative to compound <b>14</b>. The loss in potency may be due to removal of the N7 of the purine ring, which participates in a water-mediated hydrogen bonding network between the quinazolinone ring and the protein.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Removal of the 4-amino group (<b>16</b>) resulted in an additional loss of potency, illustrating the essential nature of each hinge binding component. Incorporation of a 5-cyano group, exemplified by compounds <b>17</b> and <b>18</b>, restored PI3Kδ potency with excellent selectivity over the other PI3K isoforms. We synthesized the pyridine analog <b>19</b> which exhibited a 75-fold loss in potency, demonstrating the importance of the N1 nitrogen. Finally, the regioisomer of <b>18</b>, compound <b>20</b>, resulted in lower potency and diminished selectivity over PI3Kγ. Due to its improved potency and selectivity profile, <b>18</b> was advanced into drug metabolism and pharmacokinetic (DMPK) evaluation.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Optimization of the Purine Hinge Binder</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0011.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0012.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Average of ≥1 determination. Run in quadruplicate.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Determined from isoform specific PI3K IC<sub>50</sub> values.</p></div></div><div></div></div><div class="NLM_p">The predicted clearance of compound <b>18</b> in human liver microsomes (HLM) and rat liver microsomes (RLM) was determined to be 0.1 L/h/kg and 0.2 L/h/kg, respectively. Encouraged by the low predicted clearances, we progressed <b>18</b> to in vivo pharmacokinetic evaluation (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). When administered in rats at 0.44 mg/kg intravenously, <b>18</b> demonstrated an intermediate in vivo systemic clearance of 1.1 L/h/kg indicating a 5-fold difference between the observed in vivo clearance and the predicted in vitro microsomal clearance. This discrepancy prompted us to assess susceptibility of the electron deficient 5-cyanopyrimidine ring of <b>18</b> to aldehyde oxidase (AO) metabolism. Aldehyde oxidase is a molybdenum-containing cytoplasmic enzyme that catalyzes the oxidation of nitrogen-containing heterocycles.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Microsomal assays utilize membrane fractions and do not capture clearance by AO.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> For that reason, the stability of <b>18</b> was tested in human hepatocytes (hHeps) with and without raloxifene, a known inhibitor of AO. A much higher predicted clearance of 0.88 L/h/kg in hHeps was determined for <b>18</b> relative to the 0.1 L/h/kg measured in the HLM assay. In the presence of raloxifene there was very little turnover of <b>18</b> in the hHeps and the predicted clearance was similar to that observed in HLM (hHeps + raloxifene = 0.09 L/h/kg). Metabolite identification studies revealed the presence of an M + 16 metabolite <b>21</b> (PI3Kδ IC<sub>50</sub> = 1500 nM), which was verified by independent synthesis (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). The identity of the product and inhibition of metabolism in the presence of raloxifene are consistent with the involvement of AO in the metabolism of <b>18</b>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. DMPK Profile of Compound <b>18</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">clearance (L/h/kg)</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">in vitro<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">in vivo<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>ss</sub> (L/kg)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a><sup>,</sup><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> (h)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">rat</td><td class="colsep0 rowsep0">0.2</td><td class="colsep0 rowsep0">1.1 ± 0.57</td><td class="colsep0 rowsep0">2.6 ± 0.97</td><td class="colsep0 rowsep0">2.6 ± 1.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">human</td><td class="colsep0 rowsep0">0.1</td><td class="colsep0 rowsep0"> </td><td class="colsep0 rowsep0"> </td><td class="colsep0 rowsep0"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">From hepatic microsomes.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Intravenous dose of 0.44 mg/kg.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Volume of distribution at steady state. <b>18</b> was formulated in 5% ethanol, 75% PEG 400, and 20% citrate buffer (pH 3.0) at 0.09 mg/mL and dosed in Sprague–Dawley rats.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">Number of animals per dosing route is 3.</p></div></div></div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Aldehyde oxidase mediated metabolism of <b>18</b> to its M + 16 metabolite <b>21</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00213&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Despite the high clearance of <b>18</b> in hHeps, the favorable potency and selectivity of this compound prompted us to investigate alternative substitutions at the C5-position on the pyrimidine hinge binder. We hoped to alleviate AO metabolism by modulating the electronics of the pyrimidine ring (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). Hydrolysis of the nitrile of <b>18</b> yielded the primary amide <b>22</b>, which lost potency, but showed markedly improved hepatic stability compared to <b>18</b>. However, the stability of <b>22</b> improved further upon incubation with raloxifene, indicating the involvement of AO. As anticipated, the trifluoromethylpyrimidine <b>23</b> was also a substrate for AO metabolism. We were hopeful that compound <b>24</b> would have diminished AO metabolism due to the presence of a methyl group on the pyrimidine ring. Unfortunately, this modification did not impact susceptibility of the hinge binder toward AO. In addition, <b>24</b> was much less potent than <b>18</b>, presumably due to weaker interactions of the pyrimidine with the hinge residues. Other electron donating groups such as the methoxy substituent of <b>25</b> also resulted in a loss of potency. Terminal acetylene <b>26</b> was synthesized to mimic the nitrile of compound <b>18</b> and exhibited excellent PI3Kδ potency and selectivity. Molecular modeling suggested that elaboration of the terminal acetylene of <b>26</b> could allow exploration of the affinity pocket.<a onclick="showRef(event, 'cit11a'); return false;" href="javascript:void(0);" class="ref cit11a">(11a)</a> The affinity pocket is accessed via a narrow channel proximal to the hinge region and is lined with several conserved polar residues. Additional docking studies on a number of analogs suggested that aryl and heteroaryl substituents on the acetylene of <b>26</b> may be able to interact with these residues through hydrogen bonding and/or π–cation interactions.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Effect of Modifying the Electronics of the Pyrimidine Hinge Binder</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0013.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0014.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Average of ≥1 determination. Run in quadruplicate.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">Determined from isoform specific PI3K IC<sub>50</sub> values.</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">ND: value not determined.</p></div></div><div></div></div><div class="NLM_p">To probe the affinity pocket, we prepared analogs <b>27</b>–<b>32</b> (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). Phenyl analog <b>27</b> exhibited good inhibition of PI3Kδ but diminished PI3Kβ selectivity. Compounds <b>28</b> and <b>29</b>, although potent, lost selectivity over PI3Kγ and PI3Kβ, respectively. The pyridazine analog <b>30</b> suffered considerable potency loss, possibly due to a repulsion between the heterocycle and nearby residues in the affinity pocket. An overall improvement in potency and isoform selectivity was achieved with compounds <b>31</b> and <b>32</b>. To better understand the potency of the affinity compounds, we examined an X-ray cocrystal of compound <b>32</b> bound to PI3Kδ (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>). The crystal structure illustrates the formation of two hydrogen bonds between the aminopyrimidine and the hinge residues, Val828 and Glu826. In addition, the pyrazole of <b>32</b> forms short contacts with Lys779, Asp911, and Asp787 in the affinity pocket. These supplementary hydrogen bonds help explain the gain in enzyme potency achieved with the acetylene-containing compounds. Hopeful that the significant structural modifications relative to <b>18</b> would perturb AO recognition of the hinge binder<a onclick="showRef(event, 'cit17d ref19'); return false;" href="javascript:void(0);" class="ref cit17d ref19">(17d, 19)</a> we quantified the metabolic fate for <b>31</b> in hHeps (±raloxifene). Unfortunately, compound <b>31</b> exhibited a 4-fold reduction in predicted clearance when incubated with raloxifene (0.13 L/h/kg); metabolite identification studies of <b>31</b> revealed an M + 16 metabolite <b>M1</b>, implicating AO metabolism (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). Despite marked improvement in isoform selectivity of <b>31</b> and <b>32</b>, the involvement of AO in the metabolism of these analogs deterred us from further exploration of acetylene-containing compounds.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SAR Results for Acetylene-Containing Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0015.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0016.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">Average of ≥1 determination. Run in quadruplicate.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">Determined from isoform specific PI3K IC<sub>50</sub> values.</p></div></div><div></div></div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. 2.85 Å X-ray crystal structure of <b>32</b> bound in the PI3Kδ ATP-binding site (PDB accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5I6U">5I6U</a>). In addition to the classic hinge binding interactions, the pyrazole ring forms hydrogen bonds to Lys779, Asp911, and Asp787 in the affinity pocket.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00213&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Aldehyde oxidase mediated metabolism of <b>31</b> to its metabolite <b>M1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00213&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Achieving metabolic stability was paramount in our program; electronic and structural modifications of the hinge binder failed to alleviate AO metabolism. Therefore, we decided to focus on an alternative strategy, directed at blocking oxidation of the C2-position on the pyrimidine ring. Deuteration at C2 (<b>33</b>) modestly improved predicted clearance in hHeps compared to <b>18</b> (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). Subsequent incubation of <b>33</b> with raloxifene revealed a 5-fold reduction in hepatic clearance implicating the involvement of AO. Substitution with a primary amine (<b>34</b>) afforded high potency and low clearance that was insensitive to the presence of raloxifene. The low predicted hepatic clearance of <b>34</b> was attractive but was accompanied by an increase PI3Kβ and PI3Kγ potency. Other blocking groups such as chlorine (<b>35</b>) resulted in a loss in potency, a further loss of PI3Kγ selectivity, and a higher predicted clearance relative to <b>34</b>. The poor metabolic stability is presumably due to an increase in lipophilicity (calculated log <i>P</i><b>=</b>  3.7 vs 3.0 (<b>34</b>)). Similarly, other small substituent changes around the pyrimidine ring (<b>36</b>–<b>38</b>) furnished compounds that exhibited high predicted clearances. The 2-amino substituent of <b>34</b> demonstrated a unique ability to successfully block AO metabolism at the C2-position while retaining PI3Kδ potency. The X-ray cocrystal of <b>34</b> bound to PI3Kδ reveals the triaminopyrimidine as a three-point hinge binding motif. In addition to a hydrogen bond between the N3 and the backbone NH of Val828, a second hydrogen bond is formed from the N4 to the backbone carbonyl of Glu826. The 2-amino substituent of the triaminopyrimidine supplements the typical N3 and N4 hinge binding features with a third hydrogen bond to the carbonyl of Val828 (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. SAR Results for Fully Substituted Pyrimidines</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0017.gif" alt="" id="fx7" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0018.gif" alt="" id="fx8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">Average of ≥1 determination. Run in quadruplicate.</p></div><div class="footnote" id="t5fn2"><sup>Table b</sup><p class="last">Determined from isoform specific PI3K IC<sub>50</sub> values.</p></div><div class="footnote" id="t5fn3"><sup>Table c</sup><p class="last">ND: value not determined.</p></div></div><div></div></div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. 2.4 Å X-ray crystal structure of <b>34</b> in PI3Kδ illustrates the triaminopyrimidine establishing hydrogen bonds to the hinge residues, Val828 and Glu826. A third hydrogen bond is accomplished between the N2 component of the triaminopyrimidine hinge binder and the carbonyl of Val828 (PDB accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5I4U">5I4U</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00213&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Inspired by the potency and predicted clearance of <b>34</b>, we focused our efforts upon improving isoform selectivity. The H2 region of the p110δ subunit of PI3Kδ consists of two residues lining the edge of the pocket that is filled by the phenyl ring. These residues differ among the PI3K isoforms; sequence alignments reveal Asp832/Asn836 in PI3Kδ correspond to His/Gln in PI3Kα, Glu/Asp in PI3Kβ, and Thr/Lys in PI3Kγ. As a result, the electrostatic and steric environments are significantly different across the isoforms. We hypothesized that small substituents on the phenyl ring could influence isoform selectivity. The addition of a fluoro substituent on the para position (<b>39</b>) resulted in significant loss of isoform selectivity (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). On the other hand, substitutions on the meta position (<b>40</b>–<b>45</b>) displayed similar selectivity profiles to that of <b>34</b> with respect to PI3Kγ. We thought that we may be able to further improve the isoform selectivity of compound <b>42</b> by the addition of a second group to the 5-position on the phenyl ring. Bis-nitrile <b>47</b> resulted in a considerable loss of PI3Kδ potency, possibly due to steric interference between the bulky isophthalonitrile ring and the enzyme. However, we were pleased to see that compounds <b>46</b>, <b>48</b>, and <b>49</b> demonstrated improved isoform selectivity relative to <b>34</b>. These experimental results confirmed that small substituents at the 3- and 5-positions on the phenyl ring are well accommodated in PI3Kδ.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Optimization of Phenyl Ring in H2</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0019.gif" alt="" id="fx9" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0020.gif" alt="" id="fx10" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>Table a</sup><p class="last">Average of ≥1 determination. Run in quadruplicate.</p></div><div class="footnote" id="t6fn2"><sup>Table b</sup><p class="last">Determined from isoform specific PI3K IC<sub>50</sub> values.</p></div></div><div></div></div><div class="NLM_p">While exploring alternative substitutions on the quinazolinone ring, we found that minor modifications had substantial impact on potency and selectivity. Despite the relatively high clearance of <b>49</b> in human hepatocytes (hHeps = 0.81 L/h/kg), we chose to retain the 3,5-difluoroaniline moiety since it afforded an enhanced selectivity profile over the unsubstituted phenyl ring of <b>34</b>. Addition of a fluorine atom to the 6-position of the quinazolinone, <b>50</b>, resulted in a 5-fold loss in PI3Kδ potency and lower δ/γ selectivity (<a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>). Complete removal of substitutions on the quinazolinone core (<b>51</b>) afforded a less potent and a more stable compound relative to <b>49</b>. The diminished hepatic metabolism of <b>51</b> may be due to a decrease in lipophilicity (calculated log <i>P</i> = 2.6 vs 3.3 (<b>49</b>)). We subsequently focused upon designing compounds with reduced lipophilicity relative to <b>49</b>. The fluorine analogs (<b>52</b>–<b>54</b>) were slightly less lipophilic (cLogP = 2.6 (<b>52</b>–<b>54</b>)) and offered a balance of potency and selectivity. Additionally, we were pleased to find that both <b>52</b> and <b>53</b> displayed lower predicted clearances in hHeps in comparison to <b>49</b>. We saw a substantial boost in isoform selectivity with the 8-cyano compound (<b>55</b>); unfortunately, <b>55</b> exhibited a higher clearance in hHeps relative to <b>52</b>. We found <b>52</b> to offer us a favorable combination of biochemical potency, isoform selectivity, and metabolic stability. Additionally, when tested in a whole blood basophil cellular assay (WB<sub>bas</sub>δ), analog <b>52</b> potently inhibited PI3Kδ, with an EC<sub>50</sub> of 1 nM. We further assessed <b>52</b> using the KinomeScan platform against a panel of 395 nonmutant kinases at a single concentration of 10 μM. Compound <b>52</b> displayed a high degree of kinome selectivity by only binding to other lipid kinases at less than 10% of control.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. SAR Results for Quinazolinone Ring Modifications</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0021.gif" alt="" id="fx11" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">isoform selectivity<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">PI3Kδ IC<sub>50</sub> <a class="ref internalNav" href="#t7fn1" aria-label="a">a</a> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">α/δ</th><th class="colsep0 rowsep0" align="center" char=".">β/δ</th><th class="colsep0 rowsep0" align="center" char=".">γ/δ</th><th class="colsep0 rowsep0" align="center" char=".">hHeps (L/h/kg)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">5-Cl</td><td class="colsep0 rowsep0" align="left">0.47</td><td class="colsep0 rowsep0" align="char" char=".">2600</td><td class="colsep0 rowsep0" align="char" char=".">520</td><td class="colsep0 rowsep0" align="char" char=".">110</td><td class="colsep0 rowsep0" align="char" char=".">0.81</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">5-Cl, 6-F</td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="char" char=".">780</td><td class="colsep0 rowsep0" align="char" char=".">470</td><td class="colsep0 rowsep0" align="char" char=".">74</td><td class="colsep0 rowsep0" align="char" char=".">0.39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="char" char=".">530</td><td class="colsep0 rowsep0" align="char" char=".">290</td><td class="colsep0 rowsep0" align="char" char=".">75</td><td class="colsep0 rowsep0" align="char" char=".">0.17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="left">5-F</td><td class="colsep0 rowsep0" align="left">2.2</td><td class="colsep0 rowsep0" align="char" char=".">1900</td><td class="colsep0 rowsep0" align="char" char=".">650</td><td class="colsep0 rowsep0" align="char" char=".">180</td><td class="colsep0 rowsep0" align="char" char=".">0.34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="left">6-F</td><td class="colsep0 rowsep0" align="left">4.8</td><td class="colsep0 rowsep0" align="char" char=".">600</td><td class="colsep0 rowsep0" align="char" char=".">520</td><td class="colsep0 rowsep0" align="char" char=".">160</td><td class="colsep0 rowsep0" align="char" char=".">0.29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="left">8-F</td><td class="colsep0 rowsep0" align="left">3.5</td><td class="colsep0 rowsep0" align="char" char=".">810</td><td class="colsep0 rowsep0" align="char" char=".">920</td><td class="colsep0 rowsep0" align="char" char=".">130</td><td class="colsep0 rowsep0" align="char" char=".">0.53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="left">8-CN</td><td class="colsep0 rowsep0" align="left">5.9</td><td class="colsep0 rowsep0" align="char" char=".">1700</td><td class="colsep0 rowsep0" align="char" char=".">1200</td><td class="colsep0 rowsep0" align="char" char=".">800</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Average of ≥1 determination. Run in quadruplicate.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">Determined from isoform specific PI3K IC<sub>50</sub> values.</p></div></div></div><div class="NLM_p">We next evaluated the PK profile of <b>52</b>. When administered in vivo, <b>52</b> demonstrated low to intermediate total clearance in rat and dog in comparison to hepatic blood flow in these species, high volumes of distribution, and high oral bioavailability (<a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a>). Rat PK for <b>52</b> suggested achievable target coverage at trough concentrations with twice-daily administration without compromising PI3K isoform selectivity (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>). Additionally, <b>52</b> inhibited ex vivo anti-IgD stimulation of B-cells with EC<sub>50</sub> and EC<sub>90</sub> values of 11 and 100 nM, respectively, as determined by a rat whole blood assay. Therefore, <b>52</b> was dosed to maintain these levels in a rat established collagen-induced arthritis (CIA) model.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. DMPK Profile of Compound <b>52</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">clearance (L/h/kg)</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">in vitro<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">in vivo<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t8fn6" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>ss</sub> (L/kg)<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t8fn3" aria-label="c">c</a><sup>,</sup><a class="ref internalNav" href="#t8fn6" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center"><i>b</i>/<i>p</i><a class="ref internalNav" href="#t8fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> (h)<a class="ref internalNav" href="#t8fn5" aria-label="e">e</a><sup>,</sup><a class="ref internalNav" href="#t8fn6" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)<a class="ref internalNav" href="#t8fn5" aria-label="e">e</a>,<a class="ref internalNav" href="#t8fn6" aria-label="f">f</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">rat</td><td class="colsep0 rowsep0">1.4</td><td class="colsep0 rowsep0">0.74 ± 0.04</td><td class="colsep0 rowsep0">2.6 ± 0.37</td><td class="colsep0 rowsep0">1.4</td><td class="colsep0 rowsep0">3.2 ± 0.19</td><td class="colsep0 rowsep0">106 ± 24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">dog</td><td class="colsep0 rowsep0">0.25</td><td class="colsep0 rowsep0">0.58 ± 0.16</td><td class="colsep0 rowsep0">1.30 ± 0.1</td><td class="colsep0 rowsep0">2.6</td><td class="colsep0 rowsep0">2.17 ± 0.56</td><td class="colsep0 rowsep0">100 ± 40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">human</td><td class="colsep0 rowsep0">0.34</td><td class="colsep0 rowsep0"> </td><td class="colsep0 rowsep0"> </td><td class="colsep0 rowsep0"> </td><td class="colsep0 rowsep0"> </td><td class="colsep0 rowsep0"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">From hepatocytes.</p></div><div class="footnote" id="t8fn2"><sup>b</sup><p class="last">Intravenous dose of 1 mg/kg.</p></div><div class="footnote" id="t8fn3"><sup>c</sup><p class="last">Volume of distribution at steady state.</p></div><div class="footnote" id="t8fn4"><sup>d</sup><p class="last">Blood plasma ratio.</p></div><div class="footnote" id="t8fn5"><sup>e</sup><p class="last">Oral dose of 5 mg/kg. <b>52</b> was formulated in 30% PEG 400 and 70% water for dosing in rats for both iv and po, and 5% ethanol, 55% PEG 400, and 40% citrate buffer at pH 2 (iv) and 15% Captisol (w/v) in water (po) for dosing in dogs.</p></div><div class="footnote" id="t8fn6"><sup>f</sup><p class="last">Number of animals per dosing route is 3.</p></div></div></div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0005.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Concentration–time profiles of <b>52</b> in plasma following a 30 min intravenous infusion at 1 mg/kg and an oral dose at 5 mg/kg in female Lewis rats (mean ± SD, <i>n</i> = 3). The bioavailability of <b>52</b> was 106 ± 24%. The <i>C</i><sub>max</sub> was 2830 ± 942 nM at 1 h, and AUC<sub>inf</sub> was 17000 ± 3930 nM·h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00213&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">This experimental model of polyarthritis has been widely used for preclinical testing of numerous antirheumatic agents.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> In this experiment, female Lewis rats with established CIA were treated twice daily by oral gavage for 7 days starting on the tenth day after collagen treatment, with vehicle or <b>52</b> at 0.34, 1.07, 4.6, and 10 mg/kg. Efficacy evaluation was based on reduction in paw swelling (measured by daily ankle caliper measurements and terminal hind paw weights) and histopathology parameters (amelioration of inflammatory infiltrate, pannus formation, cartilage destruction, and bone resorption). Treatment of animals with established CIA with <b>52</b> showed significant and dose-dependent reduction in ankle swelling (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>).</div><figure id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0006.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Compound <b>52</b> ameliorates ankle swelling in rat established CIA model. Female Lewis rats with CIA were treated, twice daily by oral gavage, for 7 days (study days 10–16) with vehicle, <b>52</b> (0.34, 1.07, 4.6, or 10 mg/kg), or the reference compound dexamethasone (0.03 mg/kg). Caliper measurements of right and left ankle diameters were taken every day beginning on day 9 and continuing through day 16: (∗) <i>p</i> < 0.05 versus arthritis + vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00213&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A correlation between plasma concentration of <b>52</b> and the degree of target inhibition leading to efficacy was established utilizing a rat whole-blood ex vivo BCR-induced B-cell activation assay. Compound <b>52</b> inhibited PI3Kδ-mediated B-cell activation in vivo with an EC<sub>50</sub> of 20.5 nM and an EC<sub>90</sub> of 100 nM. These values were used to assess the degree of target inhibition at the dose levels tested in the CIA model. Plasma concentrations measured on days 3 and 7 were consistent with maintaining approximately 25%, 50%, 90%, and >90% inhibition of PI3Kδ at 0.34, 1.07, 4.6, and 10 mg/kg doses, respectively, at trough levels (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>).</div><figure id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0007.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Pharmacokinetic profile of <b>52</b> in Lewis rats with established CIA. Blood samples from each dose group animals at indicated time after dosing on days 3 and 7 were analyzed for plasma concentrations of <b>52</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00213&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Histopathology showed animals treated with 1.07 mg/kg, targeting EC<sub>50</sub> inhibition at trough, had significantly ameliorated ankle inflammation (45% reduction), pannus formation (60%), cartilage damage (50%), bone resorption (63%), and periosteal bone width (52%), as compared to vehicle controls, with ED<sub>50</sub> values calculated at approximately 1.5 mg/kg on all disease parameters (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>). Maintaining PI3Kδ coverage between EC<sub>50</sub> and EC<sub>90</sub> over the dosing interval was sufficient to significantly reduce disease scores in this rat established model of RA.</div><figure id="fig10" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0008.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Analog <b>52</b> ameliorated histopathological disease severity in rats with established CIA. Ankle and knee joint tissue, sections from all animals were examined microscopically and graded on a scale from 0 to 5 for each parameter based on the degree of severity: (∗) <i>p</i> < 0.05 versus arthritis + vehicle. See <a href="/doi/suppl/10.1021/acs.jmedchem.6b00213/suppl_file/jm6b00213_si_001.pdf" class="ext-link">Supporting Information</a> for scoring guidelines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00213&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43242" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43242" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we have optimized a series of potent and highly selective PI3Kδ inhibitors. During the course of our research we discovered a novel triaminopyrimidine hinge binder that forms three hydrogen bonds with the protein. We also optimized the phenyl and the quinazolinone regions for potency and isoform selectivity. Compound <b>52</b>, although not suitable for once-daily dosing, was identified as a potent and selective inhibitor of PI3Kδ with good pharmacokinetic properties. Moreover, <b>52</b> demonstrated efficacy in a model of rat CIA with less than complete target coverage over the dosing interval. Further work and additional optimization to achieve a low dose PI3Kδ inhibitor suitable for QD administration will be presented in a future publication.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27426" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27426" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> General Procedures</h3><div class="NLM_p last">All final compounds were determined to be at least 95% pure by <sup>1</sup>H NMR and LCMS analysis. All commercial reagents and anhydrous solvents were used as provided without further purification. Microwave reactions were completed using a benchtop CEM microwave reactor. Flash chromatography was performed using an ISCO Combiflash or a Biotage Isolera purification system with Silicycle prepacked silica gel cartridges. Final compounds were purified by prep HPLC on a Gilson 271 system, with a Phenomenex Kinetex C18 column (250 mm × 30 mm, 100 A, 5 μm) and a gradient elution of acetonitrile/water with 5–95% for 20 min at a flow rate of 35 mL/min. For all samples 0.1% TFA was added to both eluents. All <sup>1</sup>H NMR spectra were recorded on a Varian 400-MR 400 MHz spectrometer. Proton chemical shifts are reported in parts per million from an internal standard or residual solvent. The purity of the tested compounds was assessed by an Agilent LCMS. A Silicycle Siliachrom SB C18 column (4.6 mm × 50 mm, 3 μm) was used with a gradient elution of acetonitrile in water, 0–95% for 7 min at a flow rate of 0.9 mL/min with detection at 256 nm. Alternatively, a Chromolith column (50 mm × 2 mm) was used with a gradient elution of acetonitrile in water, 0–95% for 3 min at a flow rate of 1.9 mL/min with detection at 256 nm. For all samples 0.1% TFA was added to both eluents.</div></div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> (<i>S</i>)-2,4-Diamino-6-((1-(5-chloro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile 2,2,2-Trifluoroacetic Acid Salt (<b>34</b>)</h3><div class="NLM_p last"><b>34</b> was synthesized according to the procedure described in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. 2,4-Diamino-6-chloropyrimidine-5-carbonitrile (391 mg, 2.31 mmol) was added to a suspension of (<i>S</i>)-2-(1-aminoethyl)-5-chloro-3-phenylquinazolin-4(3<i>H</i>)-one 2,2,2-trifluoroacetic acid salt (865 mg, 2.89 mmol) (<b>7</b>) and diisopropylethylamine (7.6 mL, 43.3 mmol) in IPA (3 mL). The resultant mixture was heated to 130 °C for 14 h, after which time the reaction was cooled to room temperature. The resultant solid was filtered and purified by HPLC, eluting with 5–95% water/acetonitrile (0.1% v/v trifluoroacetic acid). The appropriate fractions were pooled and lyophilized to afford the title compound as a white solid (575 mg). <sup>1</sup>H NMR (400 MHz, DMSO) δ 7.78 (t, <i>J</i> = 8.0 Hz, 1H), 7.63 (dd, <i>J</i> = 8.2, 1.2 Hz, 1H), 7.57 (dd, <i>J</i> = 7.8, 1.2 Hz, 1H), 7.57–7.45 (m, 5H), 6.79 (d, <i>J</i> = 7.0 Hz, 1H), 6.55 (br s, 1H), 6.25 (br s, 1H), 4.72 (dq, <i>J</i> = 6.45, 6.45 Hz, 1H), 1.29 (d, <i>J</i> = 6.8 Hz, 3H). ES/MS <i>m</i>/<i>z</i> 433.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> (<i>S</i>)-2-(1-Aminoethyl)-5-chloro-3-phenylquinazolin-4(3<i>H</i>)-one 2,2,2-Trifluoroacetic Acid Salt</h3><div class="NLM_p last">Trifluoroacetic acid (3 mL) was added to a solution of (<i>S</i>)-<i>tert</i>-butyl 1-(5-chloro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)ethylcarbamate (1 g, 2.5 mmol) in dichloromethane (3 mL). The resultant was stirred at room temperature for 3 h. The solvents were removed in vacuo to afford the title compound as a white solid (823 mg). ES/MS <i>m</i>/<i>z</i> = 300.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> (<i>S</i>)-<i>tert</i>-Butyl 1-(5-Chloro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)ethylcarbamate</h3><div class="NLM_p last">Diphenyl phosphite (1.9 mL, 10 mmol) was added to a solution of 2-amino-6-chlorobenzoic acid (495 mg, 2.9 mmol) (<b>2</b>) and (<i>S</i>)-2-(<i>tert</i>-butoxycarbonylamino)propanoic acid (710 mg, 3.77 mmol) in pyridine (3 mL). The reaction mixture was stirred at 40 °C for 2 h. Aniline (274 mg, 3.48 mmol) was then added to the reaction mixture, which was then stirred at 55 °C for 12 h. The reaction mixture was cooled to room temperature. This mixture was then diluted with EtOAc (50 mL), washed with 1 N aqueous HCl (2 × 50 mL), brine (50 mL), and dried over sodium sulfate. The organics layer was filtered and concentrated in vacuo to afford material which was purified by column chromatography on SiO<sub>2</sub> eluting with EtOAc in hexanes (0–50%) to afford the title compound as a solid (1 g). ES/MS <i>m</i>/<i>z</i> = 400.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 2,4-Diamino-6-chloropyrimidine-5-carbonitrile</h3><div class="NLM_p last">Ammonium hydroxide (20 mL) was added to a solution of 2,4,6-trichloropyrimidine-5-carbonitrile (5.0 g, 24 mmol) in dioxane (20 mL) at room temperature. The solution was warmed to 50 °C and stirred for 3 h. The reaction mixture was cooled to 10 °C, and water (50 mL) was added. The resulting solid was filtered, washed with water, and dried under high vacuum to afford the title compound as a white solid (4.5 g). <sup>13</sup>C NMR (100 MHz, DMSO) 164.8, 162.6, 161.9, 115.8, 77.6. ES/MS <i>m</i>/<i>z</i> = 169.9 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> (<i>S</i>)-2-(1-((6-Amino-5-((5-fluoropyridin-2-yl)ethynyl)pyrimidin-4-yl)amino)ethyl)-5-chloro-3-phenylquinazolin-4(3<i>H</i>)-one 2,2,2-Trifluoroacetate (<b>31</b>)</h3><div class="NLM_p last"><b>31</b> was synthesized according to the procedure described in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. To (<i>S</i>)-2-(1-aminoethyl)-5-chloro-3-phenylquinazolin-4(3<i>H</i>)-one 2,2,2-trifluoroacetic acid salt (58 mg, 0.14 mmol) and 6-chloro-5-((5-fluoropyridin-2-yl)ethynyl)pyrimidin-4-amine (35 mg, 0.14 mmol) in IPA (2 mL) was added Hünig’s base (0.14 mL, 0.7 mmol). The reagents were stirred at 130 °C for 14 h in a microwave reactor after which time the reaction mixture was cooled to room temperature. The solvent was evaporated and resultant solid was purified by HPLC eluting with 5–95% water/acetonitrile (0.1% v/v trifluoroacetic acid). The appropriate fractions were pooled and lyophilized to afford the title compound as a solid (32 mg). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.66 (d, <i>J</i> = 3.0 Hz, 1H), 7.88 (dd, <i>J</i> = 8.0, 4.0 Hz, 1H), 7.85–7.71 (m, 4H), 7.64–7.35 (m, 6H), 7.11 (d, <i>J</i> = 6.9 Hz, 1H), 6.83 (s, 2H), 4.67 (p, <i>J</i> = 6.5 Hz, 1H), 1.24 (d, <i>J</i> = 6.6 Hz, 3H). ES/MS <i>m</i>/<i>z</i> = 512.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 6-Chloro-5-((5-fluoropyridin-2-yl)ethynyl)pyrimidin-4-amine</h3><div class="NLM_p last">To 6-chloro-5-iodopyrimidin-4-amine (150 mg, 0.58 mmol) (in DMF (2 mL) were added Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (28 mg, 0.04 mmol), CuI (5.5 mg, 0.029 mmol), TEA (2 mL), and 2-ethynyl-5-fluoropyridine (70 mg, 0.58 mmol). The reaction mixture was stirred at 90 °C for 2 h, after which time the reaction mixture was cooled to ambient temperature and partitioned between ethyl acetate (20 mL) and water (20 mL). The organic layer was washed with brine (25 mL), separated, dried over magnesium sulfate, and filtered. The resultant residue was purified on silica with 0–10% methanol in dichloromethane to afford the title compound as a solid (80 mg). ES/MS <i>m</i>/<i>z</i> = 249.3 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 2-Ethynyl-5-fluoropyridine</h3><div class="NLM_p last">To 5-fluoro-2-((trimethylsilyl)ethynyl)pyridine (400 mg, 2.06 mmol) in THF (5 mL) was added tetra-<i>n</i>-butylammonium fluoride (2.0 mL, 2.0 mmol). The reaction mixture was stirred at ambient temperature for 3 h, after which time the solvent was evaporated and the resultant residue was purified on silica gel with 0 to 100% ethyl acetate in hexanes to afford the title compound as an oil (150 mg). ES/MS <i>m</i>/<i>z</i> = 122.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 5-Fluoro-2-((trimethylsilyl)ethynyl)pyridine</h3><div class="NLM_p last">To 2-bromo-5-fluoropyridine (500 mg, 2.84 mmol) in THF (5 mL) were added Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (136 mg, 0.19 mmol), CuI (26 mg, 0.13 mmol), TEA (5 mL), and ethynyltrimethylsilane (1.9 mL, 13.9 mmol). The reaction mixture was stirred at 70 °C for 2 h, after which time the solvent was evaporated. The resultant residue was purified on silica gel with 0–100% ethyl acetate in hexanes to afford the title compound as a solid (500 mg). ES/MS <i>m</i>/<i>z</i> = 226.3 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (<i>S</i>)-2-(1-((6-Aminopyrimidin-4-yl)amino)ethyl)-5-chloro-3-phenylquinazolin-4(3<i>H</i>)-one (<b>15</b>)</h3><div class="NLM_p last">The target compound was prepared in a manner analogous to that described for compound <b>34</b> as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.1 (s, 1), 7.7–7.3 (m, 8H), 5.63 (m, 1H), 5.35 (br s, 1H), 4.8 (m, 1H), 4.70 (br, 2H), 1.38 (d, 3H). ES/MS <i>m</i>/<i>z</i> 393.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (<i>S</i>)-5-Chloro-3-phenyl-2-(1-(pyrimidin-4-ylamino)ethyl)quinazolin-4(3<i>H</i>)-one (<b>16</b>)</h3><div class="NLM_p last">The target compound was prepared in a manner analogous to that described for compound <b>34</b> as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.85 (d, 1H), 8.75 (s, 1H), 8.2, (m, 1H), 7.8 (m, 1H), 7.7–7.4 (m, 7H), 6.8 (d, 1H), 4.70 (m, 1H), 1.4 (d, 3H). ES/MS <i>m</i>/<i>z</i> 378.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (<i>S</i>)-4-((1-(5-Chloro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile (<b>17</b>)</h3><div class="NLM_p last">The target compound was prepared in a manner analogous to that described for compound <b>34</b> as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. <sup>1</sup>H NMR 1H NMR (400 MHz, DMSO-d6) δ 8.60 (bs, 1H), 8.51–8.46 (m, 2H), 7.83–7.74 (m, 1H), 7.66 (dd, <i>J</i> = 8.2, 1.2 Hz, 1H), 7.59 (dd, <i>J</i> = 7.8, 1.2 Hz, 1H), 7.57–7.52 (m, 1H), 7.52–7.46 (m, 1H), 7.46–7.41 (m, 1H), 7.40–7.30 (m, 2H), 4.90 (q, <i>J</i> = 6.7 Hz, 1H), 1.43 (d, <i>J</i> = 6.7 Hz, 3H). ES/MS <i>m</i>/<i>z</i> 403.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (<i>S</i>)-4-Amino-6-((1-(5-chloro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile (<b>18</b>) As Shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a></h3><div class="NLM_p last">The target compound was prepared in a manner analogous to that described for compound <b>34</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.85 (s, 1H), 7.8–7.4 (m, 8H), 7.25 (br, 2H), 4.75 (m, 1H), 1.33 (d, 3H). ES/MS <i>m</i>/<i>z</i> 418.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (<i>S</i>)-2-Amino-4-((1-(5-chloro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)ethyl)amino)nicotinonitrile (<b>19</b>)</h3><div class="NLM_p last">The target compound was prepared in a manner analogous to that described for compound <b>34</b> as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.80 (d, <i>J</i> = 7.9 Hz, 1H), 7.67 (d, <i>J</i> = 8.0 Hz, 1H), 7.60 (d, <i>J</i> = 7.7 Hz, 1H), 7.54 (s, 2H), 7.49–7.37 (m, 5H), 6.07 (s, 1H), 4.78–4.59 (m, 1H), 1.38 (s, 3H). ES/MS <i>m</i>/<i>z</i> 417.2 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (<i>S</i>)-2-Amino-4-((1-(5-chloro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile (<b>20</b>)</h3><div class="NLM_p last">The target compound was prepared in a manner analogous to that described for compound <b>34</b> as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.12 (s, 1H), 7.8 (d, 1H), 7.64 (dd, 1H), 7.58 (d, 1H), 7.36–7.56 (m, 5H), 6.9 (br, 3H), 4.8 (m, 1H), 1.35 (d, 3H). ES/MS <i>m</i>/<i>z</i> 418.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (<i>S</i>)-4-Amino-6-((1-(5-chloro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)ethyl)amino)-2-hydroxypyrimidine-5-carbonitrile (<b>21</b>)</h3><div class="NLM_p last">To (<i>S</i>)-4-amino-6-((1-(5-chloro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)ethyl)amino)-2-(methylsulfonyl)pyrimidine-5-carbonitrile (prepared as described for <b>33</b>) in dioxane was added 1 M aqueous NaOH (10 equiv). The reaction mixture was allowed to stir at rt for 2 h. LCMS indicated consumption of starting material showing mostly desired sulfone and some sulfoxide. The material was extracted into EtOAc, concentrated to a residue which was taken up in DMSO, and purified by Prep HPLC. Clean fractions were pooled and lyophilized to give the desired product as a white powder (36% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.82–7.75 (m, 1H), 7.75–7.69 (m, 2H), 7.63 (dd, <i>J</i> = 8.2, 1.2 Hz, 1H), 7.58 (dd, <i>J</i> = 7.8, 1.2 Hz, 1H), 7.56–7.33 (m, 3H), 4.62 (t, <i>J</i> = 6.7 Hz, 1H), 1.33 (d, <i>J</i> = 6.7 Hz, 3H). ES/MS <i>m</i>/<i>z</i> 434.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> (<i>S</i>)-4-Amino-6-((1-(5-chloro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carboxamide (<b>22</b>)</h3><div class="NLM_p last">The target compound was prepared in a manner analogous to that described for compound <b>34</b> as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.88 (d, 1H), 7.83 (s, 1H), 7.75 (t, 1H), 7.4–7.6 (m, 8H), 6.6 (br, 2H), 4.7 (m, 1H), 4.1 (br 1H), 3.3 (br 1H), 1.25 (d, 3H). ES/MS <i>m</i>/<i>z</i> 436.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> (<i>S</i>)-2-(1-((6-Amino-5-(trifluoromethyl)pyrimidin-4-yl)amino)ethyl)-5-chloro-3-phenylquinazolin-4(3<i>H</i>)-one (<b>23</b>)</h3><div class="NLM_p last">The target compound was prepared in a manner analogous to that described for compound <b>34</b> as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.91 (s, 1H), 7.77 (t, 1H), 7.4–7.7 (m, 7H), 6.8 (br, 3H), 4.8 (m, 1H), 1.3 (d, 3H). ES/MS <i>m</i>/<i>z</i> 461.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (<i>S</i>)-2-(1-((6-Amino-5-methylpyrimidin-4-yl)amino)ethyl)-5-chloro-3-phenylquinazolin-4(3<i>H</i>)-one (<b>24</b>)</h3><div class="NLM_p last">The target compound was prepared in a manner analogous to that described for compound <b>34</b> as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.4–7.8 (m, 9H), 6.3 (d, 1H), 5.87 (br, 2H), 4.56 (m, 1H), 1.84 (s, 3H), 1.34 (d, 3H). ES/MS <i>m</i>/<i>z</i> 407.1(M + H)<sup>+</sup>.</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (<i>S</i>)-2-(1-((6-Amino-5-methoxypyrimidin-4-yl)amino)ethyl)-5-chloro-3-phenylquinazolin-4(3<i>H</i>)-one (<b>25</b>)</h3><div class="NLM_p last">The target compound was prepared in a manner analogous to that described for compound <b>34</b> as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.00 (s, 1H), 7.77 (m, 1H), 7.65–7.54 (m, 2H), 7.52–7.43 (m, 2H), 7.40 (s, 3H), 4.73 (m, 1H), 3.65 (s, 3H), 1.49–1.31 (m, 3H). ES/MS <i>m</i>/<i>z</i> 423.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (<i>S</i>)-2-(1-((6-Amino-5-ethynylpyrimidin-4-yl)amino)ethyl)-5-chloro-3-phenylquinazolin-4(3<i>H</i>)-one (<b>26</b>)</h3><div class="NLM_p last">The target compound was prepared in a manner analogous to that described for compound <b>31</b> as shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>, using <b>12</b> and ethynyltrimethylsilane as the starting materials. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.82 (s, 1H), 7.76 (t, 1H), 7.4–7.7 (m, 7H), 6.7 (d, 1H), 6.54 (br, 2H), 4.77 (s, 1H), 4.7 (m, 1H), 1.3 (d, 3H). ES/MS <i>m</i>/<i>z</i> 417.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (<i>S</i>)-2-(1-(6-Amino-5-(phenylethynyl)pyrimidin-4-ylamino)ethyl)-5-chloro-3-phenylquinazolin-4(3<i>H</i>)-one (<b>27</b>)</h3><div class="NLM_p last">The target compound was prepared in a manner analogous to that described for compound <b>31</b> as shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.88 (s,1H), 7.78 (t, <i>J</i> = 8.0 Hz, 1H), 7.88 (dt, <i>J</i> = 6.8, 1.6 Hz, 2H), 7.59–7.41 (m, 10H), 6.92 (d, <i>J</i> = 7.0 Hz, 1H), 6.75 (br, 2H), 4.73 (p, <i>J</i> = 6.8 Hz, 1H), 1.35 (d, <i>J</i> = 6.7 Hz, 3H). ES/MS <i>m</i>/<i>z</i> 493.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (<i>S</i>)-2-(1-(6-Amino-5-(pyridin-3-ylethynyl)pyrimidin-4-ylamino)ethyl)-5-chloro-3-phenylquinazolin-4(3<i>H</i>)-one (<b>28</b>)</h3><div class="NLM_p last">The target compound was prepared in a manner analogous to that described for compound <b>31</b> as shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.96 (d, <i>J</i> = 1.3 Hz, 1H), 8.62 (dd, <i>J</i> = 4.9, 1.7 Hz, 1H), 8.30–8.03 (m, 2H), 7.98 (s, 1H), 7.87–7.69 (m, 2H), 7.66–7.30 (m, 6H), 4.93–4.69 (m, 1H), 1.44 (d, <i>J</i> = 6.7 Hz, 3H)). ES/MS <i>m</i>/<i>z</i> 494.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (<i>S</i>)-2-(1-(6-Amino-5-(pyrazin-2-ylethynyl)pyrimidin-4-ylamino)ethyl)-5-chloro-3-phenylquinazolin-4(3<i>H</i>)-one (<b>29</b>)</h3><div class="NLM_p last">The target compound was prepared in a manner analogous to that described for compound <b>31</b> as shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.03 (d, <i>J</i> = 1.6 Hz, 1H), 8.78 (dd, <i>J</i> = 2.5, 1.6 Hz, 1H), 8.60 (d, <i>J</i> = 24.1 Hz, 1H), 8.07 (s, 1H), 7.92–7.68 (m, 2H), 7.64–7.23 (m, 9H), 4.89–4.61 (m, 1H), 1.34 (d, <i>J</i> = 6.7 Hz, 3H). ES/MS <i>m</i>/<i>z</i> 495.4 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (<i>S</i>)-2-(1-(6-Amino-5-(pyridazin-3-ylethynyl)pyrimidin-4-ylamino)ethyl)-5-chloro-3-phenylquinazolin-4(3<i>H</i>)-one (<b>30</b>)</h3><div class="NLM_p last">The target compound was prepared in a manner analogous to that described for compound <b>31</b> as shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.73 (d, <i>J</i> = 2.9 Hz, 1H), 8.01–7.79 (m, 4H), 7.73–7.39 (m, 8H), 7.38–7.17 (m, 2H), 4.85–4.74 (m, 1H), 1.35 (dd, <i>J</i> = 13.1, 6.6 Hz, 3H). ES/MS <i>m</i>/<i>z</i> 496.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (<i>S</i>)-2-(1-(5-((1<i>H</i>-Pyrazol-4-yl)ethynyl)-6-aminopyrimidin-4-ylamino)ethyl)-5-chloro-3-phenylquinazolin-4(3<i>H</i>)-one (<b>32</b>)</h3><div class="NLM_p last">The target compound was prepared in a manner analogous to that described for compound <b>31</b> as shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.11 (s, 1H), 8.01 (s, 2H), 7.76 (t, <i>J</i> = 7.6 Hz, 2H), 7.66–7.48 (m, 6H), 4.87–4.69 (m, 2H), 1.39 (d, <i>J</i> = 6.5 Hz, 3H).ES/MS 483.1 <i>m</i>/<i>z</i> (M + H)<sup>+</sup>.</div></div><div id="sec5_1_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (<i>S</i>)-4-Amino-6-((1-(5-chloro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile-2-<i>d</i> (<b>33</b>)</h3><div class="NLM_p last">To crude (<i>S</i>)-4-amino-6-((1-(5-chloro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)ethyl)amino)-2-(methylsulfonyl)pyrimidine-5-carbonitrile in MeOD-<i>d</i><sub>4</sub> (0.01M) was added NaBD<sub>4</sub> (2 equiv). The reaction mixture was allowed to stir overnight at rt. LCMS indicated consumption of starting material showing mostly desired deuterium incorporation as desired. The material was extracted into EtOAc, concentrated to a residue which was taken up in DMSO, and purified by Prep HPLC. Clean fractions were pooled and lyophilized to give the desired product as a white powder (40% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.79 (td, <i>J</i> = 8.0, 1.2 Hz, 1H), 7.72–7.62 (m, 2H), 7.58 (dt, <i>J</i> = 7.9, 1.3 Hz, 1H), 7.55–7.29 (m, 5H), 4.78 (t, <i>J</i> = 6.4 Hz, 1H), 1.37 (dd, <i>J</i> = 6.7, 1.1 Hz, 3H). ES/MS <i>m</i>/<i>z</i> 419.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> (<i>S</i>)-4-Amino-6-((1-(5-chloro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)ethyl)amino)-2-(methylsulfonyl)pyrimidine-5-carbonitrile</h3><div class="NLM_p last">To (<i>S</i>)-4-amino-6-((1-(5-chloro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)ethyl)amino)-2-(methylthio)pyrimidine-5-carbonitrile in THF (0.05M) were added MeOH (0.05 M) and water (0.05 M). Oxone (2 equiv) was added, and the reaction was allowed to stir overnight at rt. LCMS indicated consumption of starting material showing mostly desired sulfone and some sulfoxide. The crude material was extracted with EA, concentrated to an oil, and used crude in the next step.</div></div><div id="sec5_1_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> (<i>S</i>)-4-Amino-6-((1-(5-chloro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)ethyl)amino)-2-(methylthio)pyrimidine-5-carbonitrile</h3><div class="NLM_p last">To (<i>S</i>)-4-chloro-6-((1-(5-chloro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)ethyl)amino)-2-(methylthio)pyrimidine-5-carbonitrile is added ammonia in THF (13 equiv, 0.4 M). The reaction is heated at 75 °C and allowed to stir for 8 h. After cooling, hexanes were added to the reaction mixture and the solids were filtered to give the desired product as a white solid (70% yield).</div></div><div id="sec5_1_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> (<i>S</i>)-4-Chloro-6-((1-(5-chloro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)ethyl)amino)-2-(methylthio)pyrimidine-5-carbonitrile</h3><div class="NLM_p last">To (<i>S</i>)-2-(1-aminoethyl)-5-chloro-3-phenylquinazolin-4(3<i>H</i>)-one in IPA (0.05M) were added 4,6-dichloro-2-(methylthio)pyrimidine-5-carbonitrile and DIEA (4 equiv). The reaction mixture was heated overnight at 75 °C. LCMS indicated good conversion to desired material. Hexanes were added to the reaction mixture, and the solids were filtered to result in the desired product as a white solid (82% yield).</div></div><div id="sec5_1_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> (<i>S</i>)-4-Amino-2-chloro-6-((1-(5-chloro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile (<b>35</b>)</h3><div class="NLM_p last">The target compound was prepared in a manner analogous to that described for compound <b>34</b> as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.36 (d, <i>J</i> = 6.7 Hz, 2H), 7.91–7.27 (m, 9H), 4.50 (h, <i>J</i> = 6.7 Hz, 1H), 1.40–1.18 (m, 3H). ES/MS <i>m</i>/<i>z</i> 452.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (<i>S</i>)-5-Chloro-2-(1-((2,6-diamino-5-chloropyrimidin-4-yl)amino)ethyl)-3-phenylquinazolin-4(3<i>H</i>)-one (<b>36</b>)</h3><div class="NLM_p last">The target compound was prepared in a manner analogous to that described for compound <b>34</b> as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> using 2,4-diamino-5-chloro-6-fluoropyrimidine as the starting material. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.80 (m, 1H), 7.71 (bs, 2H), 7.68 (dd, <i>J</i> = 8.2, 1.2 Hz, 1H), 7.60 (dd, <i>J</i> = 7.8, 1.2 Hz, 1H), 7.54–7.51 (m, 2H), 7.47 (bs, 2H), 7.43–7.40 (m, 3H), 7.32 (bs, 2H), 4.85 (p, <i>J</i> = 6.7 Hz, 1H), 1.36 (d, <i>J</i> = 6.7 Hz, 3H). ES/MS <i>m</i>/<i>z</i> 442.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 2,4-Diamino-5-chloro-6-fluoropyrimidine</h3><div class="NLM_p last">To 2,4,6-trifluoropyrimidine (10 g, 75 mmol) in acetonitrile (100 mL) cooled to 0 °C was added conc NH<sub>4</sub>OH (50 mL) in three portions. The reaction mixture was stirred at 40 °C for 12 h, after which time the reaction mixture was cooled to room temperature and concentrated in vacuo. The resulting solid was dissolved in MeOH/EtOH (250 mL, 1:1) and cooled to 0 °C. <i>N</i>-Chlorosuccinimide (13 g, 97 mmol) was added portionwise to the solution. The reaction mixture was stirred at 50 °C for 12 h, after which time the cooled reaction mixture was concentrated to approximately 150 mL in vacuo. The resultant suspension was cooled to −10 °C and the solid formed was collected by filtration and washed with water (100 mL) followed by 0.1 M NaOH (100 mL) and dried under high vacuum to afford the title compound as a white solid (8.7 g). ES/MS <i>m</i>/<i>z</i> = 163.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> (<i>S</i>)-2-Amino-4-chloro-6-((1-(5-chloro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile (<b>37</b>)</h3><div class="NLM_p last">The target compound was prepared in a manner analogous to that described for compound <b>34</b> as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.88–7.71 (m, 2H), 7.66 (dt, <i>J</i> = 8.2, 1.0 Hz, 1H), 7.59 (dt, <i>J</i> = 7.8, 1.0 Hz, 1H), 7.57–7.45 (m, 3H), 7.50–7.41 (m, 1H), 7.45–7.33 (m, 2H), 7.25 (s, 1H), 4.85 (q, <i>J</i> = 6.7 Hz, 1H), 1.36 (d, <i>J</i> = 6.6 Hz, 3H). ES/MS <i>m</i>/<i>z</i> 452.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> (<i>S</i>)-2-Amino-4-((1-(5-chloro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)ethyl)amino)-6-methylpyrimidine-5-carbonitrile (<b>38</b>)</h3><div class="NLM_p last">The target compound was prepared in a manner analogous to that described for compound <b>34</b> as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.14 (s, 1H), 7.85–7.75 (m, 1H), 7.75–7.63 (m, 1H), 7.60 (dd, <i>J</i> = 7.8, 1.4 Hz, 1H), 7.54 (s, 2H), 7.55–7.46 (m, 2H), 7.47–7.33 (m, 3H), 4.94–4.83 (m, 1H), 2.35–2.29 (m, 3H), 1.37 (dt, <i>J</i> = 6.7, 1.5 Hz, 3H). ES/MS <i>m</i>/<i>z</i> 532.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> (<i>S</i>)-2,4-Diamino-6-((1-(5-chloro-3-(4-fluorophenyl)-4-oxo-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile (<b>39</b>)</h3><div class="NLM_p last">The target compound was prepared in a manner analogous to that described for compound <b>34</b> as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.90 (br, 1H), 7.8 (br, 1H), 7.78 (t, 1H), 7.65 (dd, <i>J</i> = 8.2, 1.2 Hz, 1H), 7.6 (m, 1H), 7.59 (dd, <i>J</i> = 7.8, 1.2 Hz, 1H), 7.44 (ddd, <i>J</i> = 8.7, 5.0, 2.7 Hz, 1H), 7.34 (td, <i>J</i> = 8.7, 3.0 Hz, 1H), 7.26 (td, <i>J</i> = 8.7, 3.0 Hz, 1H), 4.85 (m, 1H), 1.34 (d, <i>J</i> = 6.6 Hz, 3H). ES/MS <i>m</i>/<i>z</i> 451.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> (<i>S</i>)-2,4-dDiamino-6-((1-(5-chloro-3-(3-fluorophenyl)-4-oxo-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile (<b>40</b>)</h3><div class="NLM_p last">The target compound was prepared in a manner analogous to that described for compound <b>34</b> as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.0–7.75 (m, 4H), 7.80 (t, 1H), 7.67 (ddt, <i>J</i> = 8.1, 2.9, 1.0 Hz, 1H), 7.60 (d, 1H), 7.55–7.35 (m, 3H), 7.26 (m, 2H), 4.90 (dq, <i>J</i> = 9.5, 6.7 Hz, 1H), 1.36 (dd, <i>J</i> = 6.8, 2.2 Hz, 3H). ES/MS <i>m</i>/<i>z</i> 451.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> (<i>S</i>)-2,4-Diamino-6-(1-(5-chloro-3-(3-chlorophenyl)-4-oxo-3,4-dihydroquinazolin-2-yl)ethylamino)pyrimidine-5-carbonitrile (<b>41</b>)</h3><div class="NLM_p last">The target compound was prepared in a manner analogous to that described for compound <b>34</b> as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.79 (ddd, <i>J</i> = 17.0, 10.3, 3.2 Hz, 1H), 7.67 (ddd, <i>J</i> = 13.3, 8.2, 1.2 Hz, 1H), 7.60 (ddd, <i>J</i> = 7.8, 4.6, 1.2 Hz, 1H), 7.53–7.44 (m, 2H), 7.40 (qd, <i>J</i> = 6.6, 4.6 Hz, 1H), 5.00–4.83 (m, 1H), 1.36 (dd, <i>J</i> = 9.4, 6.7 Hz, 2H). ES/MS 467.3 <i>m</i>/<i>z</i> (M + H)<sup>+</sup>.</div></div><div id="sec5_1_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> (<i>S</i>)-2,4-Diamino-6-(1-(5-chloro-3-(3-cyanophenyl)-4-oxo-3,4-dihydroquinazolin-2-yl)ethylamino)pyrimidine-5-carbonitrile (<b>42</b>)</h3><div class="NLM_p last">The target compound was prepared in a manner analogous to that described for compound <b>34</b> as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.13 (t, <i>J</i> = 1.6 Hz, 1H), 7.93 (ddd, <i>J</i> = 8.0, 2.0, 1.2 Hz, 1H), 7.88–7.83 (m, 1H), 7.80 (dd, <i>J</i> = 9.5, 1.7 Hz, 2H), 7.75–7.66 (m, 3H), 7.61 (ddd, <i>J</i> = 7.5, 4.3, 3.2 Hz, 1H), 7.18–7.08 (m, 1H), 6.77–6.68 (m, 1H), 4.96–4.77 (m, 1H), 1.33 (t, <i>J</i> = 16.1 Hz, 3H). ES/MS <i>m</i>/<i>z</i> 457.9 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> (<i>S</i>)-2,4-Diamino-6-((1-(5-chloro-3-(3-methoxyphenyl)-4-oxo-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile (<b>43</b>)</h3><div class="NLM_p last">The target compound was prepared in a manner analogous to that described for compound <b>34</b> as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.82–6.85 (m, 7H), 5.01–4.90 (m, 1H), 3.74 (s, 3H), 1.35 (d, <i>J</i> = 6.6 Hz, 3H). ES/MS <i>m</i>/<i>z</i> 463.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> (<i>S</i>)-2,4-Diamino-6-(1-(5-chloro-4-oxo-3-(3-(trifluoromethyl)phenyl)-3,4-dihydroquinazolin-2-yl)ethylamino)pyrimidine-5-carbonitrile (<b>44</b>)</h3><div class="NLM_p last">The target compound was prepared in a manner analogous to that described for compound <b>34</b> as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.01 (d, <i>J</i> = 38.7 Hz, 1H), 7.91–7.75 (m, 3H), 7.75–7.63 (m, 4H), 7.63–7.52 (m, 2H), 5.02–4.74 (m, 1H), 1.43–1.19 (m, 3H). ES/MS 500.1 <i>m</i>/<i>z</i> (M + H)<sup>+</sup>.</div></div><div id="sec5_1_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> (<i>S</i>)-2,4-Diamino-6-((1-(5-chloro-3-(3-(2,2-difluoroethyl)phenyl)-4-oxo-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile (<b>45</b>)</h3><div class="NLM_p last">The target compound was prepared in a manner analogous to that described for compound <b>34</b> as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.89–7.70 (m, 2H), 7.73–7.61 (m, 2H), 7.62–7.41 (m, 3H), 4.86 (dt, <i>J</i> = 57.5, 6.8 Hz, 1H), 1.93 (dt, <i>J</i> = 34.0, 18.9 Hz, 2H), 1.33 (dd, <i>J</i> = 13.4, 6.6 Hz, 3H). ES/MS 497.1 <i>m</i>/<i>z</i> (M + H)<sup>+</sup>.</div></div><div id="sec5_1_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> (<i>S</i>)-2,4-Diamino-6-((1-(5-chloro-3-(3-(difluoromethyl)phenyl)-4-oxo-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile (<b>46</b>)</h3><div class="NLM_p last">The target compound was prepared in a manner analogous to that described for compound <b>34</b> as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.1–7.2 (m, 9H), 7.02 (m, 1H), 4.90 (m, 1H), 1.35 (m, 3H). ES/MS <i>m</i>/<i>z</i> 483.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> (<i>S</i>)-5-(5-Chloro-2-(1-((2,6-diamino-5-cyanopyrimidin-4-yl)amino)ethyl)-4-oxoquinazolin-3(4<i>H</i>)-yl)isophthalonitrile (<b>47</b>)</h3><div class="NLM_p last">The target compound was prepared in a manner analogous to that described for compound <b>34</b> as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.57–8.42 (m, 2H), 8.11 (q, <i>J</i> = 1.3 Hz, 1H), 7.86 (td, <i>J</i> = 8.0, 1.2 Hz, 1H), 7.74 (dt, <i>J</i> = 8.2, 1.2 Hz, 1H), 7.66 (dt, <i>J</i> = 7.8, 1.2 Hz, 1H), 4.90 (t, <i>J</i> = 6.8 Hz, 1H), 1.46–1.24 (m, 3H). ES/MS <i>m</i>/<i>z</i> 483.9 (M + H)<sup>+</sup></div></div><div id="sec5_1_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> (<i>S</i>)-2,4-Diamino-6-(1-(5-chloro-3-(3-chloro-5-(difluoromethyl)phenyl)-4-oxo-3,4-dihydroquinazolin-2-yl)ethylamino)pyrimidine-5-carbonitrile (<b>48</b>)</h3><div class="NLM_p last">The target compound was prepared in a manner analogous to that described for compound <b>34</b> as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, using 3-chloro-5-(difluoromethyl)aniline as the starting material. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.96–7.75 (m, 3H), 7.72–7.64 (m, 2H), 7.63–7.50 (m, 4H), 7.21–6.78 (m, 3H), 4.97–4.87 (m, 1H), 1.39–1.31 (m, 3H). ES/MS <i>m</i>/<i>z</i> 517.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 3-Chloro-5-(difluoromethyl)aniline</h3><div class="NLM_p last">A mixture of 1-chloro-3-(difluoromethyl)-5-nitrobenzene (980, 4.72 mmol) and 10% Pd/C (530 mg, 0.50 mmol) in ethyl acetate (20 mL) was stirred under an atmosphere of hydrogen for overnight. The reaction mixture was filtered over Celite followed by concentration to afford the title compound as a brown solid (578 mg).</div></div><div id="sec5_1_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 1-Chloro-3-(difluoromethyl)-5-nitrobenzene</h3><div class="NLM_p last">To a solution of 3-chloro-5-nitrobenzaldehyde (1.0 g, 5.38 mmol) in dichloromethane (30 mL) at 0 °C was added dropwise (diethylamino)sulfur trifluoride (1.42 mL, 10.8 mmol). The reaction mixture was stirred at room temperature for overnight. Water was slowly added, and the mixture was extracted twice with dichloromethane. The combined organic phases were washed with brine, dried over MgSO4, filtered, and concentrated. The crude product was purified by silica gel column chromatography using 0–30% ethyl acetate in hexane to afford the title compound (980 mg).</div></div><div id="sec5_1_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> (<i>S</i>)-2,4-Diamino-6-(1-(5-chloro-3-(3,5-difluorophenyl)-4-oxo-3,4-dihydroquinazolin-2-yl)ethylamino)pyrimidine-5-carbonitrile (<b>49</b>)</h3><div class="NLM_p last">The target compound was prepared in a manner analogous to that described for compound <b>34</b> as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.78 (t, <i>J</i> = 8.0 Hz, 1H), 7.65 (dd, <i>J</i> = 8.2, 1.2 Hz, 1H), 7.58 (dd, <i>J</i> = 7.8, 1.2 Hz, 1H), 7.43 (dm, <i>J</i> = 9.2 Hz, 1H), 7.29 (dt, <i>J</i> = 9.2, 2.4 Hz, 1H), 7.24 (dm, <i>J</i> = 11 Hz, 1H), 6.83 (d, <i>J</i> = 6.8 Hz, 1H), 6.51 (br s, 1H), 6.24 (br s, 1H), 4.82 (dq, <i>J</i> = 6.65, 6.65 Hz, 1H), 1.34 (d, <i>J</i> = 6.65 Hz, 3H). ES/MS <i>m</i>/<i>z</i> 469.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> (<i>S</i>)-2,4-Diamino-6-((1-(5-chloro-3-(3,5-difluorophenyl)-6-fluoro-4-oxo-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile (<b>50</b>)</h3><div class="NLM_p last">The target compound was prepared in a manner analogous to that described for compound <b>34</b> as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.01–7.72 (m, 7H), 7.49 (dm, <i>J</i> = 8.8 Hz, 1H), 7.34 (tt, <i>J</i> = 9.4, 2.4 Hz, 1H), 7.19–7.12 (m, 1H), 4.98 (p, <i>J</i> = 6.7 Hz, 1H), 1.40 (d, <i>J</i> = 6.6 Hz, 3H). ES/MS 487.1 <i>m</i>/<i>z</i> (M + H)<sup>+</sup>.</div></div><div id="sec5_1_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> (<i>S</i>)-2,4-Diamino-6-(1-(3-(3,5-difluorophenyl)-4-oxo-3,4-dihydroquinazolin-2-yl)ethylamino)pyrimidine-5-carbonitrile (<b>51</b>)</h3><div class="NLM_p last">The target compound was prepared in a manner analogous to that described for compound <b>34</b> as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.32–8.10 (m, 1H), 7.91 (ddd, <i>J</i> = 23.8, 12.7, 9.1 Hz, 1H), 7.76 (dd, <i>J</i> = 14.1, 6.5 Hz, 1H), 7.68–7.56 (m, 1H), 7.50 (d, <i>J</i> = 9.2 Hz, 1H), 7.32 (tt, <i>J</i> = 9.3, 2.4 Hz, 1H), 7.18 (d, <i>J</i> = 9.1 Hz, 1H), 5.08–4.94 (m, 1H), 1.54–1.31 (m, 3H). ES/MS <i>m</i>/<i>z</i> 435.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> (<i>S</i>)-2,4-Diamino-6-(1-(3-(3,5-difluorophenyl)-5-fluoro-4-oxo-3,4-dihydroquinazolin-2-yl)ethylamino)pyrimidine-5-carbonitrile (<b>52</b>)</h3><div class="NLM_p last">The target compound was prepared in a manner analogous to that described for compound <b>34</b> as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.87 (dd, <i>J</i> = 13.6, 8.1 Hz, 1H), 7.57 (s, 2H), 7.55 (d, <i>J</i> = 8.2 Hz, 1H), 7.46 (d, <i>J</i> = 8.7 Hz, 1H), 7.38–7.19 (m, 2H), 7.15 (d, <i>J</i> = 8.6 Hz, 1H), 5.11–4.85 (m, 1H), 1.38 (d, <i>J</i> = 6.6 Hz, 3H). ES/MS <i>m</i>/<i>z</i> 453.3 (M + H).</div></div><div id="sec5_1_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> (<i>S</i>)-2,4-Diamino-6-(1-(3-(3,5-difluorophenyl)-6-fluoro-4-oxo-3,4-dihydroquinazolin-2-yl)ethylamino)pyrimidine-5-carbonitrile (<b>53</b>)</h3><div class="NLM_p last">The target compound was prepared in a manner analogous to that described for compound <b>34</b> as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.88–7.67 (m, 4H), 7.48 (d, <i>J</i> = 9.1 Hz, 1H), 7.38–7.18 (m, 2H), 7.12 (d, <i>J</i> = 8.4 Hz, 2H), 5.11–4.88 (m, 1H), 1.34 (t, <i>J</i> = 37.5 Hz, 3H). ES/MS <i>m</i>/<i>z</i> 453.2 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> (<i>S</i>)-2,4-Diamino-6-(1-(3-(3,5-difluorophenyl)-8-fluoro-4-oxo-3,4-dihydroquinazolin-2-yl)ethylamino)pyrimidine-5-carbonitrile (<b>54</b>)</h3><div class="NLM_p last">The target compound was prepared in a manner analogous to that described for compound <b>34</b> as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.95 (d, <i>J</i> = 8.0 Hz, 2H), 7.86–7.69 (m, 2H), 7.58 (td, <i>J</i> = 8.0, 4.7 Hz, 2H), 7.48 (d, <i>J</i> = 9.0 Hz, 1H), 7.41–7.18 (m, 2H), 7.14 (d, <i>J</i> = 9.0 Hz, 1H), 5.09–4.86 (m, 1H), 1.40 (d, <i>J</i> = 6.6 Hz, 3H). ES/MS <i>m</i>/<i>z</i> 453.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> (<i>S</i>)-2-(1-((2,6-Diamino-5-cyanopyrimidin-4-yl)amino)ethyl)-3-(3,5-difluorophenyl)-4-oxo-3,4-dihydroquinazoline-8-carbonitrile (<b>55</b>)</h3><div class="NLM_p last">A mixture of (<i>S</i>)-2,4-diamino-6-((1-(3-(3,5-difluorophenyl)-8-iodo-4-oxo-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile (38 mg, 0.07 mmol) (synthesized in a manner analogous to <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) and copper(I) cyanide (1.5 eqiv, 9 mg, 0.10 mmol) was taken up in <i>N</i>-methylpyrrolidinone (0.25 mL) in a 2–5 mL Smith process vial. The mixture was treated with tetrakis(triphenylphosphine)palladium(0) (10 mol %, 8 mg, 0.007 mmol) and irradiated for 1 h at 150 °C. The reaction mixture was partitioned between ethyl acetate and 10% aqueous hydrochloric acid. The insoluble brown material was removed by filtration. The aqueous phase was basified with concentrated ammonium hydroxide and was then extracted three times with ethyl acetate. The combined organics were washed once with saturated aqueous sodium chloride solution, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by prep HPLC appropriate and fractions were combined and concentrated to afford the title compound (69 mg). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.46 (dd, <i>J</i> = 10.8, 1.6 Hz, 1H), 8.44 (dd, <i>J</i> = 11.2, 1.6 Hz, 1H), 7.87 (bs, 2H), 7.75 (t, <i>J</i> = 7.8 Hz, 1H), 7.74 (bs, 2H), 7.49 (m, 1H), 7.31 (tt, <i>J</i> = 9.3, 2.4 Hz, 1H), 7.06 (m, 1H), 5.14 (p, <i>J</i> = 6.6 Hz, 1H), 1.48 (d, <i>J</i> = 6.6 Hz, 3H). ES/MS <i>m</i>/<i>z</i> 460.1 (M + H)<sup>+</sup>.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> PI3K Biochemical Assay</h3><div class="NLM_p last">Enzymatic activity of the class I PI3K isoforms was measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay that monitors formation of the product 3,4,5-inositol trisphosphate molecule (PIP3). Human full length p110α and human p110δ catalytic subunits were coexpressed with the p85α regulatory subunit and purified as heterodimers. Human full length p110γ was expressed and purified without a regulatory subunit. PI3Kβ was purchased from Millipore (Billerica, MA) (item 14-603, lot 1994929-B). All assay reagents and buffers for the TR-FRET assay were purchased from Millipore (Dundee, Ireland) (item 33-036, lot 1812413). PI3K isoforms were assayed under initial rate conditions at the following concentrations for each isoform: PI3Kα, -β, -δ at 50 pM and PI3Kγ at 5 nM. After an assay reaction time of 30 min at 25 °C, reactions were terminated with a final concentration of 10 mM EDTA, 10 nM labeled-PIP3, and 35 nM europium labeled GRP-1 detector protein before reading TR-FRET on an Envision plate reader (Ex, 340 nm; Em, 615/665 nm). Data were normalized based on a positive (1 μM wortmannin) and negative (0.5% DMSO) control, and IC<sub>50</sub> values were calculated from the fit of the dose–response curves to a four-parameter equation. All IC<sub>50</sub> values represent geometric mean values of a minimum of four determinations.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> EC<sub>50</sub>, Whole Blood Basophil δ</h3><div class="NLM_p last">Basophil activation was measured in human whole blood using the Flow2 CAST kit (Buhlmann Laboratories AG, Baselstrasse, Switzerland) following the protocol provided by the manufacturer with minor modifications. Human whole blood was collected into K2-EDTA venipuncture tubes. Whole blood samples were incubated with either DMSO (0.3% final) or a serial dilution of compounds in DMSO for 60 min at 37 °C. To activate basophils using the anti-FceRI mAb; 50 μL of whole blood was mixed with 130 μL of stimulation buffer and 10 μL of anti-FceRI. Stimulation buffer alone was used as a negative control. The cells were stained with anti-CD63-FITC and anti-CCR3 (CD193)-PE antibodies for 25 min at 37 °C. Two mL lysis solution was added to lyse erythrocytes and to fix blood cells. After a 10 min incubation at room temperature, cells were pelleted and resuspended in wash buffer and analyzed by flow cytometry on a FC500MPL flow cytometer (Beckman Coulter Inc., Fullerton, CA). Degranulation was detected via CD63 surface expression on CCR3 positive cells. The percent CD63 positive cells within the gated basophil population was determined in different treatment groups and normalized to the vehicle control (0.3% DMSO).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> EC<sub>50</sub>, B-Cell Activation Assay</h3><div class="NLM_p last">The B-cell activation was measured in rat whole blood. Briefly, p110δ was activated with BCR cross-linking with anti-IgD in the absence or presence of increasing concentrations of 52. Whole blood was incubated with anti-IgD for 18–24 h to activate B-cells. To monitor the B-cell population and cellular activation in rats, anti-CD45RA- ECD (B-cell marker in Rats) and anti-CD86-PC5 (marker of B-cell activation in rats) antibodies were added to each sample. Flow cytometric analysis of the B-cell activation was performed on a FC500MPL flow cytometer (Beckman Coulter Inc., Fullerton, CA). CD45RA-staining and side scatter were applied to gate at least 4000 B-cells that expressed a high density of CD45RA. The percentage of CD86 positive cells within the gated CD45RA+ B-cell population was determined in treatment groups and normalized to the vehicle control (0.3% DMSO). The final compound concentration was adjusted to correct for the dilution effect of added reagents. In this assay, the final serum concentration at the time of B-cell activation in rat whole blood was about 96%.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> Microsome Stability Assay</h3><div class="NLM_p last">Metabolic stability in vitro was determined using pooled hepatic microsomal fractions (final protein concentration of 0.5 mg/mL) at a final test compound concentration of 1 μM. The reaction was initiated by the addition of an NADPH-regenerating system. An aliquot of 25 μL of the reaction mixture was transferred at various time points to plates containing a quenching solution. The test compound concentration in the reaction mixture was determined with LC/MS/MS. Predicted clearance was calculated using the well-stirred liver model without protein restriction.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> Hepatocyte Stability Assay</h3><div class="NLM_p last">Metabolic stability in vitro was determined using human cryopreserved hepatocytes (1 × 10<sup>6</sup> viable cells/mL per well) at a final test compound concentration of 1 μM in the presence or absence of raloxifene (5 uM), a known inhibitor of aldehyde oxidase. An aliquot of 25 μL of the reaction mixture was transferred at various time points to plates containing a quenching solution. The test compound concentration in the reaction mixture was determined with LC/MS/MS. Predicted clearance was calculated using the well-stirred liver model without protein restriction during incubation.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> X-ray Crystallography</h3><div class="NLM_p last">The crystallization and structure determination of PI3Kδ bound with <b>32</b> and with <b>34</b> were determined using methods described previously.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The PI3Kδ/<b>32</b> structure was refined to 2.85 Å resolution to an <i>R</i>-factor of 0.212 and an <i>R</i><sub>free</sub> of 0.306. The rms deviations from ideal bond distances and angles are 0.014 Å and 1.73°, respectively. The PI3Kδ/<b>34</b> structure was refined using data to 2.4 Å to an <i>R</i>-factor of 0.222 and an <i>R</i><sub>free</sub> of 0.290. The rms deviations from ideal bond distances and angles are 0.010 Å and 1.31°, respectively.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> DiscoveRx Screen</h3><div class="NLM_p last">Compound <b>52</b> was screened at 10 μM in the KINOMEscan (DiscoveRx, San Diego, CA) assay, and the results for the primary screen binding interactions are reported as “percent control”, where lower numbers indicate stronger hits in the matrix. See <a href="/doi/suppl/10.1021/acs.jmedchem.6b00213/suppl_file/jm6b00213_si_001.pdf" class="ext-link">Supporting Information</a> for assay results.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> Pharmacokinetics</h3><div class="NLM_p last">Pharmacokinetic studies for <b>52</b> were performed in female naive Lewis rats and non-naive beagle dogs (three animals per dosing route) following federal and Institutional Animal Care and Use Committee (IACUC) guidelines. Intravenous (iv) administration was dosed via infusion over 30 min. The intravenous dose for rats was formulated in a sterile solution of 30% PEG 400 (v/v) in water, while the intravenous dose for dogs was formulated in a sterile solution of 15% Captisol (w/v) in water. Oral dosing was administered by gavage. The oral dose for rats was formulated in a vehicle containing 30% PEG 400 (v/v) in water, while the oral dose for dogs was formulated in a vehicle of 5% ethanol, 55% PEG 400, and 40% citrate, pH 2. Blood samples were collected over a 24 h period postdose into Vacutainer tubes containing EDTA-K2. Plasma was isolated, and the concentration of the test compound in plasma was determined with LC/MS/MS after protein precipitation with acetonitrile. Noncompartmental pharmacokinetic analysis was performed on the plasma concentration–time data.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> Rat-Collagen-Induced Arthritis (CIA) Model</h3><div class="NLM_p last">The experiments were performed at Bolder BioPATH, Inc.<a onclick="showRef(event, 'cit20a cit20b'); return false;" href="javascript:void(0);" class="ref cit20a cit20b">(20a, 20b)</a> Female Lewis rats from Charles River (mean mass 180 g, (eight rats/group for arthritis, six rats/group for PK arm) were anesthetized with isoflurane and injected with 400 mL of Freund’s incomplete adjuvant (Sigma-Aldrich) containing 2 mg/mL porcine type II collagen (Chondrex) at two sites (200 mL per site) at the base of the tail on day 0 and then 100 mL in one site at the base of the tail on day 7. On day 10 (day 1 of arthritis), rats were randomized into treatment groups such that each group had approximately equal mean ankle caliper measurements. Oral dosing was performed (twice daily at 12 h intervals) for 7 days (study days 10–16) with vehicle (30% PEG400/70% 10 mM, pH 2.2 citrate buffer), <b>52</b> (0.34, 1.07, 4.6, or 10 mg/kg), or the reference compound dexamethasone (Dex, 0.03 mg/kg). Rats were euthanized on days 16–17 (arthritis days 7–8). Rats were weighed on study days 9–17. Caliper measurements of right and left ankle diameters were taken every day beginning on day 9 (day 0 of arthritis) and continuing through day 16. Ankle caliper measurements were made with a Digitrix II micrometer (Fowler & NSK). Baseline measurements were taken using one ankle with values rounded to 1000th of an inch. Measurements were confirmed as clinically normal (0.260–0.264 in.) by comparison with historical values for rats based on a range of body weights. Baseline measurements were then applied to both ankles, and these values remained with the animal so long as the ankle was clinically normal with good definition of all the ankle bones and no evidence of inflammation. Body weight change and ankle diameter area under the curve (AUC) were calculated from dosing initiation through study termination (study days 10–16). Interim PK blood sampling was performed on study days 12 and 16 (arthritis days 3 and 7) at 2, 4, 8, and 12 h. Efficacy evaluation was based on animal body masses, daily ankle caliper measurements, ankle diameters expressed as the area under the curve (AUC), terminal hind paw masses, and histopathologic evaluation of ankles and knees.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i79"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00213">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74658" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74658" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b00213" class="ext-link">10.1021/acs.jmedchem.6b00213</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Histopathology scoring criteria for rat CIA model, DiscoveRx primary screen data and selectivity scores for <b>52</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00213/suppl_file/jm6b00213_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00213/suppl_file/jm6b00213_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00213/suppl_file/jm6b00213_si_001.pdf">jm6b00213_si_001.pdf (144.6 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00213/suppl_file/jm6b00213_si_002.csv">jm6b00213_si_002.csv (3.63 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB code for idelalisib is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4XE0">4XE0</a>. PDB code for compound <b>32</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5I6U">5I6U</a>. PDB code for compound <b>34</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5I4U">5I4U</a>.</p><div class="testing" data-doi="10.1021/acs.jmedchem.6b00213" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52520" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52520" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leena Patel</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 199 E
Blaine Street, Seattle, Washington 98102, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Gilead Sciences,
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#dcb0b9b9b2bdf2acbda8b9b09cbbb5b0b9bdb8f2bfb3b1"><span class="__cf_email__" data-cfemail="e68a83838887c8968792838aa6818f8a838782c885898b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jayaraman Chandrasekhar</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 199 E
Blaine Street, Seattle, Washington 98102, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Gilead Sciences,
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jerry Evarts</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 199 E
Blaine Street, Seattle, Washington 98102, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Gilead Sciences,
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aaron C. Haran</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 199 E
Blaine Street, Seattle, Washington 98102, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Gilead Sciences,
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carmen Ip</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 199 E
Blaine Street, Seattle, Washington 98102, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Gilead Sciences,
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joshua A. Kaplan</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 199 E
Blaine Street, Seattle, Washington 98102, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Gilead Sciences,
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Musong Kim</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 199 E
Blaine Street, Seattle, Washington 98102, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Gilead Sciences,
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Koditek</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 199 E
Blaine Street, Seattle, Washington 98102, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Gilead Sciences,
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Latesh Lad</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 199 E
Blaine Street, Seattle, Washington 98102, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Gilead Sciences,
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eve-Irene Lepist</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 199 E
Blaine Street, Seattle, Washington 98102, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Gilead Sciences,
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mary E. McGrath</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 199 E
Blaine Street, Seattle, Washington 98102, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Gilead Sciences,
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nikolai Novikov</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 199 E
Blaine Street, Seattle, Washington 98102, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Gilead Sciences,
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephane Perreault</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 199 E
Blaine Street, Seattle, Washington 98102, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Gilead Sciences,
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kamal D. Puri</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 199 E
Blaine Street, Seattle, Washington 98102, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Gilead Sciences,
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John R. Somoza</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 199 E
Blaine Street, Seattle, Washington 98102, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Gilead Sciences,
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bart H. Steiner</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 199 E
Blaine Street, Seattle, Washington 98102, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Gilead Sciences,
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kirk L. Stevens</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 199 E
Blaine Street, Seattle, Washington 98102, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Gilead Sciences,
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph Therrien</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 199 E
Blaine Street, Seattle, Washington 98102, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Gilead Sciences,
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennifer Treiberg</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 199 E
Blaine Street, Seattle, Washington 98102, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Gilead Sciences,
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Armando G. Villaseñor</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 199 E
Blaine Street, Seattle, Washington 98102, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Gilead Sciences,
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arthur Yeung</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 199 E
Blaine Street, Seattle, Washington 98102, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Gilead Sciences,
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gary Phillips</span> - <span class="hlFld-Affiliation affiliation">Gilead
Sciences, Inc., 199 E
Blaine Street, Seattle, Washington 98102, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Gilead Sciences,
Inc., 333 Lakeside Drive, Foster City, California 94404, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s):The authors are employees of Gilead Sciences except for J.E. and K.D.P. who were employed at Gilead Sciences during this research. All authors are shareholders of Gilead Sciences.<br /></br></div></li></ul></div><div class="ack" id="ACK-d593e4091-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i83">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86645" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86645" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Scott A. Mitchell and Jennifer Loyer-Drew for thoughtful review of the manuscript.</p></div><div class="postAsapNotesSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="postAsapNotesSection">Note Added After ASAP Publication</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71576" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71576" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="first last">After this paper was published ASAP on March 29, 2016, ref 13 was replaced. The corrected version was reposted April 5, 2016</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i84" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i84"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i85" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i85"> Abbreviations Used</h2><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphoinositide 3-kinase</p></td></tr><tr><td class="NLM_term">Akt</td><td class="NLM_def"><p class="first last">protein kinase B</p></td></tr><tr><td class="NLM_term">BCR</td><td class="NLM_def"><p class="first last">B-cell receptor</p></td></tr><tr><td class="NLM_term">RA</td><td class="NLM_def"><p class="first last">rheumatoid arthritis</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr><tr><td class="NLM_term">hHeps</td><td class="NLM_def"><p class="first last">human hepatocytes</p></td></tr><tr><td class="NLM_term">AO</td><td class="NLM_def"><p class="first last">aldehyde oxidase</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">CIA</td><td class="NLM_def"><p class="first last">collagen-induced arthritis</p></td></tr><tr><td class="NLM_term">IgD</td><td class="NLM_def"><p class="first last">immunoglobulin D</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i86">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23806" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23806" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 20 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Engelman, J. A.</span><span> </span><span class="NLM_article-title">Targeting PI3K signalling in cancer: opportunities, challenges and limitations</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">550</span><span class="NLM_x">–</span> <span class="NLM_lpage">562</span><span class="refDoi"> DOI: 10.1038/nrc2664</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1038%2Fnrc2664" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=19629070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovFylsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=550-562&issue=8&author=J.+A.+Engelman&title=Targeting+PI3K+signalling+in+cancer%3A+opportunities%2C+challenges+and+limitations&doi=10.1038%2Fnrc2664"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting PI3K signalling in cancer: opportunities, challenges and limitations</span></div><div class="casAuthors">Engelman, Jeffrey A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">550-562</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There are ample genetic and lab. studies that suggest the PI3K-Akt pathway is vital to the growth and survival of cancer cells.  Inhibitors targeting this pathway are entering the clinic at a rapid pace.  In this Review, the therapeutic potential of drugs targeting PI3K-Akt signaling for the treatment of cancer is discussed.  I focus on the advantages and drawbacks of different treatment strategies for targeting this pathway, the cancers that might respond best to these therapies and the challenges and limitations that confront their clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCwdUnGEC20LVg90H21EOLACvtfcHk0liFS1fkSyeOxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovFylsrg%253D&md5=f0d4cc1fabf879e95f8b76e48cc9c1ad</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1038%2Fnrc2664&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2664%26sid%3Dliteratum%253Aachs%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26atitle%3DTargeting%2520PI3K%2520signalling%2520in%2520cancer%253A%2520opportunities%252C%2520challenges%2520and%2520limitations%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26issue%3D8%26spage%3D550%26epage%3D562%26doi%3D10.1038%2Fnrc2664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Witzig, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, M.</span><span> </span><span class="NLM_article-title">Signal transduction inhibitor therapy for lymphoma</span> <span class="citation_source-journal">Hematology A. Soc. Hemato. Educ. Program</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2010</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">270</span><span class="refDoi"> DOI: 10.1182/asheducation-2010.1.265</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1182%2Fasheducation-2010.1.265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=21239804" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2010&publication_year=2010&pages=265-270&author=T.+E.+Witzigauthor=M.+Gupta&title=Signal+transduction+inhibitor+therapy+for+lymphoma&doi=10.1182%2Fasheducation-2010.1.265"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1182%2Fasheducation-2010.1.265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fasheducation-2010.1.265%26sid%3Dliteratum%253Aachs%26aulast%3DWitzig%26aufirst%3DT.%2BE.%26aulast%3DGupta%26aufirst%3DM.%26atitle%3DSignal%2520transduction%2520inhibitor%2520therapy%2520for%2520lymphoma%26jtitle%3DHematology%2520A.%2520Soc.%2520Hemato.%2520Educ.%2520Program%26date%3D2010%26volume%3D2010%26spage%3D265%26epage%3D270%26doi%3D10.1182%2Fasheducation-2010.1.265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lannutti, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meadows, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herman, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashishian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrd, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyner, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loriaux, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deininger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druker, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puri, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulrich, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giese, N. A.</span><span> </span><span class="NLM_article-title">CAL-101, a p110delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">591</span><span class="NLM_x">–</span> <span class="NLM_lpage">594</span><span class="refDoi"> DOI: 10.1182/blood-2010-03-275305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1182%2Fblood-2010-03-275305" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2011&pages=591-594&issue=2&author=B.+J.+Lannuttiauthor=S.+A.+Meadowsauthor=S.+E.+Hermanauthor=A.+Kashishianauthor=B.+Steinerauthor=A.+J.+Johnsonauthor=J.+C.+Byrdauthor=J.+W.+Tynerauthor=M.+M.+Loriauxauthor=M.+Deiningerauthor=B.+J.+Drukerauthor=K.+D.+Puriauthor=R.+G.+Ulrichauthor=N.+A.+Giese&title=CAL-101%2C+a+p110delta+selective+phosphatidylinositol-3-kinase+inhibitor+for+the+treatment+of+B-cell+malignancies%2C+inhibits+PI3K+signaling+and+cellular+viability&doi=10.1182%2Fblood-2010-03-275305"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1182%2Fblood-2010-03-275305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2010-03-275305%26sid%3Dliteratum%253Aachs%26aulast%3DLannutti%26aufirst%3DB.%2BJ.%26aulast%3DMeadows%26aufirst%3DS.%2BA.%26aulast%3DHerman%26aufirst%3DS.%2BE.%26aulast%3DKashishian%26aufirst%3DA.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DJohnson%26aufirst%3DA.%2BJ.%26aulast%3DByrd%26aufirst%3DJ.%2BC.%26aulast%3DTyner%26aufirst%3DJ.%2BW.%26aulast%3DLoriaux%26aufirst%3DM.%2BM.%26aulast%3DDeininger%26aufirst%3DM.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DPuri%26aufirst%3DK.%2BD.%26aulast%3DUlrich%26aufirst%3DR.%2BG.%26aulast%3DGiese%26aufirst%3DN.%2BA.%26atitle%3DCAL-101%252C%2520a%2520p110delta%2520selective%2520phosphatidylinositol-3-kinase%2520inhibitor%2520for%2520the%2520treatment%2520of%2520B-cell%2520malignancies%252C%2520inhibits%2520PI3K%2520signaling%2520and%2520cellular%2520viability%26jtitle%3DBlood%26date%3D2011%26volume%3D117%26issue%3D2%26spage%3D591%26epage%3D594%26doi%3D10.1182%2Fblood-2010-03-275305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Meadows, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashishian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diehl, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Younes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lannutti, B. J.</span><span> </span><span class="NLM_article-title">PI3Kdelta inhibitor, GS-1101 (CAL-101), attenuates pathway signaling, induces apoptosis, and overcomes signals from the microenvironment in cellular models of Hodgkin lymphoma</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1897</span><span class="NLM_x">–</span> <span class="NLM_lpage">1900</span><span class="refDoi"> DOI: 10.1182/blood-2011-10-386763</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1182%2Fblood-2011-10-386763" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2012&pages=1897-1900&issue=8&author=S.+A.+Meadowsauthor=F.+Vegaauthor=A.+Kashishianauthor=D.+Johnsonauthor=V.+Diehlauthor=L.+L.+Millerauthor=A.+Younesauthor=B.+J.+Lannutti&title=PI3Kdelta+inhibitor%2C+GS-1101+%28CAL-101%29%2C+attenuates+pathway+signaling%2C+induces+apoptosis%2C+and+overcomes+signals+from+the+microenvironment+in+cellular+models+of+Hodgkin+lymphoma&doi=10.1182%2Fblood-2011-10-386763"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=10.1182%2Fblood-2011-10-386763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2011-10-386763%26sid%3Dliteratum%253Aachs%26aulast%3DMeadows%26aufirst%3DS.%2BA.%26aulast%3DVega%26aufirst%3DF.%26aulast%3DKashishian%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DD.%26aulast%3DDiehl%26aufirst%3DV.%26aulast%3DMiller%26aufirst%3DL.%2BL.%26aulast%3DYounes%26aufirst%3DA.%26aulast%3DLannutti%26aufirst%3DB.%2BJ.%26atitle%3DPI3Kdelta%2520inhibitor%252C%2520GS-1101%2520%2528CAL-101%2529%252C%2520attenuates%2520pathway%2520signaling%252C%2520induces%2520apoptosis%252C%2520and%2520overcomes%2520signals%2520from%2520the%2520microenvironment%2520in%2520cellular%2520models%2520of%2520Hodgkin%2520lymphoma%26jtitle%3DBlood%26date%3D2012%26volume%3D119%26issue%3D8%26spage%3D1897%26epage%3D1900%26doi%3D10.1182%2Fblood-2011-10-386763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lemmon, M. A.</span><span> </span><span class="NLM_article-title">Membrane recognition by phospholipid-binding domains</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">111</span><span class="refDoi"> DOI: 10.1038/nrm2328</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1038%2Fnrm2328" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=18216767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovFOntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=99-111&issue=2&author=M.+A.+Lemmon&title=Membrane+recognition+by+phospholipid-binding+domains&doi=10.1038%2Fnrm2328"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane recognition by phospholipid-binding domains</span></div><div class="casAuthors">Lemmon, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-111</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Many different globular domains bind to the surfaces of cellular membranes, or to specific phospholipid components in these membranes, and this binding is often tightly regulated.  Examples include pleckstrin homol. and C2 domains, which are among the largest domain families in the human proteome.  Crystal structures, binding studies, and analyses of subcellular localization have provided much insight into how members of this diverse group of domains bind to membranes, what features they recognize and how binding is controlled.  A full appreciation of these processes is crucial for understanding how protein localization and membrane topog. and trafficking are regulated in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM8KKjaRpyL7Vg90H21EOLACvtfcHk0ljKqQyRZS-9Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovFOntQ%253D%253D&md5=dd633108d380d534c7af57d31cfb2bd1</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1038%2Fnrm2328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2328%26sid%3Dliteratum%253Aachs%26aulast%3DLemmon%26aufirst%3DM.%2BA.%26atitle%3DMembrane%2520recognition%2520by%2520phospholipid-binding%2520domains%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2008%26volume%3D9%26issue%3D2%26spage%3D99%26epage%3D111%26doi%3D10.1038%2Fnrm2328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bilancio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okkenhaug, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camps, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emery, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruckle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanhaesebroeck, B.</span><span> </span><span class="NLM_article-title">Key role of the p110delta isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110delta function in B cells</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">642</span><span class="NLM_x">–</span> <span class="NLM_lpage">650</span><span class="refDoi"> DOI: 10.1182/blood-2005-07-3041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1182%2Fblood-2005-07-3041" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2006&pages=642-650&issue=2&author=A.+Bilancioauthor=K.+Okkenhaugauthor=M.+Campsauthor=J.+L.+Emeryauthor=T.+Ruckleauthor=C.+Rommelauthor=B.+Vanhaesebroeck&title=Key+role+of+the+p110delta+isoform+of+PI3K+in+B-cell+antigen+and+IL-4+receptor+signaling%3A+comparative+analysis+of+genetic+and+pharmacologic+interference+with+p110delta+function+in+B+cells&doi=10.1182%2Fblood-2005-07-3041"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1182%2Fblood-2005-07-3041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2005-07-3041%26sid%3Dliteratum%253Aachs%26aulast%3DBilancio%26aufirst%3DA.%26aulast%3DOkkenhaug%26aufirst%3DK.%26aulast%3DCamps%26aufirst%3DM.%26aulast%3DEmery%26aufirst%3DJ.%2BL.%26aulast%3DRuckle%26aufirst%3DT.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DVanhaesebroeck%26aufirst%3DB.%26atitle%3DKey%2520role%2520of%2520the%2520p110delta%2520isoform%2520of%2520PI3K%2520in%2520B-cell%2520antigen%2520and%2520IL-4%2520receptor%2520signaling%253A%2520comparative%2520analysis%2520of%2520genetic%2520and%2520pharmacologic%2520interference%2520with%2520p110delta%2520function%2520in%2520B%2520cells%26jtitle%3DBlood%26date%3D2006%26volume%3D107%26issue%3D2%26spage%3D642%26epage%3D650%26doi%3D10.1182%2Fblood-2005-07-3041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Chantry, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vojtek, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashishian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holtzman, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoekstra, M. F.</span><span> </span><span class="NLM_article-title">p110δ, a novel phosphatidylinositol 3-kinase catalytic subunit that associates with p85 and is expressed predominantly in leukocytes</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x"> (</span><span class="NLM_issue">31</span><span class="NLM_x">) </span> <span class="NLM_fpage">19236</span><span class="NLM_x">–</span> <span class="NLM_lpage">19241</span><span class="refDoi"> DOI: 10.1074/jbc.272.31.19236</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1074%2Fjbc.272.31.19236" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=19236-19241&issue=31&author=D.+Chantryauthor=A.+Vojtekauthor=A.+Kashishianauthor=D.+A.+Holtzmanauthor=C.+Woodauthor=P.+W.+Grayauthor=J.+A.+Cooperauthor=M.+F.+Hoekstra&title=p110%CE%B4%2C+a+novel+phosphatidylinositol+3-kinase+catalytic+subunit+that+associates+with+p85+and+is+expressed+predominantly+in+leukocytes&doi=10.1074%2Fjbc.272.31.19236"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.31.19236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.31.19236%26sid%3Dliteratum%253Aachs%26aulast%3DChantry%26aufirst%3DD.%26aulast%3DVojtek%26aufirst%3DA.%26aulast%3DKashishian%26aufirst%3DA.%26aulast%3DHoltzman%26aufirst%3DD.%2BA.%26aulast%3DWood%26aufirst%3DC.%26aulast%3DGray%26aufirst%3DP.%2BW.%26aulast%3DCooper%26aufirst%3DJ.%2BA.%26aulast%3DHoekstra%26aufirst%3DM.%2BF.%26atitle%3Dp110%25CE%25B4%252C%2520a%2520novel%2520phosphatidylinositol%25203-kinase%2520catalytic%2520subunit%2520that%2520associates%2520with%2520p85%2520and%2520is%2520expressed%2520predominantly%2520in%2520leukocytes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26issue%3D31%26spage%3D19236%26epage%3D19241%26doi%3D10.1074%2Fjbc.272.31.19236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Bernal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastore, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asgary, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesarman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liou, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schattner, E. J.</span><span> </span><span class="NLM_article-title">Survival of leukemic B cells promoted by engagement of the antigen receptor</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">3050</span><span class="NLM_x">–</span> <span class="NLM_lpage">3057</span><span class="refDoi"> DOI: 10.1182/blood.V98.10.3050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1182%2Fblood.V98.10.3050" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=3050-3057&issue=10&author=A.+Bernalauthor=R.+D.+Pastoreauthor=Z.+Asgaryauthor=S.+A.+Kellerauthor=E.+Cesarmanauthor=H.+C.+Liouauthor=E.+J.+Schattner&title=Survival+of+leukemic+B+cells+promoted+by+engagement+of+the+antigen+receptor&doi=10.1182%2Fblood.V98.10.3050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1182%2Fblood.V98.10.3050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood.V98.10.3050%26sid%3Dliteratum%253Aachs%26aulast%3DBernal%26aufirst%3DA.%26aulast%3DPastore%26aufirst%3DR.%2BD.%26aulast%3DAsgary%26aufirst%3DZ.%26aulast%3DKeller%26aufirst%3DS.%2BA.%26aulast%3DCesarman%26aufirst%3DE.%26aulast%3DLiou%26aufirst%3DH.%2BC.%26aulast%3DSchattner%26aufirst%3DE.%2BJ.%26atitle%3DSurvival%2520of%2520leukemic%2520B%2520cells%2520promoted%2520by%2520engagement%2520of%2520the%2520antigen%2520receptor%26jtitle%3DBlood%26date%3D2001%26volume%3D98%26issue%3D10%26spage%3D3050%26epage%3D3057%26doi%3D10.1182%2Fblood.V98.10.3050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Bartok, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bugbee, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Firestein, G. S.</span><span> </span><span class="NLM_article-title">PI3 kinase δ is a key regulator of synoviocyte function in rheumatoid arthritis</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">180</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1906</span><span class="NLM_x">–</span> <span class="NLM_lpage">1916</span><span class="refDoi"> DOI: 10.1016/j.ajpath.2012.01.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1016%2Fj.ajpath.2012.01.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=22433439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsF2ksbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2012&pages=1906-1916&issue=5&author=B.+Bartokauthor=D.+L.+Boyleauthor=Y.+Liuauthor=P.+Renauthor=S.+T.+Ballauthor=W.+D.+Bugbeeauthor=C.+Rommelauthor=G.+S.+Firestein&title=PI3+kinase+%CE%B4+is+a+key+regulator+of+synoviocyte+function+in+rheumatoid+arthritis&doi=10.1016%2Fj.ajpath.2012.01.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">PI3 kinase δ is a key regulator of synoviocyte function in rheumatoid arthritis</span></div><div class="casAuthors">Bartok, Beatrix; Boyle, David L.; Liu, Yi; Ren, Pingda; Ball, Scott T.; Bugbee, William D.; Rommel, Christian; Firestein, Gary S.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1906-1916</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Class I phosphoinositide 3 kinase (PI3K) δ is a promising therapeutic target for rheumatoid arthritis (RA) because of its contribution to leukocyte biol.  However, its contribution in fibroblasts has not been studied as a mechanism that contributes to efficacy.  We investigated the expression and function of PI3Kδ in synovium and cultured fibroblast-like synoviocytes (FLS).  Immunohistochem. demonstrated that PI3Kδ is highly expressed in RA synovium, esp. in the synovial lining.  Using quant. PCR and Western blot anal., we found that PI3Kδ mRNA and protein expression is higher in RA than in osteoarthritis (OA) synovium.  PI3Kδ was also expressed in cultured FLS, along with PI3Kα and PI3Kβ, whereas PI3Kγ was not detectable.  PI3Kδ mRNA expression was selectively induced by inflammatory cytokines tumor necrosis factor (TNF) and interleukin-1 (IL-1) but not by growth factors platelet-derived growth factor (PDGF) and transforming growth factor β (TGFβ).  The use of inhibitors that block individual PI3K isoforms, including the novel selective PI3Kδ inhibitor EVK007, showed that PI3Kδ is required for PDGF- and TNF-induced Akt activation.  PI3Kδ inhibition also diminished PDGF-mediated synoviocyte growth and sensitized cells to H2O2-induced apoptosis.  These data are the first documentation of increased PI3Kδ expression in both RA synovium and cultured synoviocytes.  Furthermore, these are the first data demonstrating that PI3Kδ is a major regulator of PDGF-mediated fibroblast growth and survival via Akt.  Thus, targeting PI3Kδ in RA could modulate synoviocyte function via anti-inflammatory and disease-altering mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjfN_H4ikqvrVg90H21EOLACvtfcHk0lgp7xU--uRGyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsF2ksbs%253D&md5=60cbfbf9ba761bb351eee34612ccf45b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2012.01.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2012.01.030%26sid%3Dliteratum%253Aachs%26aulast%3DBartok%26aufirst%3DB.%26aulast%3DBoyle%26aufirst%3DD.%2BL.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DRen%26aufirst%3DP.%26aulast%3DBall%26aufirst%3DS.%2BT.%26aulast%3DBugbee%26aufirst%3DW.%2BD.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DFirestein%26aufirst%3DG.%2BS.%26atitle%3DPI3%2520kinase%2520%25CE%25B4%2520is%2520a%2520key%2520regulator%2520of%2520synoviocyte%2520function%2520in%2520rheumatoid%2520arthritis%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2012%26volume%3D180%26issue%3D5%26spage%3D1906%26epage%3D1916%26doi%3D10.1016%2Fj.ajpath.2012.01.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Randis, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puri, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diacovo, T. G.</span><span> </span><span class="NLM_article-title">Role of PI3Kδ and PI3Kγ in inflammatory arthritis and tissue localization of neutrophils</span> <span class="citation_source-journal">Eur. J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1215</span><span class="NLM_x">–</span> <span class="NLM_lpage">1224</span><span class="refDoi"> DOI: 10.1002/eji.200838266</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1002%2Feji.200838266" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2008&pages=1215-1224&issue=5&author=T.+M.+Randisauthor=K.+D.+Puriauthor=H.+Zhouauthor=T.+G.+Diacovo&title=Role+of+PI3K%CE%B4+and+PI3K%CE%B3+in+inflammatory+arthritis+and+tissue+localization+of+neutrophils&doi=10.1002%2Feji.200838266"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Feji.200838266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Feji.200838266%26sid%3Dliteratum%253Aachs%26aulast%3DRandis%26aufirst%3DT.%2BM.%26aulast%3DPuri%26aufirst%3DK.%2BD.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DDiacovo%26aufirst%3DT.%2BG.%26atitle%3DRole%2520of%2520PI3K%25CE%25B4%2520and%2520PI3K%25CE%25B3%2520in%2520inflammatory%2520arthritis%2520and%2520tissue%2520localization%2520of%2520neutrophils%26jtitle%3DEur.%2520J.%2520Immunol.%26date%3D2008%26volume%3D38%26issue%3D5%26spage%3D1215%26epage%3D1224%26doi%3D10.1002%2Feji.200838266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Ali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilancio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearce, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilfillan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tkaczyk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuehn, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giddings, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peskett, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruce, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okkenhaug, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanhaesebroeck, B.</span><span> </span><span class="NLM_article-title">Essential role for the p110delta phosphoinositide 3-kinase in the allergic response</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">431</span><span class="NLM_x"> (</span><span class="NLM_issue">7011</span><span class="NLM_x">) </span> <span class="NLM_fpage">1007</span><span class="NLM_x">–</span> <span class="NLM_lpage">1011</span><span class="refDoi"> DOI: 10.1038/nature02991</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1038%2Fnature02991" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=431&publication_year=2004&pages=1007-1011&issue=7011&author=K.+Aliauthor=A.+Bilancioauthor=M.+Thomasauthor=W.+Pearceauthor=A.+M.+Gilfillanauthor=C.+Tkaczykauthor=N.+Kuehnauthor=A.+Grayauthor=J.+Giddingsauthor=E.+Peskettauthor=R.+Foxauthor=I.+Bruceauthor=C.+Walkerauthor=C.+Sawyerauthor=K.+Okkenhaugauthor=P.+Finanauthor=B.+Vanhaesebroeck&title=Essential+role+for+the+p110delta+phosphoinositide+3-kinase+in+the+allergic+response&doi=10.1038%2Fnature02991"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature02991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02991%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DK.%26aulast%3DBilancio%26aufirst%3DA.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DPearce%26aufirst%3DW.%26aulast%3DGilfillan%26aufirst%3DA.%2BM.%26aulast%3DTkaczyk%26aufirst%3DC.%26aulast%3DKuehn%26aufirst%3DN.%26aulast%3DGray%26aufirst%3DA.%26aulast%3DGiddings%26aufirst%3DJ.%26aulast%3DPeskett%26aufirst%3DE.%26aulast%3DFox%26aufirst%3DR.%26aulast%3DBruce%26aufirst%3DI.%26aulast%3DWalker%26aufirst%3DC.%26aulast%3DSawyer%26aufirst%3DC.%26aulast%3DOkkenhaug%26aufirst%3DK.%26aulast%3DFinan%26aufirst%3DP.%26aulast%3DVanhaesebroeck%26aufirst%3DB.%26atitle%3DEssential%2520role%2520for%2520the%2520p110delta%2520phosphoinositide%25203-kinase%2520in%2520the%2520allergic%2520response%26jtitle%3DNature%26date%3D2004%26volume%3D431%26issue%3D7011%26spage%3D1007%26epage%3D1011%26doi%3D10.1038%2Fnature02991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Puri, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doggett, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douangpanya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tino, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clayton, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayflick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diacovo, T. G.</span><span> </span><span class="NLM_article-title">Mechanisms and implications of phosphoinositide 3-kinase delta in promoting neutrophil trafficking into inflamed tissue</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">3448</span><span class="NLM_x">–</span> <span class="NLM_lpage">3456</span><span class="refDoi"> DOI: 10.1182/blood-2003-05-1667</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1182%2Fblood-2003-05-1667" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2004&pages=3448-3456&issue=9&author=K.+D.+Puriauthor=T.+A.+Doggettauthor=J.+Douangpanyaauthor=Y.+Houauthor=W.+T.+Tinoauthor=T.+Wilsonauthor=T.+Grafauthor=E.+Claytonauthor=M.+Turnerauthor=J.+S.+Hayflickauthor=T.+G.+Diacovo&title=Mechanisms+and+implications+of+phosphoinositide+3-kinase+delta+in+promoting+neutrophil+trafficking+into+inflamed+tissue&doi=10.1182%2Fblood-2003-05-1667"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1182%2Fblood-2003-05-1667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2003-05-1667%26sid%3Dliteratum%253Aachs%26aulast%3DPuri%26aufirst%3DK.%2BD.%26aulast%3DDoggett%26aufirst%3DT.%2BA.%26aulast%3DDouangpanya%26aufirst%3DJ.%26aulast%3DHou%26aufirst%3DY.%26aulast%3DTino%26aufirst%3DW.%2BT.%26aulast%3DWilson%26aufirst%3DT.%26aulast%3DGraf%26aufirst%3DT.%26aulast%3DClayton%26aufirst%3DE.%26aulast%3DTurner%26aufirst%3DM.%26aulast%3DHayflick%26aufirst%3DJ.%2BS.%26aulast%3DDiacovo%26aufirst%3DT.%2BG.%26atitle%3DMechanisms%2520and%2520implications%2520of%2520phosphoinositide%25203-kinase%2520delta%2520in%2520promoting%2520neutrophil%2520trafficking%2520into%2520inflamed%2520tissue%26jtitle%3DBlood%26date%3D2004%26volume%3D103%26issue%3D9%26spage%3D3448%26epage%3D3456%26doi%3D10.1182%2Fblood-2003-05-1667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Soond, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjorgo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moltu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dale, V. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patton, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torgersen, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galleway, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Twomey, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaston, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasken, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunyard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okkenhaug, K.</span><span> </span><span class="NLM_article-title">PI3K p110delta regulates T-cell cytokine production during primary and secondary immune responses in mice and humans</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">2203</span><span class="NLM_x">–</span> <span class="NLM_lpage">2213</span><span class="refDoi"> DOI: 10.1182/blood-2009-07-232330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1182%2Fblood-2009-07-232330" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2010&pages=2203-2213&issue=11&author=D.+R.+Soondauthor=E.+Bjorgoauthor=K.+Moltuauthor=V.+Q.+Daleauthor=D.+T.+Pattonauthor=K.+M.+Torgersenauthor=F.+Gallewayauthor=B.+Twomeyauthor=J.+Clarkauthor=J.+S.+Gastonauthor=K.+Taskenauthor=P.+Bunyardauthor=K.+Okkenhaug&title=PI3K+p110delta+regulates+T-cell+cytokine+production+during+primary+and+secondary+immune+responses+in+mice+and+humans&doi=10.1182%2Fblood-2009-07-232330"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1182%2Fblood-2009-07-232330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2009-07-232330%26sid%3Dliteratum%253Aachs%26aulast%3DSoond%26aufirst%3DD.%2BR.%26aulast%3DBjorgo%26aufirst%3DE.%26aulast%3DMoltu%26aufirst%3DK.%26aulast%3DDale%26aufirst%3DV.%2BQ.%26aulast%3DPatton%26aufirst%3DD.%2BT.%26aulast%3DTorgersen%26aufirst%3DK.%2BM.%26aulast%3DGalleway%26aufirst%3DF.%26aulast%3DTwomey%26aufirst%3DB.%26aulast%3DClark%26aufirst%3DJ.%26aulast%3DGaston%26aufirst%3DJ.%2BS.%26aulast%3DTasken%26aufirst%3DK.%26aulast%3DBunyard%26aufirst%3DP.%26aulast%3DOkkenhaug%26aufirst%3DK.%26atitle%3DPI3K%2520p110delta%2520regulates%2520T-cell%2520cytokine%2520production%2520during%2520primary%2520and%2520secondary%2520immune%2520responses%2520in%2520mice%2520and%2520humans%26jtitle%3DBlood%26date%3D2010%26volume%3D115%26issue%3D11%26spage%3D2203%26epage%3D2213%26doi%3D10.1182%2Fblood-2009-07-232330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Somoza, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koditek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villasenor, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novikov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liclican, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagpacan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papalia, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lad, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrath, M. E.</span><span> </span><span class="NLM_article-title">Structural, biochemical, and biophysical characterization of idelalisib binding to phosphoinositide 3-kinase δ</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">8439</span><span class="NLM_x">–</span> <span class="NLM_lpage">8446</span><span class="refDoi"> DOI: 10.1074/jbc.M114.634683</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1074%2Fjbc.M114.634683" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=8439-8446&issue=13&author=J.+R.+Somozaauthor=D.+Koditekauthor=A.+G.+Villasenorauthor=N.+Novikovauthor=M.+H.+Wongauthor=A.+Liclicanauthor=W.+Xingauthor=L.+Lagpacanauthor=R.+Wangauthor=B.+E.+Schultzauthor=G.+A.+Papaliaauthor=D.+Samuelauthor=L.+Ladauthor=M.+E.+McGrath&title=Structural%2C+biochemical%2C+and+biophysical+characterization+of+idelalisib+binding+to+phosphoinositide+3-kinase+%CE%B4&doi=10.1074%2Fjbc.M114.634683"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.634683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.634683%26sid%3Dliteratum%253Aachs%26aulast%3DSomoza%26aufirst%3DJ.%2BR.%26aulast%3DKoditek%26aufirst%3DD.%26aulast%3DVillasenor%26aufirst%3DA.%2BG.%26aulast%3DNovikov%26aufirst%3DN.%26aulast%3DWong%26aufirst%3DM.%2BH.%26aulast%3DLiclican%26aufirst%3DA.%26aulast%3DXing%26aufirst%3DW.%26aulast%3DLagpacan%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DSchultz%26aufirst%3DB.%2BE.%26aulast%3DPapalia%26aufirst%3DG.%2BA.%26aulast%3DSamuel%26aufirst%3DD.%26aulast%3DLad%26aufirst%3DL.%26aulast%3DMcGrath%26aufirst%3DM.%2BE.%26atitle%3DStructural%252C%2520biochemical%252C%2520and%2520biophysical%2520characterization%2520of%2520idelalisib%2520binding%2520to%2520phosphoinositide%25203-kinase%2520%25CE%25B4%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26issue%3D13%26spage%3D8439%26epage%3D8446%26doi%3D10.1074%2Fjbc.M114.634683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Berndt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houseman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacold, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorrec, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hon, W.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaillard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruckle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. L.</span><span> </span><span class="NLM_article-title">The p110δ crystal structure uncovers mechanisms for selectivity and potency of novel PI3K inhibitors</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span><span class="refDoi"> DOI: 10.1038/nchembio.293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1038%2Fnchembio.293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=20081827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvFGrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=117-124&issue=2&author=A.+Berndtauthor=S.+Millerauthor=O.+Williamsauthor=D.+D.+Leauthor=B.+T.+Housemanauthor=J.+I.+Pacoldauthor=F.+Gorrecauthor=W.-C.+Honauthor=Y.+Liuauthor=C.+Rommelauthor=P.+Gaillardauthor=T.+Ruckleauthor=M.+K.+Schwarzauthor=K.+M.+Shokatauthor=J.+P.+Shawauthor=R.+L.+Williams&title=The+p110%CE%B4+crystal+structure+uncovers+mechanisms+for+selectivity+and+potency+of+novel+PI3K+inhibitors&doi=10.1038%2Fnchembio.293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors</span></div><div class="casAuthors">Berndt, Alex; Miller, Simon; Williams, Olusegun; Le, Daniel D.; Houseman, Benjamin T.; Pacold, Joseph I.; Gorrec, Fabrice; Hon, Wai-Ching; Liu, Yi; Rommel, Christian; Gaillard, Pascale; Rueckle, Thomas; Schwarz, Matthias K.; Shokat, Kevan M.; Shaw, Jeffrey P.; Williams, Roger L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">117-124</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Deregulation of the phosphoinositide-3-OH kinase (PI(3)K) pathway has been implicated in numerous pathologies including cancer, diabetes, thrombosis, rheumatoid arthritis, and asthma.  Recently, small-mol. and ATP-competitive PI(3)K inhibitors with a wide range of selectivities have entered clin. development.  To understand the mechanisms underlying the isoform selectivity of these inhibitors, we developed a new expression strategy that enabled us to det. to our knowledge the first crystal structure of the catalytic subunit of the class IA PI(3)K p110δ.  Structures of this enzyme in complex with a broad panel of isoform- and pan-selective class I PI(3)K inhibitors reveal that selectivity toward p110δ can be achieved by exploiting its conformational flexibility and the sequence diversity of active site residues that do not contact ATP.  We have used these observations to rationalize and synthesize highly selective inhibitors for p110δ with greatly improved potencies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL8d01cEl_y7Vg90H21EOLACvtfcHk0lg9IzHfjPWkTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvFGrsw%253D%253D&md5=8a0ce73ab8ca88ea9a48a2cb7fdb1975</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.293%26sid%3Dliteratum%253Aachs%26aulast%3DBerndt%26aufirst%3DA.%26aulast%3DMiller%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DO.%26aulast%3DLe%26aufirst%3DD.%2BD.%26aulast%3DHouseman%26aufirst%3DB.%2BT.%26aulast%3DPacold%26aufirst%3DJ.%2BI.%26aulast%3DGorrec%26aufirst%3DF.%26aulast%3DHon%26aufirst%3DW.-C.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DGaillard%26aufirst%3DP.%26aulast%3DRuckle%26aufirst%3DT.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DShaw%26aufirst%3DJ.%2BP.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26atitle%3DThe%2520p110%25CE%25B4%2520crystal%2520structure%2520uncovers%2520mechanisms%2520for%2520selectivity%2520and%2520potency%2520of%2520novel%2520PI3K%2520inhibitors%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26issue%3D2%26spage%3D117%26epage%3D124%26doi%3D10.1038%2Fnchembio.293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunder, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldenberg, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loewith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokoe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">A pharmacological map of the PI3-K family defines a role for p110α in insulin signaling</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">733</span><span class="NLM_x">–</span> <span class="NLM_lpage">747</span><span class="refDoi"> DOI: 10.1016/j.cell.2006.03.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1016%2Fj.cell.2006.03.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=16647110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=1%3ACAS%3A528%3ADC%252BD28XltlSkt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2006&pages=733-747&issue=4&author=Z.+A.+Knightauthor=B.+Gonzalezauthor=M.+E.+Feldmanauthor=E.+R.+Zunderauthor=D.+D.+Goldenbergauthor=O.+Williamsauthor=R.+Loewithauthor=D.+Stokoeauthor=A.+Ballaauthor=B.+Tothauthor=T.+Ballaauthor=W.+A.+Weissauthor=R.+L.+Williamsauthor=K.+M.+Shokat&title=A+pharmacological+map+of+the+PI3-K+family+defines+a+role+for+p110%CE%B1+in+insulin+signaling&doi=10.1016%2Fj.cell.2006.03.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">A pharmacological map of the PI3-K family defines a role for p110α in insulin signaling</span></div><div class="casAuthors">Knight, Zachary A.; Gonzalez, Beatriz; Feldman, Morri E.; Zunder, Eli R.; Goldenberg, David D.; Williams, Olusegun; Loewith, Robbie; Stokoe, David; Balla, Andras; Toth, Balazs; Balla, Tamas; Weiss, William A.; Williams, Roger L.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">733-747</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Phosphoinositide 3-kinases (PI3-Ks) are an important emerging class of drug targets, but the unique roles of PI3-K isoforms remain poorly defined.  We describe here an approach to pharmacol. interrogate the PI3-K family.  A chem. diverse panel of PI3-K inhibitors was synthesized, and their target selectivity was biochem. enumerated, revealing cryptic homologies across targets and chemotypes.  Crystal structures of three inhibitors bound to p110γ identify a conformationally mobile region that is uniquely exploited by selective compds.  This chem. array was then used to define the PI3-K isoforms required for insulin signaling.  We find that p110α is the primary insulin-responsive PI3-K in cultured cells, whereas p110β is dispensable but sets a phenotypic threshold for p110α activity.  Compds. targeting p110α block the acute effects of insulin treatment in vivo, whereas a p110β inhibitor has no effect.  These results illustrate systematic target validation using a matrix of inhibitors that span a protein family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrozjvOeMXP3bVg90H21EOLACvtfcHk0liOahbDRhK6Fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltlSkt7o%253D&md5=b95a8cb433927ff9a75b33fc4ac2c8a0</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.03.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.03.035%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DGonzalez%26aufirst%3DB.%26aulast%3DFeldman%26aufirst%3DM.%2BE.%26aulast%3DZunder%26aufirst%3DE.%2BR.%26aulast%3DGoldenberg%26aufirst%3DD.%2BD.%26aulast%3DWilliams%26aufirst%3DO.%26aulast%3DLoewith%26aufirst%3DR.%26aulast%3DStokoe%26aufirst%3DD.%26aulast%3DBalla%26aufirst%3DA.%26aulast%3DToth%26aufirst%3DB.%26aulast%3DBalla%26aufirst%3DT.%26aulast%3DWeiss%26aufirst%3DW.%2BA.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DA%2520pharmacological%2520map%2520of%2520the%2520PI3-K%2520family%2520defines%2520a%2520role%2520for%2520p110%25CE%25B1%2520in%2520insulin%2520signaling%26jtitle%3DCell%26date%3D2006%26volume%3D125%26issue%3D4%26spage%3D733%26epage%3D747%26doi%3D10.1016%2Fj.cell.2006.03.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Chemically targeting the PI3K family</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">245</span><span class="NLM_x">–</span> <span class="NLM_lpage">249</span><span class="refDoi"> DOI: 10.1042/BST0350245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1042%2FBST0350245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=17371250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjt1Wrsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=245-249&issue=2&author=Z.+A.+Knightauthor=K.+M.+Shokat&title=Chemically+targeting+the+PI3K+family&doi=10.1042%2FBST0350245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">Chemically targeting the PI3K family</span></div><div class="casAuthors">Knight, Z. A.; Shokat, K. M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">245-249</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  PI3K (phosphoinositide 3-kinase) is a key regulator of cell growth, metab., and survival.  The frequent activation of the PI3K pathway in cancer has stimulated widespread interest in identifying potent and selective inhibitors of PI3K isoforms.  The present paper highlights recent progress in identifying such mols. and the challenges that remain for efforts to pharmacol. target the PI3K family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtmivxnuTfQ7Vg90H21EOLACvtfcHk0liOahbDRhK6Fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjt1Wrsb4%253D&md5=b7243ad076ba15f65214acc8a3b09d65</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1042%2FBST0350245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0350245%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DChemically%2520targeting%2520the%2520PI3K%2520family%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2007%26volume%3D35%26issue%3D2%26spage%3D245%26epage%3D249%26doi%3D10.1042%2FBST0350245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Flinn, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horwitz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Younes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahl, B.</span><span> </span><span class="NLM_article-title">Clinical safety and activity in a phase 1 trial of IPI-145, a potent inhibitor of phosphoinositide-3-kinase (δ/γ), in patients with advanced hematologic malignancies</span> <span class="citation_source-journal">Blood (ASH Annual Meeting Abstracts)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">3663</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=3663&author=I.+Flinnauthor=S.+Horwitzauthor=M.+Patelauthor=A.+Younesauthor=J.+Porterauthor=J.+Sweeneyauthor=K.+Allenauthor=P.+Kellyauthor=B.+Kahl&title=Clinical+safety+and+activity+in+a+phase+1+trial+of+IPI-145%2C+a+potent+inhibitor+of+phosphoinositide-3-kinase+%28%CE%B4%2F%CE%B3%29%2C+in+patients+with+advanced+hematologic+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFlinn%26aufirst%3DI.%26aulast%3DHorwitz%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DYounes%26aufirst%3DA.%26aulast%3DPorter%26aufirst%3DJ.%26aulast%3DSweeney%26aufirst%3DJ.%26aulast%3DAllen%26aufirst%3DK.%26aulast%3DKelly%26aufirst%3DP.%26aulast%3DKahl%26aufirst%3DB.%26atitle%3DClinical%2520safety%2520and%2520activity%2520in%2520a%2520phase%25201%2520trial%2520of%2520IPI-145%252C%2520a%2520potent%2520inhibitor%2520of%2520phosphoinositide-3-kinase%2520%2528%25CE%25B4%252F%25CE%25B3%2529%252C%2520in%2520patients%2520with%2520advanced%2520hematologic%2520malignancies%26jtitle%3DBlood%2520%2528ASH%2520Annual%2520Meeting%2520Abstracts%2529%26date%3D2012%26volume%3D120%26spage%3D3663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Cushing, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardozo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duquette, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Lopez de Turiso, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henne, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarter, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGee, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">San Miguel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pattaropong, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettus, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichelt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rzasa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seganish, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasker, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wannberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whoriskey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zalameda, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metz, D. P.</span><span> </span><span class="NLM_article-title">Discovery and in Vivo Evaluation of (<i>S</i>)-<i>N</i>-(1-(7-Fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9<i>H</i>-purin-6-amine (AMG319) and Related PI3Kδ Inhibitors for Inflammation and Autoimmune Disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">480</span><span class="NLM_x">–</span> <span class="NLM_lpage">511</span><span class="refDoi"> DOI: 10.1021/jm501624r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501624r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=480-511&issue=1&author=T.+D.+Cushingauthor=X.+Haoauthor=Y.+Shinauthor=K.+Andrewsauthor=M.+Brownauthor=M.+Cardozoauthor=Y.+Chenauthor=J.+Duquetteauthor=B.+Fisherauthor=F.+Gonzalez-Lopez+de+Turisoauthor=X.+Heauthor=K.+R.+Henneauthor=Y.-L.+Huauthor=R.+Hungateauthor=M.+G.+Johnsonauthor=R.+C.+Kellyauthor=B.+Lucasauthor=J.+D.+McCarterauthor=L.+R.+McGeeauthor=J.+C.+Medinaauthor=T.+San+Miguelauthor=D.+Mohnauthor=V.+Pattaropongauthor=L.+H.+Pettusauthor=A.+Reicheltauthor=R.+M.+Rzasaauthor=J.+Seganishauthor=A.+S.+Taskerauthor=R.+C.+Wahlauthor=S.+Wannbergauthor=D.+A.+Whittingtonauthor=J.+Whoriskeyauthor=G.+Yuauthor=L.+Zalamedaauthor=D.+Zhangauthor=D.+P.+Metz&title=Discovery+and+in+Vivo+Evaluation+of+%28S%29-N-%281-%287-Fluoro-2-%28pyridin-2-yl%29quinolin-3-yl%29ethyl%29-9H-purin-6-amine+%28AMG319%29+and+Related+PI3K%CE%B4+Inhibitors+for+Inflammation+and+Autoimmune+Disease&doi=10.1021%2Fjm501624r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm501624r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501624r%26sid%3Dliteratum%253Aachs%26aulast%3DCushing%26aufirst%3DT.%2BD.%26aulast%3DHao%26aufirst%3DX.%26aulast%3DShin%26aufirst%3DY.%26aulast%3DAndrews%26aufirst%3DK.%26aulast%3DBrown%26aufirst%3DM.%26aulast%3DCardozo%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DDuquette%26aufirst%3DJ.%26aulast%3DFisher%26aufirst%3DB.%26aulast%3DGonzalez-Lopez%2Bde%2BTuriso%26aufirst%3DF.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DHenne%26aufirst%3DK.%2BR.%26aulast%3DHu%26aufirst%3DY.-L.%26aulast%3DHungate%26aufirst%3DR.%26aulast%3DJohnson%26aufirst%3DM.%2BG.%26aulast%3DKelly%26aufirst%3DR.%2BC.%26aulast%3DLucas%26aufirst%3DB.%26aulast%3DMcCarter%26aufirst%3DJ.%2BD.%26aulast%3DMcGee%26aufirst%3DL.%2BR.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26aulast%3DSan%2BMiguel%26aufirst%3DT.%26aulast%3DMohn%26aufirst%3DD.%26aulast%3DPattaropong%26aufirst%3DV.%26aulast%3DPettus%26aufirst%3DL.%2BH.%26aulast%3DReichelt%26aufirst%3DA.%26aulast%3DRzasa%26aufirst%3DR.%2BM.%26aulast%3DSeganish%26aufirst%3DJ.%26aulast%3DTasker%26aufirst%3DA.%2BS.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWannberg%26aufirst%3DS.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DWhoriskey%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DG.%26aulast%3DZalameda%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DMetz%26aufirst%3DD.%2BP.%26atitle%3DDiscovery%2520and%2520in%2520Vivo%2520Evaluation%2520of%2520%2528S%2529-N-%25281-%25287-Fluoro-2-%2528pyridin-2-yl%2529quinolin-3-yl%2529ethyl%2529-9H-purin-6-amine%2520%2528AMG319%2529%2520and%2520Related%2520PI3K%25CE%25B4%2520Inhibitors%2520for%2520Inflammation%2520and%2520Autoimmune%2520Disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D1%26spage%3D480%26epage%3D511%26doi%3D10.1021%2Fjm501624r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Currie, K. S.</span><span> </span><span class="NLM_article-title">Targeting the B-cell receptor pathway in hematological malignancies</span> <span class="citation_source-journal">Med. Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">230</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2015&pages=230-231&author=K.+S.+Currie&title=Targeting+the+B-cell+receptor+pathway+in+hematological+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCurrie%26aufirst%3DK.%2BS.%26atitle%3DTargeting%2520the%2520B-cell%2520receptor%2520pathway%2520in%2520hematological%2520malignancies%26jtitle%3DMed.%2520Chem.%2520Rev.%26date%3D2015%26volume%3D50%26spage%3D230%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Johnson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcus, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebsworth, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sablan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dairaghi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonn, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schall, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J.</span><span> </span><span class="NLM_article-title">Discovery and optimization of a series of quinazolinone-derived antagonists of CXCR3</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">3339</span><span class="NLM_x">–</span> <span class="NLM_lpage">3343</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.03.106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1016%2Fj.bmcl.2007.03.106" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3339-3343&issue=12&author=M.+Johnsonauthor=A.-R.+Liauthor=J.+Liuauthor=Z.+Fuauthor=L.+Zhuauthor=S.+Miaoauthor=X.+Wangauthor=Q.+Xuauthor=A.+Huangauthor=A.+Marcusauthor=F.+Xuauthor=K.+Ebsworthauthor=E.+Sablanauthor=J.+Danaoauthor=J.+Kumerauthor=D.+Dairaghiauthor=C.+Lawrenceauthor=T.+Sullivanauthor=G.+Tonnauthor=T.+Schallauthor=T.+Collinsauthor=J.+Medina&title=Discovery+and+optimization+of+a+series+of+quinazolinone-derived+antagonists+of+CXCR3&doi=10.1016%2Fj.bmcl.2007.03.106"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.03.106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.03.106%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DA.-R.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DMiao%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DHuang%26aufirst%3DA.%26aulast%3DMarcus%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DF.%26aulast%3DEbsworth%26aufirst%3DK.%26aulast%3DSablan%26aufirst%3DE.%26aulast%3DDanao%26aufirst%3DJ.%26aulast%3DKumer%26aufirst%3DJ.%26aulast%3DDairaghi%26aufirst%3DD.%26aulast%3DLawrence%26aufirst%3DC.%26aulast%3DSullivan%26aufirst%3DT.%26aulast%3DTonn%26aufirst%3DG.%26aulast%3DSchall%26aufirst%3DT.%26aulast%3DCollins%26aufirst%3DT.%26aulast%3DMedina%26aufirst%3DJ.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520a%2520series%2520of%2520quinazolinone-derived%2520antagonists%2520of%2520CXCR3%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26issue%3D12%26spage%3D3339%26epage%3D3343%26doi%3D10.1016%2Fj.bmcl.2007.03.106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robeson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilbert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramanathan, S.</span><span> </span><span class="NLM_article-title">Clinical drug interaction profile of idelalisib in healthy subjects</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">919</span><span class="refDoi"> DOI: 10.1002/jcph.495</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1002%2Fjcph.495" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=25760671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFCru7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2015&pages=909-919&issue=8&author=F.+Jinauthor=M.+Robesonauthor=H.+Zhouauthor=C.+Moyerauthor=S.+Wilbertauthor=B.+Murrayauthor=S.+Ramanathan&title=Clinical+drug+interaction+profile+of+idelalisib+in+healthy+subjects&doi=10.1002%2Fjcph.495"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical drug interaction profile of idelalisib in healthy subjects</span></div><div class="casAuthors">Jin, Feng; Robeson, Michelle; Zhou, Huafeng; Moyer, Candra; Wilbert, Sibylle; Murray, Bernard; Ramanathan, Srini</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">909-919</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Idelalisib, a potent phosphatidylinositol-3-kinase delta (PI3Kδ) inhibitor, is metabolized primarily by aldehyde oxidase to form GS-563117 and to a lesser extent by cytochrome P 450 (CYP) 3A and uridine 5'-diphospho-glucuronosyltransferase 1A4.  In vitro, idelalisib inhibits P-glycoprotein (P-gp) and org. anion transporting polypeptides 1B1 and 1B3, and GS-563117 is a time-dependent CYP3A inhibitor.  This study enrolled 24 healthy subjects and evaluated (1) the effect of idelalisib on the pharmacokinetics (PK) of digoxin, a P-gp probe substrate, rosuvastatin, a breast cancer resistance protein, and OATP1B1/OATP1B3 substrate, and midazolam, a CYP3A substrate; and (2) the effect of a strong inducer, rifampin, on idelalisib PK.  On treatment, the most common clin. adverse events (AEs) were headache and pyrexia.  Grade 3 transaminase increases were obsd. in 5 of 24 subjects and were reversible.  Two subjects had serious AEs after treatment completion (grade 3 pyrexia and/or drug-induced liver injury).  Idelalisib coadministration did not affect digoxin and rosuvastatin PK.  Coadministration with idelalisib increased plasma exposures of midazolam (138% and 437% for max. obsd. plasma concn. [Cmax] and area under the plasma concn.-time curve from time 0 extrapolated to infinity [AUCinf], resp.), consistent with the in vitro finding of CYP3A inhibition by GS-563117.  Rifampin caused a substantial decrease in idelalisib (58% and 75%, Cmax and AUCinf, resp.) and GS-563117 exposures, indicating an enhanced contribution of CYP3A to idelalisib metab. under a strongly induced state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnGy4bARtgkLVg90H21EOLACvtfcHk0ljLp4kRp8zPVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFCru7%252FM&md5=b4e8bb97a51561cecda3ecd0c7a16372</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1002%2Fjcph.495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcph.495%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DF.%26aulast%3DRobeson%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DMoyer%26aufirst%3DC.%26aulast%3DWilbert%26aufirst%3DS.%26aulast%3DMurray%26aufirst%3DB.%26aulast%3DRamanathan%26aufirst%3DS.%26atitle%3DClinical%2520drug%2520interaction%2520profile%2520of%2520idelalisib%2520in%2520healthy%2520subjects%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2015%26volume%3D55%26issue%3D8%26spage%3D909%26epage%3D919%26doi%3D10.1002%2Fjcph.495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ramanathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kearney, B. P.</span><span> </span><span class="NLM_article-title">Clinical pharmacokinetic and pharmacodynamic profile of idelalisib</span> <span class="citation_source-journal">Clin. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span><span class="refDoi"> DOI: 10.1007/s40262-015-0304-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1007%2Fs40262-015-0304-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=26242379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlSit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=33-45&author=S.+Ramanathanauthor=F.+Jinauthor=S.+Sharmaauthor=B.+P.+Kearney&title=Clinical+pharmacokinetic+and+pharmacodynamic+profile+of+idelalisib&doi=10.1007%2Fs40262-015-0304-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical Pharmacokinetic and Pharmacodynamic Profile of Idelalisib</span></div><div class="casAuthors">Ramanathan, Srinivasan; Jin, Feng; Sharma, Shringi; Kearney, Brian P.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-45</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Idelalisib is a potent and selective phosphatidylinositol 3-kinase-δ inhibitor, which is a first-in-class agent to be approved for the treatment of relapsed chronic lymphocytic leukemia, follicular B cell non-Hodgkin's lymphoma and small lymphocytic lymphoma.  In dose-ranging studies, idelalisib exposure increased in a less than dose-proportional manner, likely because of soly.-limited absorption.  The approved starting dose of 150 mg twice daily was supported by extensive exposure-response evaluations, with dose redn. to 100 mg twice daily being allowed for specific toxicities.  Idelalisib may be administered without regard to food on the basis of the absence of clin. relevant food effects, and was accordingly dosed in primary efficacy/safety studies.  Idelalisib is metabolized primarily via aldehyde oxidase (AO) and, to a lesser extent, via cytochrome P 450 (CYP) 3A.  Coadministration with the strong CYP3A inhibitor ketoconazole 400 mg once daily resulted in a ∼79 % increase in the idelalisib area under the plasma concn.-time curve (AUC).  Administration with the potent inducer rifampin resulted in a 75 % decrease in idelalisib exposure (AUC) and, as such, coadministration with strong inducers should be avoided.  GS-563117 is an inactive primary circulating metabolite of idelalisib formed mainly via AO.  Unlike idelalisib, GS-563117 is a mechanism-based inhibitor of CYP3A.  Accordingly, idelalisib 150 mg twice-daily dosing increases the midazolam AUC 5.4-fold.  Clin., idelalisib is not an inhibitor of the transporters P-glycoprotein, breast cancer resistance protein, org. anion-transporting polypeptide (OATP) 1B1 or OAPT1B3.  In a population pharmacokinetic model, no meaningful impact on idelalisib pharmacokinetics was noted for any of the covariates tested.  Idelalisib exposure was ∼60 % higher with moderate/severe hepatic impairment; no relevant changes were obsd. with severe renal impairment.  This article reviews a comprehensive pharmacol. program, including drug-drug interaction studies and mechanistic and special population studies, which has allowed a thorough understanding of idelalisib clin. pharmacokinetics and their impact on clin. safety and efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprSL8hV_Gha7Vg90H21EOLACvtfcHk0ljLp4kRp8zPVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlSit7o%253D&md5=df1082fcbb0e1a9aa941769ade9fe962</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1007%2Fs40262-015-0304-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40262-015-0304-0%26sid%3Dliteratum%253Aachs%26aulast%3DRamanathan%26aufirst%3DS.%26aulast%3DJin%26aufirst%3DF.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DKearney%26aufirst%3DB.%2BP.%26atitle%3DClinical%2520pharmacokinetic%2520and%2520pharmacodynamic%2520profile%2520of%2520idelalisib%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2016%26volume%3D55%26spage%3D33%26epage%3D45%26doi%3D10.1007%2Fs40262-015-0304-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hall, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krenitsky, T. A.</span><span> </span><span class="NLM_article-title">Aldehyde oxidase from rabbit liver: specificity toward purines and their analogs</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">251</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">36</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span><span class="refDoi"> DOI: 10.1016/0003-9861(86)90048-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1016%2F0003-9861%2886%2990048-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=1986&pages=36-46&issue=1&author=W.+W.+Hallauthor=T.+A.+Krenitsky&title=Aldehyde+oxidase+from+rabbit+liver%3A+specificity+toward+purines+and+their+analogs&doi=10.1016%2F0003-9861%2886%2990048-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1016%2F0003-9861%2886%2990048-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-9861%252886%252990048-2%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DW.%2BW.%26aulast%3DKrenitsky%26aufirst%3DT.%2BA.%26atitle%3DAldehyde%2520oxidase%2520from%2520rabbit%2520liver%253A%2520specificity%2520toward%2520purines%2520and%2520their%2520analogs%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1986%26volume%3D251%26issue%3D1%26spage%3D36%26epage%3D46%26doi%3D10.1016%2F0003-9861%2886%2990048-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Torres, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korzekwa, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMasters, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. P.</span><span> </span><span class="NLM_article-title">Use of density functional calculations to predict the regioselectivity of drugs and molecules metabolized by aldehyde oxidase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">4642</span><span class="NLM_x">–</span> <span class="NLM_lpage">4647</span><span class="refDoi"> DOI: 10.1021/jm0703690</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0703690" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsVKnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4642-4647&issue=19&author=R.+A.+Torresauthor=K.+R.+Korzekwaauthor=D.+R.+McMastersauthor=C.+M.+Fandozziauthor=J.+P.+Jones&title=Use+of+density+functional+calculations+to+predict+the+regioselectivity+of+drugs+and+molecules+metabolized+by+aldehyde+oxidase&doi=10.1021%2Fjm0703690"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Use of Density Functional Calculations To Predict the Regioselectivity of Drugs and Molecules Metabolized by Aldehyde Oxidase</span></div><div class="casAuthors">Torres, Rhonda A.; Korzekwa, Kenneth R.; McMasters, Daniel R.; Fandozzi, Christine M.; Jones, Jeffrey P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4642-4647</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aldehyde oxidase is a molybdenum hydroxylase that catalyzes the oxidn. of aldehydes and nitrogen-contg. heterocycles.  The enzyme plays a dual role in the metab. of physiol. important endogenous compds. and the biotransformation of xenobiotics.  Using d. functional theory methods, geometry optimization of tetrahedral intermediates of drugs and druglike compds. was examd. to predict the likely metabolites of aldehyde oxidase.  The calcns. suggest that the lowest energy tetrahedral intermediate resulting from the initial substrate corresponds to the obsd. metabolite ≥90% of the time.  Addnl. calcns. were performed on a series of heterocyclic compds. where the products resulting from metab. by xanthine oxidase and aldehyde oxidase differ in many instances.  Again, the lowest energy tetrahedral intermediate corresponded to the obsd. product of aldehyde oxidase metab. ≥90% for the compds. examd., while the obsd. products of xanthine oxidase were not well predicted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmnIR2Ha4_oLVg90H21EOLACvtfcHk0liFZipeIY-9Xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsVKnsb4%253D&md5=514ee5703f306287a3b7315fc5cea434</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1021%2Fjm0703690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0703690%26sid%3Dliteratum%253Aachs%26aulast%3DTorres%26aufirst%3DR.%2BA.%26aulast%3DKorzekwa%26aufirst%3DK.%2BR.%26aulast%3DMcMasters%26aufirst%3DD.%2BR.%26aulast%3DFandozzi%26aufirst%3DC.%2BM.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26atitle%3DUse%2520of%2520density%2520functional%2520calculations%2520to%2520predict%2520the%2520regioselectivity%2520of%2520drugs%2520and%2520molecules%2520metabolized%2520by%2520aldehyde%2520oxidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D19%26spage%3D4642%26epage%3D4647%26doi%3D10.1021%2Fjm0703690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Linton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ornelas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kephart, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pairish, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, C.</span><span> </span><span class="NLM_article-title">Systematic structure modifications of imidazo[1,2-a]pyrimidine to reduce metabolism mediated by aldehyde oxidase (AO)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">7705</span><span class="NLM_x">–</span> <span class="NLM_lpage">7712</span><span class="refDoi"> DOI: 10.1021/jm2010942</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2010942" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1ynu7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7705-7712&issue=21&author=A.+Lintonauthor=P.+Kangauthor=M.+Ornelasauthor=S.+Kephartauthor=Q.+Huauthor=M.+Pairishauthor=Y.+Jiangauthor=C.+Guo&title=Systematic+structure+modifications+of+imidazo%5B1%2C2-a%5Dpyrimidine+to+reduce+metabolism+mediated+by+aldehyde+oxidase+%28AO%29&doi=10.1021%2Fjm2010942"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17cR"><div class="casContent"><span class="casTitleNuber">17c</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic Structure Modifications of Imidazo[1,2-a]pyrimidine to Reduce Metabolism Mediated by Aldehyde Oxidase (AO)</span></div><div class="casAuthors">Linton, Angelica; Kang, Ping; Ornelas, Martha; Kephart, Susan; Hu, Qiyue; Pairish, Mason; Jiang, Ying; Guo, Chuangxing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7705-7712</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-{trans-3-[(5-Cyano-6-methylpyridin-2-yl)oxy]-2,2,4,4-tetramethylcyclobutyl}imidazo[1,2-a]pyrimidine-3-carboxamide (I) was recently identified as a full antagonist of the androgen receptor, demonstrating excellent in vivo tumor growth inhibition in castration-resistant prostate cancer (CRPC).  However, the imidazo[1,2-a]pyrimidine moiety is rapidly metabolized by aldehyde oxidase (AO).  The present paper describes a no. of medicinal chem. strategies taken to avoid the AO-mediated oxidn. of this particular system.  Guided by an AO protein structure-based model, the investigation revealed the most probable site of AO oxidn. and the observation that altering the heterocycle or blocking the reactive site are two of the more effective strategies for reducing AO metab.  These strategies may be useful for other drug discovery programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQMDVJxz6g_bVg90H21EOLACvtfcHk0liFZipeIY-9Xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1ynu7bL&md5=b6da895d38c71f90eb4f83716f1060f0</span></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=10.1021%2Fjm2010942&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2010942%26sid%3Dliteratum%253Aachs%26aulast%3DLinton%26aufirst%3DA.%26aulast%3DKang%26aufirst%3DP.%26aulast%3DOrnelas%26aufirst%3DM.%26aulast%3DKephart%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DPairish%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DC.%26atitle%3DSystematic%2520structure%2520modifications%2520of%2520imidazo%255B1%252C2-a%255Dpyrimidine%2520to%2520reduce%2520metabolism%2520mediated%2520by%2520aldehyde%2520oxidase%2520%2528AO%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D21%26spage%3D7705%26epage%3D7712%26doi%3D10.1021%2Fjm2010942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Pryde, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.-D.</span><span> </span><span class="NLM_article-title">Aldehyde oxidase: an enzyme of emerging importance in drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">8441</span><span class="NLM_x">–</span> <span class="NLM_lpage">8460</span><span class="refDoi"> DOI: 10.1021/jm100888d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100888d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFygt73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8441-8460&issue=24&author=D.+C.+Prydeauthor=D.+Dalvieauthor=Q.+Huauthor=P.+Jonesauthor=R.+S.+Obachauthor=T.-D.+Tran&title=Aldehyde+oxidase%3A+an+enzyme+of+emerging+importance+in+drug+discovery&doi=10.1021%2Fjm100888d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17dR"><div class="casContent"><span class="casTitleNuber">17d</span><div class="casTitle"><span class="NLM_cas:atitle">Aldehyde Oxidase: An Enzyme of Emerging Importance in Drug Discovery</span></div><div class="casAuthors">Pryde, David C.; Dalvie, Deepak; Hu, Qiyue; Jones, Peter; Obach, R. Scott; Tran, Thien-Duc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8441-8460</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Aldehyde oxidase has for many years been recognized as a metabolizing enzyme contained within the cytosolic compartment of many tissues and in many species.  The first literature ref. to AO dates from the 1930s, but literature citations to this enzyme have been steadily growing ever since, esp. in the past decade.  It has been increasingly recognized in this past decade that AO, through its unique structure, distribution, and substrate recognition, has an important role to play in the metab. of drugs.  In this timely Perspective, we present the current knowledge of the enzyme's expression, its structure, and its distribution across species.  We offer an anal. of substrates recognized by AO and highlight clin. examples where metab. by this enzyme has had significant clin. impact or led to the termination of a drug development program.  Finally, through anal. of the structure of known substrates, we present data to suggest the significant impact AO could play on future drug discovery programs along with strategies that could be employed to mitigate this.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqALwFS70G6tLVg90H21EOLACvtfcHk0liO9AoboieD1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFygt73N&md5=972eb9862a7dc7bff024b530ab40de7f</span></div><a href="/servlet/linkout?suffix=cit17d&amp;dbid=16384&amp;doi=10.1021%2Fjm100888d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100888d%26sid%3Dliteratum%253Aachs%26aulast%3DPryde%26aufirst%3DD.%2BC.%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DTran%26aufirst%3DT.-D.%26atitle%3DAldehyde%2520oxidase%253A%2520an%2520enzyme%2520of%2520emerging%2520importance%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D24%26spage%3D8441%26epage%3D8460%26doi%3D10.1021%2Fjm100888d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Rashidi, M.-R.; Pashaei-Asl, R.</span><span> </span><span class="NLM_article-title">Role of aldehyde oxidase and xanthine oxidase in the metabolism of purine-related drugs</span>.  <span class="citation_source-book">Readings in Advanced Pharmacokinetics. Theory, Methods and Applications</span>, <span class="NLM_edition">1</span>st ed.; <span class="NLM_contrib-group">Noreddin, A.</span>, Ed.; <span class="NLM_publisher-name">InTech</span>: <span class="NLM_publisher-loc">Rijeka, Croatia</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">285</span><span class="NLM_x">–</span> <span class="NLM_lpage">314</span>, DOI: <span class="refDoi"> DOI: 10.5772/33202</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.5772%2F33202" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=285-314&author=M.-R.+Rashidi&author=R.+Pashaei-Aslauthor=A.+Noreddin&title=Readings+in+Advanced+Pharmacokinetics.+Theory%2C+Methods+and+Applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17e&amp;dbid=16384&amp;doi=10.5772%2F33202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.5772%252F33202%26sid%3Dliteratum%253Aachs%26aulast%3DRashidi%26aufirst%3DM.-R.%26atitle%3DRole%2520of%2520aldehyde%2520oxidase%2520and%2520xanthine%2520oxidase%2520in%2520the%2520metabolism%2520of%2520purine-related%2520drugs%26btitle%3DReadings%2520in%2520Advanced%2520Pharmacokinetics.%2520Theory%252C%2520Methods%2520and%2520Applications%26aulast%3DNoreddin%26aufirst%3DA.%26pub%3DInTech%26date%3D2012%26spage%3D285%26epage%3D314%26doi%3D10.5772%2F33202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Zientek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span> </span><span class="NLM_article-title">In vitro-in vivo correlation for intrinsic clearance for drugs metabolized by human aldehyde oxidase</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1322</span><span class="NLM_x">–</span> <span class="NLM_lpage">1327</span><span class="refDoi"> DOI: 10.1124/dmd.110.033555</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1124%2Fdmd.110.033555" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=20444863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVWktrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=1322-1327&issue=8&author=M.+Zientekauthor=Y.+Jiangauthor=K.+Youdimauthor=R.+S.+Obach&title=In+vitro-in+vivo+correlation+for+intrinsic+clearance+for+drugs+metabolized+by+human+aldehyde+oxidase&doi=10.1124%2Fdmd.110.033555"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro-in vivo correlation for intrinsic clearance for drugs metabolized by human aldehyde oxidase</span></div><div class="casAuthors">Zientek, Michael; Jiang, Ying; Youdim, Kuresh; Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1322-1327</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The ability to predict in vivo clearance from in vitro intrinsic clearance for compds. metabolized by aldehyde oxidase has not been demonstrated.  To date, there is no established scaling method for predicting aldehyde oxidase-mediated clearance using in vitro or animal data.  This challenge is exacerbated by the fact that rats and dogs, two of the lab. animal species commonly used to develop in vitro-in vivo correlations of clearance, differ from humans with regard to expression of aldehyde oxidase.  The objective of this investigation was to develop an in vitro-in vivo correlation of intrinsic clearance for aldehyde oxidase, using 11 drugs known to be metabolized by this enzyme.  The set consisted of methotrexate, XK-469, (±-4-(4-cyanoanilino)-5,6-dihydro-7-hydroxy-7H-cyclopenta[d]pyrimidine (RS-8359), zaleplon, 6-deoxypenciclovir, zoniporide, O6-benzylguanine, N-[(2'-dimethylamino)ethyl]acridine-4-carboxamide (DACA), carbazeran, PF-4217903, and PF-945863.  These compds. were assayed using two in vitro systems (pooled human liver cytosol and liver S-9 fractions) to calc. scaled unbound intrinsic clearance, and they were then compared with calcd. in vivo unbound intrinsic clearance.  The investigation provided a relative scale that can be used for in vitro-in vivo correlation of aldehyde oxidase clearance and suggests limits as to when a potential new drug candidate that is metabolized by this enzyme will possess acceptable human clearance, or when structural modification is required to reduce aldehyde oxidase catalyzed metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFkx3d5zxrd7Vg90H21EOLACvtfcHk0li9gj7bKnYWNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVWktrjJ&md5=296ee366707d82b416e70eb8161f923b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1124%2Fdmd.110.033555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.110.033555%26sid%3Dliteratum%253Aachs%26aulast%3DZientek%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DYoudim%26aufirst%3DK.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DIn%2520vitro-in%2520vivo%2520correlation%2520for%2520intrinsic%2520clearance%2520for%2520drugs%2520metabolized%2520by%2520human%2520aldehyde%2520oxidase%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26issue%3D8%26spage%3D1322%26epage%3D1327%26doi%3D10.1124%2Fdmd.110.033555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Pryde, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duckworth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyland, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenham, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span> </span><span class="NLM_article-title">Medicinal chemistry approaches to avoid aldehyde oxidase metabolism</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">2856</span><span class="NLM_x">–</span> <span class="NLM_lpage">2860</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.02.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1016%2Fj.bmcl.2012.02.069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=22429467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=1%3ACAS%3A528%3ADC%252BC38XktFSitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2856-2860&issue=8&author=D.+C.+Prydeauthor=T.-D.+Tranauthor=P.+Jonesauthor=J.+Duckworthauthor=M.+Howardauthor=I.+Gardnerauthor=R.+Hylandauthor=R.+Websterauthor=T.+Wenhamauthor=S.+Bagalauthor=K.+Omotoauthor=R.+P.+Schneiderauthor=J.+Lin&title=Medicinal+chemistry+approaches+to+avoid+aldehyde+oxidase+metabolism&doi=10.1016%2Fj.bmcl.2012.02.069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry approaches to avoid aldehyde oxidase metabolism</span></div><div class="casAuthors">Pryde, David C.; Tran, Thien-Duc; Jones, Peter; Duckworth, Jonathan; Howard, Martin; Gardner, Iain; Hyland, Ruth; Webster, Rob; Wenham, Tracey; Bagal, Sharan; Omoto, Kiyoyuki; Schneider, Richard P.; Lin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2856-2860</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aldehyde oxidase (AO) is a molybdenum-contg. enzyme distributed throughout the animal kingdom and capable of metabolising a wide range of aldehydes and N-heterocyclic compds.  Although metab. by this enzyme in man is recognized to have significant clin. impact where human AO activity was not predicted by screening in preclin. species, there is very little reported literature offering real examples where drug discoverers have successfully designed away from AO oxidn.  This article reports on some strategies adopted in the Pfizer TLR7 agonist program to successfully switch off AO metab. that was seen principally in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZKVEe9ZUzMbVg90H21EOLACvtfcHk0li9gj7bKnYWNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktFSitbs%253D&md5=4c4c68b64f1c7013ad978408add0b09a</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.069%26sid%3Dliteratum%253Aachs%26aulast%3DPryde%26aufirst%3DD.%2BC.%26aulast%3DTran%26aufirst%3DT.-D.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DDuckworth%26aufirst%3DJ.%26aulast%3DHoward%26aufirst%3DM.%26aulast%3DGardner%26aufirst%3DI.%26aulast%3DHyland%26aufirst%3DR.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DWenham%26aufirst%3DT.%26aulast%3DBagal%26aufirst%3DS.%26aulast%3DOmoto%26aufirst%3DK.%26aulast%3DSchneider%26aufirst%3DR.%2BP.%26aulast%3DLin%26aufirst%3DJ.%26atitle%3DMedicinal%2520chemistry%2520approaches%2520to%2520avoid%2520aldehyde%2520oxidase%2520metabolism%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26issue%3D8%26spage%3D2856%26epage%3D2860%26doi%3D10.1016%2Fj.bmcl.2012.02.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bendele, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McComb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gould, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAbee, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sennello, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chlipala, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guy, M.</span><span> </span><span class="NLM_article-title">Animal models of arthritis: relevance to human disease</span> <span class="citation_source-journal">Toxicol. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">134</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span><span class="refDoi"> DOI: 10.1177/019262339902700125</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1177%2F019262339902700125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10367688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=1%3ACAS%3A280%3ADyaK1M3psVWjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1999&pages=134-42&issue=1&author=A.+Bendeleauthor=J.+McCombauthor=T.+Gouldauthor=T.+McAbeeauthor=G.+Sennelloauthor=E.+Chlipalaauthor=M.+Guy&title=Animal+models+of+arthritis%3A+relevance+to+human+disease&doi=10.1177%2F019262339902700125"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">Animal models of arthritis: relevance to human disease</span></div><div class="casAuthors">Bendele A; McComb J; Gould T; McAbee T; Sennello G; Chlipala E; Guy M</div><div class="citationInfo"><span class="NLM_cas:title">Toxicologic pathology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">134-42</span>
        ISSN:<span class="NLM_cas:issn">0192-6233</span>.
    </div><div class="casAbstract">Animal models of arthritis are used to evaluate potential antiarthritis drugs for clinical use.  Therefore capacity of the model to predict efficacy in human disease is one of the most important criteria in model selection.  Animal models of rheumatoid arthritis (RA) with a proven track record of predictability include rat adjuvant arthritis, rat type II collagen arthritis, mouse type II collagen arthritis, and antigen-induced arthritis in several species.  Agents currently in clinical use (or trials) that are active in these models include corticosteroids, methotrexate, nonsteroidal anti-inflammatory drugs, cyclosporin A, leflunomide, interleukin-1 receptor antagonist, and soluble tumor necrosis factor receptors.  For some of these agents, the models also predict that toxicities seen at higher doses for prolonged periods would preclude dosing in humans at levels that might provide disease-modifying effects.  Animal models of osteoarthritis (OA) include mouse and guinea pig spontaneous OA, meniscectomy and ligament transection in guinea pigs, meniscectomy in rabbits, and meniscectomy and cruciate transection in dogs.  None of these models have a proven track record of predictability in human disease because there are no agents that have been proven to provide anything other than symptomatic relief in human OA.  Efficacy data and features of the various models of RA and OA are discussed with emphasis on their proven relevance to human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSl_Wv0PotC6OkdrW1FkXG-fW6udTcc2eakCWvfUf5tDLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M3psVWjug%253D%253D&md5=1b6484ca61fd10dbb07f090d376730a4</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1177%2F019262339902700125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F019262339902700125%26sid%3Dliteratum%253Aachs%26aulast%3DBendele%26aufirst%3DA.%26aulast%3DMcComb%26aufirst%3DJ.%26aulast%3DGould%26aufirst%3DT.%26aulast%3DMcAbee%26aufirst%3DT.%26aulast%3DSennello%26aufirst%3DG.%26aulast%3DChlipala%26aufirst%3DE.%26aulast%3DGuy%26aufirst%3DM.%26atitle%3DAnimal%2520models%2520of%2520arthritis%253A%2520relevance%2520to%2520human%2520disease%26jtitle%3DToxicol.%2520Pathol.%26date%3D1999%26volume%3D27%26issue%3D1%26spage%3D134%26epage%3D42%26doi%3D10.1177%2F019262339902700125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bendele, A. M.</span><span> </span><span class="NLM_article-title">Animal models of rheumatoid arthritis</span> <span class="citation_source-journal">J. Musculoskeletal Neuronal Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">377</span><span class="NLM_x">–</span> <span class="NLM_lpage">385</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=15758488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltVOhu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=377-385&issue=4&author=A.+M.+Bendele&title=Animal+models+of+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Animal models of rheumatoid arthritis</span></div><div class="casAuthors">Bendele, A. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Musculoskeletal & Neuronal Interactions</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">377-385</span>CODEN:
                <span class="NLM_cas:coden">JMNIB3</span>;
        ISSN:<span class="NLM_cas:issn">1108-7161</span>.
    
            (<span class="NLM_cas:orgname">Journal of Musculoskeletal and Neuronal Interactions</span>)
        </div><div class="casAbstract">A review.  Animal models of arthritis are used to study pathogenesis of disease and to evaluate potential anti-arthritic drugs for clin. use.  Therefore morphol. similarities to human disease and capacity of the model to predict efficacy in humans are important criteria in model selection.  Animal models of rheumatoid arthritis (RA) with a proven track record of predictability for efficacy in humans include: rat adjuvant arthritis, rat type II collagen arthritis, mouse type II collagen arthritis and antigen-induced arthritis in several species.  Agents currently in clin. use (or trials) that are active in these models include: corticosteroids, methotrexate, nonsteroidal anti-inflammatory drugs, cyclosporin A, leflunomide interleukin-1 receptor antagonist (IL-1ra) and sol. TNF receptors.  For some of these agents, the models also predict that toxicities seen at higher doses for prolonged dosing periods would preclude dosing in humans at levels that might provide disease modifying effects.  Data, conduct and features of the various models of these commonly utilized models of RA as well as some transgenic mouse models and less commonly utilized rodent models will be discussed with emphasis on their similarities to human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwhtLWBEJFcbVg90H21EOLACvtfcHk0ljYlw_bQ4MNlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltVOhu7o%253D&md5=21f16894bcfdad981a6b7d32773431cf</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBendele%26aufirst%3DA.%2BM.%26atitle%3DAnimal%2520models%2520of%2520rheumatoid%2520arthritis%26jtitle%3DJ.%2520Musculoskeletal%2520Neuronal%2520Interact.%26date%3D2001%26volume%3D1%26issue%3D4%26spage%3D377%26epage%3D385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Trentham, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townes, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, A. H.</span><span> </span><span class="NLM_article-title">Autoimmunity to type II collagen an experimental model of arthritis</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">146</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">857</span><span class="NLM_x">–</span> <span class="NLM_lpage">868</span><span class="refDoi"> DOI: 10.1084/jem.146.3.857</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1084%2Fjem.146.3.857" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=1977&pages=857-868&issue=3&author=D.+E.+Trenthamauthor=A.+S.+Townesauthor=A.+H.+Kang&title=Autoimmunity+to+type+II+collagen+an+experimental+model+of+arthritis&doi=10.1084%2Fjem.146.3.857"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20c&amp;dbid=16384&amp;doi=10.1084%2Fjem.146.3.857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.146.3.857%26sid%3Dliteratum%253Aachs%26aulast%3DTrentham%26aufirst%3DD.%2BE.%26aulast%3DTownes%26aufirst%3DA.%2BS.%26aulast%3DKang%26aufirst%3DA.%2BH.%26atitle%3DAutoimmunity%2520to%2520type%2520II%2520collagen%2520an%2520experimental%2520model%2520of%2520arthritis%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1977%26volume%3D146%26issue%3D3%26spage%3D857%26epage%3D868%26doi%3D10.1084%2Fjem.146.3.857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c','cit1d'],'ref2':['cit2a','cit2b'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11a','cit11b','cit11c'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16a','cit16b'],'ref17':['cit17a','cit17b','cit17c','cit17d','cit17e'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20a','cit20b','cit20c']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 36 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Kongjun Liu, Dan Li, Wei Zheng, Mingsong Shi, Yong Chen, Minghai Tang, Tao Yang, Min Zhao, Dexin Deng, Chufeng Zhang, Jiang Liu, Xue Yuan, Zhuang Yang, <span class="NLM_string-name hlFld-ContribAuthor">Lijuan Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery, Optimization, and Evaluation of Quinazolinone Derivatives with Novel Linkers as Orally Efficacious Phosphoinositide-3-Kinase Delta Inhibitors for Treatment of Inflammatory Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (13)
                                     , 8951-8970. <a href="https://doi.org/10.1021/acs.jmedchem.1c00004" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00004%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%25252C%252BOptimization%25252C%252Band%252BEvaluation%252Bof%252BQuinazolinone%252BDerivatives%252Bwith%252BNovel%252BLinkers%252Bas%252BOrally%252BEfficacious%252BPhosphoinositide-3-Kinase%252BDelta%252BInhibitors%252Bfor%252BTreatment%252Bof%252BInflammatory%252BDiseases%26aulast%3DLiu%26aufirst%3DKongjun%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D03012021%26date%3D17062021%26volume%3D64%26issue%3D13%26spage%3D8951%26epage%3D8970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Manojkumar R. Shukla, Sukanya Patra, Mahip Verma, Gayathri Sadasivam, Nirmal Jana, Sachin J. Mahangare, Prashant Vidhate, Dipak Lagad, Anand Tarage, Murthy Cheemala, Chaitanya Kulkarni, Shankar Bhagwat, Vinod D. Chaudhari, Majid Sayyed, Vipul Pachpute, Ramesh Phadtare, Gopal Gole, Samiron Phukan, Brahmam Sunkara, Charudatt Samant, Manisha Shingare, Aditya Naik, Sneha Trivedi, Ajit Kumar Marisetti, Madhusudhan Reddy, Milind Gholve, Nilesh Mahajan, Sudeep Sabde, Vinod Patil, Dipak Modi, Maneesh Mehta, Prashant Nigade, Kaustubh Tamane, Swati Tota, Hemant Goyal, Harish Volam, Shashikant Pawar, Prajakta Ahirrao, Lal Dinchhana, Sadanand Mallurwar, Atul Akarte, Anand Bokare, Rupesh Kanhere, Neetinkumar Reddy, Sarita Koul, Manoj Dandekar, Minakshi Singh, Peter R. Bernstein, Lakshmi Narasimham, Mandar Bhonde, Jayasagar Gundu, Rajan Goel, Sanjeev Kulkarni, Sharad Sharma, Rajender Kumar Kamboj, <span class="NLM_string-name hlFld-ContribAuthor">Venkata P. Palle</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent and Selective PI3Kδ Inhibitor (S)-2,4-Diamino-6-((1-(7-fluoro-1-(4-fluorophenyl)-4-oxo-3-phenyl-4H-quinolizin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile with Improved Pharmacokinetic Profile and Superior Efficacy in Hematological Cancer Models. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (23)
                                     , 14700-14723. <a href="https://doi.org/10.1021/acs.jmedchem.0c01264" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01264</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01264%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%252Band%252BSelective%252BPI3K%2525CE%2525B4%252BInhibitor%252B%252528S%252529-2%25252C4-Diamino-6-%252528%2525281-%2525287-fluoro-1-%2525284-fluorophenyl%252529-4-oxo-3-phenyl-4H-quinolizin-2-yl%252529ethyl%252529amino%252529pyrimidine-5-carbonitrile%252Bwith%252BImproved%252BPharmacokinetic%252BProfile%252Band%252BSuperior%252BEfficacy%252Bin%252BHematological%252BCancer%252BModels%26aulast%3DShukla%26aufirst%3DManojkumar%2BR.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D20072020%26date%3D02122020%26volume%3D63%26issue%3D23%26spage%3D14700%26epage%3D14723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ashish Thakur, Gregory J. Tawa, Mark J. Henderson, Carina Danchik, Suiyang Liu, Pranav Shah, Amy Q. Wang, Garrett Dunn, Md Kabir, Elias C. Padilha, Xin Xu, Anton Simeonov, Surender Kharbanda, Richard Stone, <span class="NLM_string-name hlFld-ContribAuthor">Gurmit Grewal</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Quinazolin-4-one-Based Hydroxamic Acids as Dual PI3K/HDAC Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (8)
                                     , 4256-4292. <a href="https://doi.org/10.1021/acs.jmedchem.0c00193" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00193</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00193%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BQuinazolin-4-one-Based%252BHydroxamic%252BAcids%252Bas%252BDual%252BPI3K%25252FHDAC%252BInhibitors%26aulast%3DThakur%26aufirst%3DAshish%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03022020%26date%3D08042020%26date%3D26032020%26volume%3D63%26issue%3D8%26spage%3D4256%26epage%3D4292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Gilles Ouvry, Laurence Clary, Loïc Tomas, Michèle Aurelly, Laetitia Bonnary, Emilie Borde, Claire Bouix-Peter, Laurent Chantalat, Claire Defoin-Platel, Sophie Deret, Mathieu Forissier, Craig S. Harris, Tatiana Isabet, Laurent Lamy, Anne-Pascale Luzy, Jonathan Pascau, Catherine Soulet, Alessandro Taddei, Nathalie Taquet, Etienne Thoreau, Emeric Varvier, Emmanuel Vial, <span class="NLM_string-name hlFld-ContribAuthor">Laurent F. Hennequin</span>. </span><span class="cited-content_cbyCitation_article-title">Impact of Minor Structural Modifications on Properties of a Series of mTOR Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (11)
                                     , 1561-1567. <a href="https://doi.org/10.1021/acsmedchemlett.9b00401" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00401</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00401%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DImpact%252Bof%252BMinor%252BStructural%252BModifications%252Bon%252BProperties%252Bof%252Ba%252BSeries%252Bof%252BmTOR%252BInhibitors%26aulast%3DOuvry%26aufirst%3DGilles%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D30082019%26date%3D04102019%26date%3D08102019%26date%3D04102019%26volume%3D10%26issue%3D11%26spage%3D1561%26epage%3D1567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Matthew W. D. Perry, Raolat Abdulai, Mickael Mogemark, Jens Petersen, Matthew J. Thomas, Barbara Valastro, <span class="NLM_string-name hlFld-ContribAuthor">Annika Westin Eriksson</span>. </span><span class="cited-content_cbyCitation_article-title">Evolution of PI3Kγ and δ Inhibitors for Inflammatory and Autoimmune Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (10)
                                     , 4783-4814. <a href="https://doi.org/10.1021/acs.jmedchem.8b01298" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01298</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01298%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEvolution%252Bof%252BPI3K%2525CE%2525B3%252Band%252B%2525CE%2525B4%252BInhibitors%252Bfor%252BInflammatory%252Band%252BAutoimmune%252BDiseases%26aulast%3DPerry%26aufirst%3DMatthew%2BW.%2BD.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D16082018%26date%3D24122018%26volume%3D62%26issue%3D10%26spage%3D4783%26epage%3D4814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Aimie
E. Garces, <span class="NLM_string-name hlFld-ContribAuthor">Michael J. Stocks</span>. </span><span class="cited-content_cbyCitation_article-title">Class 1 PI3K Clinical Candidates and Recent Inhibitor Design Strategies: A Medicinal Chemistry Perspective. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (10)
                                     , 4815-4850. <a href="https://doi.org/10.1021/acs.jmedchem.8b01492" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01492</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01492%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DClass%252B1%252BPI3K%252BClinical%252BCandidates%252Band%252BRecent%252BInhibitor%252BDesign%252BStrategies%25253A%252BA%252BMedicinal%252BChemistry%252BPerspective%26aulast%3DGarces%26aufirst%3DAimie%2BE.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D25092018%26date%3D24122018%26volume%3D62%26issue%3D10%26spage%3D4815%26epage%3D4850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Klemens  Hoegenauer</span>, <span class="hlFld-ContribAuthor ">Nicolas  Soldermann</span>, <span class="hlFld-ContribAuthor ">Frédéric  Zécri</span>, <span class="hlFld-ContribAuthor ">Ross S.  Strang</span>, <span class="hlFld-ContribAuthor ">Nadege  Graveleau</span>, <span class="hlFld-ContribAuthor ">Romain M.  Wolf</span>, <span class="hlFld-ContribAuthor ">Nigel G.  Cooke</span>, <span class="hlFld-ContribAuthor ">Alexander B.  Smith</span>, <span class="hlFld-ContribAuthor ">Gregory J.  Hollingworth</span>, <span class="hlFld-ContribAuthor ">Joachim  Blanz</span>, <span class="hlFld-ContribAuthor ">Sascha  Gutmann</span>, <span class="hlFld-ContribAuthor ">Gabriele  Rummel</span>, <span class="hlFld-ContribAuthor ">Amanda  Littlewood-Evans</span>, and <span class="hlFld-ContribAuthor ">Christoph  Burkhart</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of CDZ173 (Leniolisib), Representing a Structurally Novel Class of PI3K Delta-Selective Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (9)
                                     , 975-980. <a href="https://doi.org/10.1021/acsmedchemlett.7b00293" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00293</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00293%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BCDZ173%252B%252528Leniolisib%252529%25252C%252BRepresenting%252Ba%252BStructurally%252BNovel%252BClass%252Bof%252BPI3K%252BDelta-Selective%252BInhibitors%26aulast%3DHoegenauer%26aufirst%3DKlemens%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D19072017%26date%3D25082017%26date%3D05092017%26date%3D14092017%26date%3D25082017%26volume%3D8%26issue%3D9%26spage%3D975%26epage%3D980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingjie  Liu</span>, <span class="hlFld-ContribAuthor ">Qing  Shi</span>, <span class="hlFld-ContribAuthor ">David  Marcoux</span>, <span class="hlFld-ContribAuthor ">Douglas G.  Batt</span>, <span class="hlFld-ContribAuthor ">Lyndon  Cornelius</span>, <span class="hlFld-ContribAuthor ">Lan-Ying  Qin</span>, <span class="hlFld-ContribAuthor ">Zheming  Ruan</span>, <span class="hlFld-ContribAuthor ">James  Neels</span>, <span class="hlFld-ContribAuthor ">Myra  Beaudoin-Bertrand</span>, <span class="hlFld-ContribAuthor ">Anurag S.  Srivastava</span>, <span class="hlFld-ContribAuthor ">Ling  Li</span>, <span class="hlFld-ContribAuthor ">Robert J.  Cherney</span>, <span class="hlFld-ContribAuthor ">Hua  Gong</span>, <span class="hlFld-ContribAuthor ">Scott H.  Watterson</span>, <span class="hlFld-ContribAuthor ">Carolyn  Weigelt</span>, <span class="hlFld-ContribAuthor ">Kathleen M.  Gillooly</span>, <span class="hlFld-ContribAuthor ">Kim W.  McIntyre</span>, <span class="hlFld-ContribAuthor ">Jenny H.  Xie</span>, <span class="hlFld-ContribAuthor ">Mary T.  Obermeier</span>, <span class="hlFld-ContribAuthor ">Aberra  Fura</span>, <span class="hlFld-ContribAuthor ">Bogdan  Sleczka</span>, <span class="hlFld-ContribAuthor ">Kevin  Stefanski</span>, <span class="hlFld-ContribAuthor ">R. M.  Fancher</span>, <span class="hlFld-ContribAuthor ">Shweta  Padmanabhan</span>, <span class="hlFld-ContribAuthor ">Thatipamula  RP</span>, <span class="hlFld-ContribAuthor ">Ipsit  Kundu</span>, <span class="hlFld-ContribAuthor ">Kallem  Rajareddy</span>, <span class="hlFld-ContribAuthor ">Rodney  Smith</span>, <span class="hlFld-ContribAuthor ">James K.  Hennan</span>, <span class="hlFld-ContribAuthor ">Dezhi  Xing</span>, <span class="hlFld-ContribAuthor ">Jingsong  Fan</span>, <span class="hlFld-ContribAuthor ">Paul C.  Levesque</span>, <span class="hlFld-ContribAuthor ">Qian  Ruan</span>, <span class="hlFld-ContribAuthor ">Sidney  Pitt</span>, <span class="hlFld-ContribAuthor ">Rosemary  Zhang</span>, <span class="hlFld-ContribAuthor ">Donna  Pedicord</span>, <span class="hlFld-ContribAuthor ">Jie  Pan</span>, <span class="hlFld-ContribAuthor ">Melissa  Yarde</span>, <span class="hlFld-ContribAuthor ">Hao  Lu</span>, <span class="hlFld-ContribAuthor ">Jonathan  Lippy</span>, <span class="hlFld-ContribAuthor ">Christine  Goldstine</span>, <span class="hlFld-ContribAuthor ">Stacey  Skala</span>, <span class="hlFld-ContribAuthor ">Richard A.  Rampulla</span>, <span class="hlFld-ContribAuthor ">Arvind  Mathur</span>, <span class="hlFld-ContribAuthor ">Anuradha  Gupta</span>, <span class="hlFld-ContribAuthor ">Pirama Nayagam  Arunachalam</span>, <span class="hlFld-ContribAuthor ">John S.  Sack</span>, <span class="hlFld-ContribAuthor ">Jodi K.  Muckelbauer</span>, <span class="hlFld-ContribAuthor ">Mary Ellen  Cvijic</span>, <span class="hlFld-ContribAuthor ">Luisa M.  Salter-Cid</span>, <span class="hlFld-ContribAuthor ">Rajeev S.  Bhide</span>, <span class="hlFld-ContribAuthor ">Michael A.  Poss</span>, <span class="hlFld-ContribAuthor ">John  Hynes</span>, <span class="hlFld-ContribAuthor ">Percy H.  Carter</span>, <span class="hlFld-ContribAuthor ">John E.  Macor</span>, <span class="hlFld-ContribAuthor ">Stefan  Ruepp</span>, <span class="hlFld-ContribAuthor ">Gary L.  Schieven</span>, and <span class="hlFld-ContribAuthor ">Joseph A.  Tino</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of a Potent, Selective, and Efficacious Phosphatidylinositol 3-Kinase δ (PI3Kδ) Inhibitor for the Treatment of Immunological Disorders. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (12)
                                     , 5193-5208. <a href="https://doi.org/10.1021/acs.jmedchem.7b00618" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00618</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00618%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Ba%252BPotent%25252C%252BSelective%25252C%252Band%252BEfficacious%252BPhosphatidylinositol%252B3-Kinase%252B%2525CE%2525B4%252B%252528PI3K%2525CE%2525B4%252529%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BImmunological%252BDisorders%26aulast%3DLiu%26aufirst%3DQingjie%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D27042017%26date%3D05062017%26date%3D22062017%26date%3D25052017%26volume%3D60%26issue%3D12%26spage%3D5193%26epage%3D5208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephane  Perreault</span>, <span class="hlFld-ContribAuthor ">Jayaraman  Chandrasekhar</span>, <span class="hlFld-ContribAuthor ">Zhi-Hua  Cui</span>, <span class="hlFld-ContribAuthor ">Jerry  Evarts</span>, <span class="hlFld-ContribAuthor ">Jia  Hao</span>, <span class="hlFld-ContribAuthor ">Joshua A.  Kaplan</span>, <span class="hlFld-ContribAuthor ">Adam  Kashishian</span>, <span class="hlFld-ContribAuthor ">Kathleen S.  Keegan</span>, <span class="hlFld-ContribAuthor ">Thomas  Kenney</span>, <span class="hlFld-ContribAuthor ">David  Koditek</span>, <span class="hlFld-ContribAuthor ">Latesh  Lad</span>, <span class="hlFld-ContribAuthor ">Eve-Irene  Lepist</span>, <span class="hlFld-ContribAuthor ">Mary E.  McGrath</span>, <span class="hlFld-ContribAuthor ">Leena  Patel</span>, <span class="hlFld-ContribAuthor ">Bart  Phillips</span>, <span class="hlFld-ContribAuthor ">Joseph  Therrien</span>, <span class="hlFld-ContribAuthor ">Jennifer  Treiberg</span>, <span class="hlFld-ContribAuthor ">Anella  Yahiaoui</span>, and <span class="hlFld-ContribAuthor ">Gary  Phillips</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Phosphoinositide 3-Kinase (PI3K) β/δ Inhibitor for the Treatment of Phosphatase and Tensin Homolog (PTEN) Deficient Tumors: Building PI3Kβ Potency in a PI3Kδ-Selective Template by Targeting Nonconserved Asp856. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (4)
                                     , 1555-1567. <a href="https://doi.org/10.1021/acs.jmedchem.6b01821" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01821</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01821%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BPhosphoinositide%252B3-Kinase%252B%252528PI3K%252529%252B%2525CE%2525B2%25252F%2525CE%2525B4%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BPhosphatase%252Band%252BTensin%252BHomolog%252B%252528PTEN%252529%252BDeficient%252BTumors%25253A%252BBuilding%252BPI3K%2525CE%2525B2%252BPotency%252Bin%252Ba%252BPI3K%2525CE%2525B4-Selective%252BTemplate%252Bby%252BTargeting%252BNonconserved%252BAsp856%26aulast%3DPerreault%26aufirst%3DStephane%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D14122016%26date%3D07022017%26date%3D23022017%26date%3D20012017%26volume%3D60%26issue%3D4%26spage%3D1555%26epage%3D1567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leena  Patel</span>, <span class="hlFld-ContribAuthor ">Jayaraman  Chandrasekhar</span>, <span class="hlFld-ContribAuthor ">Jerry  Evarts</span>, <span class="hlFld-ContribAuthor ">Kristen  Forseth</span>, <span class="hlFld-ContribAuthor ">Aaron C.  Haran</span>, <span class="hlFld-ContribAuthor ">Carmen  Ip</span>, <span class="hlFld-ContribAuthor ">Adam  Kashishian</span>, <span class="hlFld-ContribAuthor ">Musong  Kim</span>, <span class="hlFld-ContribAuthor ">David  Koditek</span>, <span class="hlFld-ContribAuthor ">Sandy  Koppenol</span>, <span class="hlFld-ContribAuthor ">Latesh  Lad</span>, <span class="hlFld-ContribAuthor ">Eve-Irene  Lepist</span>, <span class="hlFld-ContribAuthor ">Mary E.  McGrath</span>, <span class="hlFld-ContribAuthor ">Stephane  Perreault</span>, <span class="hlFld-ContribAuthor ">Kamal D.  Puri</span>, <span class="hlFld-ContribAuthor ">Armando G.  Villaseñor</span>, <span class="hlFld-ContribAuthor ">John R.  Somoza</span>, <span class="hlFld-ContribAuthor ">Bart H.  Steiner</span>, <span class="hlFld-ContribAuthor ">Joseph  Therrien</span>, <span class="hlFld-ContribAuthor ">Jennifer  Treiberg</span>, and <span class="hlFld-ContribAuthor ">Gary  Phillips</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Orally Efficacious Phosphoinositide 3-Kinase δ Inhibitors with Improved Metabolic Stability. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (19)
                                     , 9228-9242. <a href="https://doi.org/10.1021/acs.jmedchem.6b01169" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01169</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01169%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BOrally%252BEfficacious%252BPhosphoinositide%252B3-Kinase%252B%2525CE%2525B4%252BInhibitors%252Bwith%252BImproved%252BMetabolic%252BStability%26aulast%3DPatel%26aufirst%3DLeena%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D04082016%26date%3D03102016%26date%3D13102016%26date%3D23092016%26volume%3D59%26issue%3D19%26spage%3D9228%26epage%3D9242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Felix  Gonzalez-Lopez de Turiso</span>, <span class="hlFld-ContribAuthor ">Xiaolin  Hao</span>, <span class="hlFld-ContribAuthor ">Youngsook  Shin</span>, <span class="hlFld-ContribAuthor ">Minna  Bui</span>, <span class="hlFld-ContribAuthor ">Iain D. G.  Campuzano</span>, <span class="hlFld-ContribAuthor ">Mario  Cardozo</span>, <span class="hlFld-ContribAuthor ">Michelle C.  Dunn</span>, <span class="hlFld-ContribAuthor ">Jason  Duquette</span>, <span class="hlFld-ContribAuthor ">Benjamin  Fisher</span>, <span class="hlFld-ContribAuthor ">Robert S.  Foti</span>, <span class="hlFld-ContribAuthor ">Kirk  Henne</span>, <span class="hlFld-ContribAuthor ">Xiao  He</span>, <span class="hlFld-ContribAuthor ">Yi-Ling  Hu</span>, <span class="hlFld-ContribAuthor ">Ron C.  Kelly</span>, <span class="hlFld-ContribAuthor ">Michael G.  Johnson</span>, <span class="hlFld-ContribAuthor ">Brian S.  Lucas</span>, <span class="hlFld-ContribAuthor ">John  McCarter</span>, <span class="hlFld-ContribAuthor ">Lawrence R.  McGee</span>, <span class="hlFld-ContribAuthor ">Julio C.  Medina</span>, <span class="hlFld-ContribAuthor ">Daniela  Metz</span>, <span class="hlFld-ContribAuthor ">Tisha  San Miguel</span>, <span class="hlFld-ContribAuthor ">Deanna  Mohn</span>, <span class="hlFld-ContribAuthor ">Thuy  Tran</span>, <span class="hlFld-ContribAuthor ">Christine  Vissinga</span>, <span class="hlFld-ContribAuthor ">Sharon  Wannberg</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">John  Whoriskey</span>, <span class="hlFld-ContribAuthor ">Gang  Yu</span>, <span class="hlFld-ContribAuthor ">Leeanne  Zalameda</span>, <span class="hlFld-ContribAuthor ">Xuxia  Zhang</span>, and <span class="hlFld-ContribAuthor ">Timothy D.  Cushing</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and in Vivo Evaluation of the Potent and Selective PI3Kδ Inhibitors 2-((1S)-1-((6-Amino-5-cyano-4-pyrimidinyl)amino)ethyl)-6-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-0687) and 2-((1S)-1-((6-Amino-5-cyano-4-pyrimidinyl)amino)ethyl)-5-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-1430). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (15)
                                     , 7252-7267. <a href="https://doi.org/10.1021/acs.jmedchem.6b00827" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00827</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00827&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00827%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252Bin%252BVivo%252BEvaluation%252Bof%252Bthe%252BPotent%252Band%252BSelective%252BPI3K%2525CE%2525B4%252BInhibitors%252B2-%252528%2525281S%252529-1-%252528%2525286-Amino-5-cyano-4-pyrimidinyl%252529amino%252529ethyl%252529-6-fluoro-N-methyl-3-%2525282-pyridinyl%252529-4-quinolinecarboxamide%252B%252528AM-0687%252529%252Band%252B2-%252528%2525281S%252529-1-%252528%2525286-Amino-5-cyano-4-pyrimidinyl%252529amino%252529ethyl%252529-5-fluoro-N-methyl-3-%2525282-pyridinyl%252529-4-quinolinecarboxamide%252B%252528AM-1430%252529%26aulast%3DGonzalez-Lopez%2Bde%2BTuriso%26aufirst%3DFelix%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D01062016%26date%3D25072016%26date%3D11082016%26date%3D14072016%26volume%3D59%26issue%3D15%26spage%3D7252%26epage%3D7267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yeon Su  Kim</span>, <span class="hlFld-ContribAuthor ">Min Gyeong  Cheon</span>, <span class="hlFld-ContribAuthor ">Pulla Reddy  Boggu</span>, <span class="hlFld-ContribAuthor ">Su Youn  Koh</span>, <span class="hlFld-ContribAuthor ">Gi Min  Park</span>, <span class="hlFld-ContribAuthor ">Gahee  Kim</span>, <span class="hlFld-ContribAuthor ">Seo Hyun  Park</span>, <span class="hlFld-ContribAuthor ">Sung Lyea  Park</span>, <span class="hlFld-ContribAuthor ">Chi Woo  Lee</span>, <span class="hlFld-ContribAuthor ">Jong Woo  Kim</span>, <span class="hlFld-ContribAuthor ">Young Hoon  Jung</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of novel purinyl quinazolinone derivatives as PI3Kδ-specific inhibitors for the treatment of hematologic malignancies. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>45 </em>, 116312. <a href="https://doi.org/10.1016/j.bmc.2021.116312" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.116312</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.116312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.116312%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bpurinyl%252Bquinazolinone%252Bderivatives%252Bas%252BPI3K%2525CE%2525B4-specific%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bhematologic%252Bmalignancies%26aulast%3DKim%26aufirst%3DYeon%2BSu%26date%3D2021%26volume%3D45%26spage%3D116312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eclair Venturini  Filho</span>, <span class="hlFld-ContribAuthor ">Erick M.C.  Pinheiro</span>, <span class="hlFld-ContribAuthor ">Sergio  Pinheiro</span>, <span class="hlFld-ContribAuthor ">Sandro J.  Greco</span>. </span><span class="cited-content_cbyCitation_article-title">Aminopyrimidines: Recent synthetic procedures and anticancer activities. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2021,</strong> <em>92 </em>, 132256. <a href="https://doi.org/10.1016/j.tet.2021.132256" title="DOI URL">https://doi.org/10.1016/j.tet.2021.132256</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2021.132256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2021.132256%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DAminopyrimidines%25253A%252BRecent%252Bsynthetic%252Bprocedures%252Band%252Banticancer%252Bactivities%26aulast%3DFilho%26aufirst%3DEclair%2BVenturini%26date%3D2021%26volume%3D92%26spage%3D132256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingyu  Zhu</span>, <span class="hlFld-ContribAuthor ">Lei  Jia</span>, <span class="hlFld-ContribAuthor ">Yingmin  Jiang</span>, <span class="hlFld-ContribAuthor ">Qianqian  Yu</span>, <span class="hlFld-ContribAuthor ">Lei  Xu</span>, <span class="hlFld-ContribAuthor ">Yanfei  Cai</span>, <span class="hlFld-ContribAuthor ">Yun  Chen</span>, <span class="hlFld-ContribAuthor ">Huazhong  Li</span>, <span class="hlFld-ContribAuthor ">Huang  Gang</span>, <span class="hlFld-ContribAuthor ">Wenqing  Liang</span>, <span class="hlFld-ContribAuthor ">Jian  Jin</span>. </span><span class="cited-content_cbyCitation_article-title">Integrated molecular modeling techniques to reveal selective mechanisms of inhibitors to PI3Kδ with marketed Idelalisib. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2021,</strong> <em>97 </em>
                                    (6)
                                     , 1158-1169. <a href="https://doi.org/10.1111/cbdd.13838" title="DOI URL">https://doi.org/10.1111/cbdd.13838</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13838&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13838%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DIntegrated%252Bmolecular%252Bmodeling%252Btechniques%252Bto%252Breveal%252Bselective%252Bmechanisms%252Bof%252Binhibitors%252Bto%252BPI3K%2525CE%2525B4%252Bwith%252Bmarketed%252BIdelalisib%26aulast%3DZhu%26aufirst%3DJingyu%26date%3D2021%26date%3D2021%26volume%3D97%26issue%3D6%26spage%3D1158%26epage%3D1169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoyu  Li</span>, <span class="hlFld-ContribAuthor ">Jennifer E.  Golden</span>. </span><span class="cited-content_cbyCitation_article-title">Construction of
              N
              ‐Boc‐2‐Alkylaminoquinazolin‐4(3
              H
              )‐Ones via a Three‐Component, One‐Pot Protocol Mediated by Copper(II) Chloride that Spares Enantiomeric Purity. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2021,</strong> <em>363 </em>
                                    (6)
                                     , 1638-1645. <a href="https://doi.org/10.1002/adsc.202001279" title="DOI URL">https://doi.org/10.1002/adsc.202001279</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202001279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202001279%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DConstruction%252Bof%252BN%252B%2525E2%252580%252590Boc%2525E2%252580%2525902%2525E2%252580%252590Alkylaminoquinazolin%2525E2%252580%2525904%2525283%252BH%252B%252529%2525E2%252580%252590Ones%252Bvia%252Ba%252BThree%2525E2%252580%252590Component%25252C%252BOne%2525E2%252580%252590Pot%252BProtocol%252BMediated%252Bby%252BCopper%252528II%252529%252BChloride%252Bthat%252BSpares%252BEnantiomeric%252BPurity%26aulast%3DLi%26aufirst%3DXiaoyu%26date%3D2021%26date%3D2021%26volume%3D363%26issue%3D6%26spage%3D1638%26epage%3D1645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gary  Chinigo</span>, <span class="hlFld-ContribAuthor ">Yiqing  Feng</span>, <span class="hlFld-ContribAuthor ">Susan  Hoy</span>, <span class="hlFld-ContribAuthor ">Ricardo  Lira</span>, <span class="hlFld-ContribAuthor ">Matthew  Perry</span>. </span><span class="cited-content_cbyCitation_article-title">Pyridazines and Their Benzo Derivatives. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00082-2" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00082-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00082-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00082-2%26sid%3Dliteratum%253Aachs%26atitle%3DPyridazines%252Band%252BTheir%252BBenzo%252BDerivatives%26aulast%3DChinigo%26aufirst%3DGary%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2021%26volume%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiajia  Sun</span>, <span class="hlFld-ContribAuthor ">Yifan  Feng</span>, <span class="hlFld-ContribAuthor ">Yuan  Huang</span>, <span class="hlFld-ContribAuthor ">San-Qi  Zhang</span>, <span class="hlFld-ContribAuthor ">Minhang  Xin</span>. </span><span class="cited-content_cbyCitation_article-title">Research advances on selective phosphatidylinositol 3 kinase δ (PI3Kδ) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (19)
                                     , 127457. <a href="https://doi.org/10.1016/j.bmcl.2020.127457" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127457</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127457%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DResearch%252Badvances%252Bon%252Bselective%252Bphosphatidylinositol%252B3%252Bkinase%252B%2525CE%2525B4%252B%252528PI3K%2525CE%2525B4%252529%252Binhibitors%26aulast%3DSun%26aufirst%3DJiajia%26date%3D2020%26volume%3D30%26issue%3D19%26spage%3D127457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dmitry A.  Khochenkov</span>, <span class="hlFld-ContribAuthor ">Yulia A.  Khochenkova</span>, <span class="hlFld-ContribAuthor ">Yulia S.  Machkova</span>, <span class="hlFld-ContribAuthor ">Rovshan E.  Gasanov</span>, <span class="hlFld-ContribAuthor ">Eugenia V.  Stepanova</span>, <span class="hlFld-ContribAuthor ">Alexander S.  Bunev</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and cytotoxic activity of novel 4-amino-5-cyano-2-sulfonylpyrimidines. </span><span class="cited-content_cbyCitation_journal-name">Mendeleev Communications</span><span> <strong>2020,</strong> <em>30 </em>
                                    (5)
                                     , 604-606. <a href="https://doi.org/10.1016/j.mencom.2020.09.017" title="DOI URL">https://doi.org/10.1016/j.mencom.2020.09.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mencom.2020.09.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mencom.2020.09.017%26sid%3Dliteratum%253Aachs%26jtitle%3DMendeleev%2520Communications%26atitle%3DSynthesis%252Band%252Bcytotoxic%252Bactivity%252Bof%252Bnovel%252B4-amino-5-cyano-2-sulfonylpyrimidines%26aulast%3DKhochenkov%26aufirst%3DDmitry%2BA.%26date%3D2020%26volume%3D30%26issue%3D5%26spage%3D604%26epage%3D606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexey Yu.  Dubovtsev</span>, <span class="hlFld-ContribAuthor ">Nikolay V.  Shcherbakov</span>, <span class="hlFld-ContribAuthor ">Dmitry V.  Dar'in</span>, <span class="hlFld-ContribAuthor ">Vadim Yu.  Kukushkin</span>. </span><span class="cited-content_cbyCitation_article-title">The Dichotomy of Gold‐catalyzed Interplay between Cyanamides and Ynamides: Controllable Switch from [2+2+2] to [4+2] Cycloaddition. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2020,</strong> <em>362 </em>
                                    (13)
                                     , 2672-2682. <a href="https://doi.org/10.1002/adsc.202000434" title="DOI URL">https://doi.org/10.1002/adsc.202000434</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202000434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202000434%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DThe%252BDichotomy%252Bof%252BGold%2525E2%252580%252590catalyzed%252BInterplay%252Bbetween%252BCyanamides%252Band%252BYnamides%25253A%252BControllable%252BSwitch%252Bfrom%252B%25255B2%25252B2%25252B2%25255D%252Bto%252B%25255B4%25252B2%25255D%252BCycloaddition%26aulast%3DDubovtsev%26aufirst%3DAlexey%2BYu.%26date%3D2020%26date%3D2020%26volume%3D362%26issue%3D13%26spage%3D2672%26epage%3D2682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mahmoud A.  Al-Sha'er</span>, <span class="hlFld-ContribAuthor ">Rua'a A.  Al-Aqtash</span>, <span class="hlFld-ContribAuthor ">Mutasem O.  Taha</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of New Phosphoinositide 3-kinase Delta (PI3Kδ) Inhibitors via Virtual Screening using Crystallography-derived Pharmacophore Modelling and QSAR Analysis. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry</span><span> <strong>2019,</strong> <em>15 </em>
                                    (6)
                                     , 588-601. <a href="https://doi.org/10.2174/1573406415666190222125333" title="DOI URL">https://doi.org/10.2174/1573406415666190222125333</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1573406415666190222125333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1573406415666190222125333%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNew%252BPhosphoinositide%252B3-kinase%252BDelta%252B%252528PI3K%2525CE%2525B4%252529%252BInhibitors%252Bvia%252BVirtual%252BScreening%252Busing%252BCrystallography-derived%252BPharmacophore%252BModelling%252Band%252BQSAR%252BAnalysis%26aulast%3DAl-Sha%2527er%26aufirst%3DMahmoud%2BA.%26date%3D2019%26volume%3D15%26issue%3D6%26spage%3D588%26epage%3D601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingyu  Zhu</span>, <span class="hlFld-ContribAuthor ">Ke  Ke</span>, <span class="hlFld-ContribAuthor ">Lei  Xu</span>, <span class="hlFld-ContribAuthor ">Jian  Jin</span>. </span><span class="cited-content_cbyCitation_article-title">Theoretical studies on the selectivity mechanisms of PI3Kδ inhibition with marketed idelalisib and its derivatives by 3D-QSAR, molecular docking, and molecular dynamics simulation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Modeling</span><span> <strong>2019,</strong> <em>25 </em>
                                    (8)
                                     <a href="https://doi.org/10.1007/s00894-019-4129-x" title="DOI URL">https://doi.org/10.1007/s00894-019-4129-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00894-019-4129-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00894-019-4129-x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Modeling%26atitle%3DTheoretical%252Bstudies%252Bon%252Bthe%252Bselectivity%252Bmechanisms%252Bof%252BPI3K%2525CE%2525B4%252Binhibition%252Bwith%252Bmarketed%252Bidelalisib%252Band%252Bits%252Bderivatives%252Bby%252B3D-QSAR%25252C%252Bmolecular%252Bdocking%25252C%252Band%252Bmolecular%252Bdynamics%252Bsimulation%26aulast%3DZhu%26aufirst%3DJingyu%26date%3D2019%26date%3D2019%26volume%3D25%26issue%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaodong  Ma</span>, <span class="hlFld-ContribAuthor ">Jun  Wei</span>, <span class="hlFld-ContribAuthor ">Chang  Wang</span>, <span class="hlFld-ContribAuthor ">Dongyan  Gu</span>, <span class="hlFld-ContribAuthor ">Yongzhou  Hu</span>, <span class="hlFld-ContribAuthor ">Rong  Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel benzothiadiazine derivatives as potent PI3Kδ-selective inhibitors for treating B-cell-mediated malignancies. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>170 </em>, 112-125. <a href="https://doi.org/10.1016/j.ejmech.2019.03.005" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.03.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.03.005%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bbenzothiadiazine%252Bderivatives%252Bas%252Bpotent%252BPI3K%2525CE%2525B4-selective%252Binhibitors%252Bfor%252Btreating%252BB-cell-mediated%252Bmalignancies%26aulast%3DMa%26aufirst%3DXiaodong%26date%3D2019%26volume%3D170%26spage%3D112%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michelle  Miller</span>, <span class="hlFld-ContribAuthor ">Philip  Thompson</span>, <span class="hlFld-ContribAuthor ">Sandra  Gabelli</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Determinants of Isoform Selectivity in PI3K Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2019,</strong> <em>9 </em>
                                    (3)
                                     , 82. <a href="https://doi.org/10.3390/biom9030082" title="DOI URL">https://doi.org/10.3390/biom9030082</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom9030082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom9030082%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DStructural%252BDeterminants%252Bof%252BIsoform%252BSelectivity%252Bin%252BPI3K%252BInhibitors%26aulast%3DMiller%26aufirst%3DMichelle%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D3%26spage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ravi  Joshi</span>. </span><span class="cited-content_cbyCitation_article-title">Free radical induced redox reactions of 2,4,6-triaminopyrimidine: A pulse radiolysis study. </span><span class="cited-content_cbyCitation_journal-name">Radiation Physics and Chemistry</span><span> <strong>2018,</strong> <em>151 </em>, 169-178. <a href="https://doi.org/10.1016/j.radphyschem.2018.06.004" title="DOI URL">https://doi.org/10.1016/j.radphyschem.2018.06.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.radphyschem.2018.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.radphyschem.2018.06.004%26sid%3Dliteratum%253Aachs%26jtitle%3DRadiation%2520Physics%2520and%2520Chemistry%26atitle%3DFree%252Bradical%252Binduced%252Bredox%252Breactions%252Bof%252B2%25252C4%25252C6-triaminopyrimidine%25253A%252BA%252Bpulse%252Bradiolysis%252Bstudy%26aulast%3DJoshi%26aufirst%3DRavi%26date%3D2018%26volume%3D151%26spage%3D169%26epage%3D178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Minhang  Xin</span>, <span class="hlFld-ContribAuthor ">Weiming  Duan</span>, <span class="hlFld-ContribAuthor ">Yifan  Feng</span>, <span class="hlFld-ContribAuthor ">Yuan-Yuan  Hei</span>, <span class="hlFld-ContribAuthor ">Hao  Zhang</span>, <span class="hlFld-ContribAuthor ">Ying  Shen</span>, <span class="hlFld-ContribAuthor ">Hong-Yi  Zhao</span>, <span class="hlFld-ContribAuthor ">Shuai  Mao</span>, <span class="hlFld-ContribAuthor ">San-Qi  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 6-aryl substituted 4-pyrrolidineaminoquinazoline derivatives as potent phosphoinositide 3-kinase delta (PI3Kδ) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (8)
                                     , 2028-2040. <a href="https://doi.org/10.1016/j.bmc.2018.03.002" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.03.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.03.002%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DNovel%252B6-aryl%252Bsubstituted%252B4-pyrrolidineaminoquinazoline%252Bderivatives%252Bas%252Bpotent%252Bphosphoinositide%252B3-kinase%252Bdelta%252B%252528PI3K%2525CE%2525B4%252529%252Binhibitors%26aulast%3DXin%26aufirst%3DMinhang%26date%3D2018%26volume%3D26%26issue%3D8%26spage%3D2028%26epage%3D2040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Toshihiro  Hamajima</span>, <span class="hlFld-ContribAuthor ">Fumie  Takahashi</span>, <span class="hlFld-ContribAuthor ">Koji  Kato</span>, <span class="hlFld-ContribAuthor ">Koichiro  Mukoyoshi</span>, <span class="hlFld-ContribAuthor ">Kousei  Yoshihara</span>, <span class="hlFld-ContribAuthor ">Susumu  Yamaki</span>, <span class="hlFld-ContribAuthor ">Yukihito  Sugano</span>, <span class="hlFld-ContribAuthor ">Ayako  Moritomo</span>, <span class="hlFld-ContribAuthor ">Kaoru  Yamagami</span>, <span class="hlFld-ContribAuthor ">Koji  Yokoo</span>, <span class="hlFld-ContribAuthor ">Hidehiko  Fukahori</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and biological evaluation of novel pyrazolopyridine derivatives as potent and orally available PI3Kδ inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (9)
                                     , 2410-2419. <a href="https://doi.org/10.1016/j.bmc.2018.03.042" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.03.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.03.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.03.042%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bpyrazolopyridine%252Bderivatives%252Bas%252Bpotent%252Band%252Borally%252Bavailable%252BPI3K%2525CE%2525B4%252Binhibitors%26aulast%3DHamajima%26aufirst%3DToshihiro%26date%3D2018%26volume%3D26%26issue%3D9%26spage%3D2410%26epage%3D2419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">2-Aminopyrimidines. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 237-283. <a href="https://doi.org/10.1002/9781118686263.ch7" title="DOI URL">https://doi.org/10.1002/9781118686263.ch7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118686263.ch7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118686263.ch7%26sid%3Dliteratum%253Aachs%26atitle%3D2-Aminopyrimidines%26date%3D2018%26date%3D2018%26spage%3D237%26epage%3D283%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DPrivileged%252BStructures%252Bin%252BDrug%252BDiscovery%26aulast%3DYet%26aufirst%3DLarry%26date%3D2018%26volume%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manjunath G.  Sunagar</span>, <span class="hlFld-ContribAuthor ">P.  Aravind</span>, <span class="hlFld-ContribAuthor ">Supreet  Gaonkar</span>, <span class="hlFld-ContribAuthor ">K.S.  Devaraju</span>, <span class="hlFld-ContribAuthor ">Shrinivas D.  Joshi</span>, <span class="hlFld-ContribAuthor ">Sheshagiri R.  Dixit</span>, <span class="hlFld-ContribAuthor ">B.M.  Harish</span>, <span class="hlFld-ContribAuthor ">Imtiyaz Ahmed M.  Khazi</span>. </span><span class="cited-content_cbyCitation_article-title">In silico binding affinity studies of N-9 substituted 6-(4-(4-propoxyphenyl)piperazin-1-yl)-9H-purine derivatives-Target for P70-S6K1 & PI3K-δ kinases. </span><span class="cited-content_cbyCitation_journal-name">Beni-Suef University Journal of Basic and Applied Sciences</span><span> <strong>2018,</strong> <em>7 </em>
                                    (1)
                                     , 84-91. <a href="https://doi.org/10.1016/j.bjbas.2017.08.004" title="DOI URL">https://doi.org/10.1016/j.bjbas.2017.08.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bjbas.2017.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bjbas.2017.08.004%26sid%3Dliteratum%253Aachs%26jtitle%3DBeni-Suef%2520University%2520Journal%2520of%2520Basic%2520and%2520Applied%2520Sciences%26atitle%3DIn%252Bsilico%252Bbinding%252Baffinity%252Bstudies%252Bof%252BN-9%252Bsubstituted%252B6-%2525284-%2525284-propoxyphenyl%252529piperazin-1-yl%252529-9H-purine%252Bderivatives-Target%252Bfor%252BP70-S6K1%252B%252526%252BPI3K-%2525CE%2525B4%252Bkinases%26aulast%3DSunagar%26aufirst%3DManjunath%2BG.%26date%3D2018%26volume%3D7%26issue%3D1%26spage%3D84%26epage%3D91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaozhong  Qiu</span>, <span class="hlFld-ContribAuthor ">Caiyang  Zhang</span>, <span class="hlFld-ContribAuthor ">Rui  Qiu</span>, <span class="hlFld-ContribAuthor ">Guodong  Yin</span>, <span class="hlFld-ContribAuthor ">Jinkun  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">One-Pot Domino Synthesis of Diarylalkynes/1,4-Diaryl-1,3-diynes by [9,9-Dimethyl-4,5-bis(diphenylphosphino)xanthene] (Xantphos)-Copper(I) Iodide-Palladium(II) Acetate-Catalyzed Double Sonogashira-Type Reaction. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2018,</strong> <em>360 </em>
                                    (2)
                                     , 313-321. <a href="https://doi.org/10.1002/adsc.201701128" title="DOI URL">https://doi.org/10.1002/adsc.201701128</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201701128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201701128%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DOne-Pot%252BDomino%252BSynthesis%252Bof%252BDiarylalkynes%25252F1%25252C4-Diaryl-1%25252C3-diynes%252Bby%252B%25255B9%25252C9-Dimethyl-4%25252C5-bis%252528diphenylphosphino%252529xanthene%25255D%252B%252528Xantphos%252529-Copper%252528I%252529%252BIodide-Palladium%252528II%252529%252BAcetate-Catalyzed%252BDouble%252BSonogashira-Type%252BReaction%26aulast%3DQiu%26aufirst%3DShaozhong%26date%3D2018%26date%3D2018%26volume%3D360%26issue%3D2%26spage%3D313%26epage%3D321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaodong  Ma</span>, <span class="hlFld-ContribAuthor ">Xiaoqing  Lv</span>, <span class="hlFld-ContribAuthor ">Jiankang  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Exploiting polypharmacology for improving therapeutic outcome of kinase inhibitors (KIs): An update of recent medicinal chemistry efforts. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>143 </em>, 449-463. <a href="https://doi.org/10.1016/j.ejmech.2017.11.049" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.11.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.11.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.11.049%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DExploiting%252Bpolypharmacology%252Bfor%252Bimproving%252Btherapeutic%252Boutcome%252Bof%252Bkinase%252Binhibitors%252B%252528KIs%252529%25253A%252BAn%252Bupdate%252Bof%252Brecent%252Bmedicinal%252Bchemistry%252Befforts%26aulast%3DMa%26aufirst%3DXiaodong%26date%3D2018%26volume%3D143%26spage%3D449%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Minhang  Xin</span>, <span class="hlFld-ContribAuthor ">Weiming  Duan</span>, <span class="hlFld-ContribAuthor ">Yifan  Feng</span>, <span class="hlFld-ContribAuthor ">Yuan-Yuan  Hei</span>, <span class="hlFld-ContribAuthor ">Hao  Zhang</span>, <span class="hlFld-ContribAuthor ">Ying  Shen</span>, <span class="hlFld-ContribAuthor ">Hong-Yi  Zhao</span>, <span class="hlFld-ContribAuthor ">Shuai  Mao</span>, <span class="hlFld-ContribAuthor ">San-Qi  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Introduction of pyrrolidineoxy or piperidineamino group at the 4-position of quinazoline leading to novel quinazoline-based phosphoinositide 3-kinase delta (PI3Kδ) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2018,</strong> <em>33 </em>
                                    (1)
                                     , 651-656. <a href="https://doi.org/10.1080/14756366.2018.1444608" title="DOI URL">https://doi.org/10.1080/14756366.2018.1444608</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2018.1444608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2018.1444608%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DIntroduction%252Bof%252Bpyrrolidineoxy%252Bor%252Bpiperidineamino%252Bgroup%252Bat%252Bthe%252B4-position%252Bof%252Bquinazoline%252Bleading%252Bto%252Bnovel%252Bquinazoline-based%252Bphosphoinositide%252B3-kinase%252Bdelta%252B%252528PI3K%2525CE%2525B4%252529%252Binhibitors%26aulast%3DXin%26aufirst%3DMinhang%26date%3D2018%26date%3D2018%26volume%3D33%26issue%3D1%26spage%3D651%26epage%3D656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Axel  Kleemann</span>. </span><span class="cited-content_cbyCitation_article-title">Antineoplastic and Immunomodulating Agents (L). </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 1-56. <a href="https://doi.org/10.1002/14356007.a05_001.pub3" title="DOI URL">https://doi.org/10.1002/14356007.a05_001.pub3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/14356007.a05_001.pub3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F14356007.a05_001.pub3%26sid%3Dliteratum%253Aachs%26atitle%3DAntineoplastic%252Band%252BImmunomodulating%252BAgents%252B%252528L%252529%26aulast%3DKleemann%26aufirst%3DAxel%26date%3D2017%26date%3D2017%26spage%3D1%26epage%3D56%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DUllmann%252527s%252BEncyclopedia%252Bof%252BIndustrial%252BChemistry%26date%3D2000%26date%3D2000%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ina  Terstiege</span>, <span class="hlFld-ContribAuthor ">Matthew  Perry</span>, <span class="hlFld-ContribAuthor ">Jens  Petersen</span>, <span class="hlFld-ContribAuthor ">Christian  Tyrchan</span>, <span class="hlFld-ContribAuthor ">Tor  Svensson</span>, <span class="hlFld-ContribAuthor ">Helena  Lindmark</span>, <span class="hlFld-ContribAuthor ">Linda  Öster</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of triazole aminopyrazines as a highly potent and selective series of PI3Kδ inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (3)
                                     , 679-687. <a href="https://doi.org/10.1016/j.bmcl.2016.11.004" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.11.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.11.004%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Btriazole%252Baminopyrazines%252Bas%252Ba%252Bhighly%252Bpotent%252Band%252Bselective%252Bseries%252Bof%252BPI3K%2525CE%2525B4%252Binhibitors%26aulast%3DTerstiege%26aufirst%3DIna%26date%3D2017%26volume%3D27%26issue%3D3%26spage%3D679%26epage%3D687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiu Xiu  Peng</span>, <span class="hlFld-ContribAuthor ">Kai Rui  Feng</span>, <span class="hlFld-ContribAuthor ">Yu Jie  Ren</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular modeling studies of quinazolinone derivatives as novel PI3Kδ selective inhibitors. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2017,</strong> <em>7 </em>
                                    (89)
                                     , 56344-56358. <a href="https://doi.org/10.1039/C7RA10870B" title="DOI URL">https://doi.org/10.1039/C7RA10870B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7RA10870B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7RA10870B%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DMolecular%252Bmodeling%252Bstudies%252Bof%252Bquinazolinone%252Bderivatives%252Bas%252Bnovel%252BPI3K%2525CE%2525B4%252Bselective%252Binhibitors%26aulast%3DPeng%26aufirst%3DXiu%2BXiu%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D89%26spage%3D56344%26epage%3D56358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Klemens  Hoegenauer</span>, <span class="hlFld-ContribAuthor ">Nicolas  Soldermann</span>, <span class="hlFld-ContribAuthor ">Christina  Hebach</span>, <span class="hlFld-ContribAuthor ">Gregory J.  Hollingworth</span>, <span class="hlFld-ContribAuthor ">Ian  Lewis</span>, <span class="hlFld-ContribAuthor ">Anette  von Matt</span>, <span class="hlFld-ContribAuthor ">Alexander B.  Smith</span>, <span class="hlFld-ContribAuthor ">Romain M.  Wolf</span>, <span class="hlFld-ContribAuthor ">Rainer  Wilcken</span>, <span class="hlFld-ContribAuthor ">Dorothea  Haasen</span>, <span class="hlFld-ContribAuthor ">Christoph  Burkhart</span>, <span class="hlFld-ContribAuthor ">Frédéric  Zécri</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel pyrrolidineoxy-substituted heteroaromatics as potent and selective PI3K delta inhibitors with improved physicochemical properties. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (23)
                                     , 5657-5662. <a href="https://doi.org/10.1016/j.bmcl.2016.10.069" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.10.069</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.10.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.10.069%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bnovel%252Bpyrrolidineoxy-substituted%252Bheteroaromatics%252Bas%252Bpotent%252Band%252Bselective%252BPI3K%252Bdelta%252Binhibitors%252Bwith%252Bimproved%252Bphysicochemical%252Bproperties%26aulast%3DHoegenauer%26aufirst%3DKlemens%26date%3D2016%26volume%3D26%26issue%3D23%26spage%3D5657%26epage%3D5662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emily E.  Way</span>, <span class="hlFld-ContribAuthor ">Giraldina  Trevejo-Nunez</span>, <span class="hlFld-ContribAuthor ">Lawrence P.  Kane</span>, <span class="hlFld-ContribAuthor ">Bart H.  Steiner</span>, <span class="hlFld-ContribAuthor ">Kamal D.  Puri</span>, <span class="hlFld-ContribAuthor ">Jay K.  Kolls</span>, <span class="hlFld-ContribAuthor ">Kong  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Dose-Dependent Suppression of Cytokine production from T cells by a Novel Phosphoinositide 3-Kinase Delta Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2016,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep30384" title="DOI URL">https://doi.org/10.1038/srep30384</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep30384&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep30384%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DDose-Dependent%252BSuppression%252Bof%252BCytokine%252Bproduction%252Bfrom%252BT%252Bcells%252Bby%252Ba%252BNovel%252BPhosphoinositide%252B3-Kinase%252BDelta%252BInhibitor%26aulast%3DWay%26aufirst%3DEmily%2BE.%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0022.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00213&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0024.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (a) Structure of idelalisib<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> (<b>1</b>). (b) 2.4 Å X-ray crystal structure of <b>1</b> bound in the PI3Kδ ATP-binding site (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4XE0">4XE0</a>). Idelalisib (<b>1</b>) binds in a propeller shape with the quinazolinone ring occupying an induced specificity pocket formed by Trp760 and Met752. The N3 of the purine hinge binder interacts with the backbone NH of Val828, while the N9 forms short contacts with the backbone carbonyl of Glu826. Blue dashed lines show hydrogen bond contacts between the inhibitor and protein. The Asn836 and Asp832 residues differ among the PI3K isoforms. For clarity, all other residues have been removed.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00213&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0025.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. PI3Kδ inhibitors in clinical trials.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00213&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0009.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00213&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) pyridine, HOP(OPh)<sub>2</sub>, 50 °C, 2 h, 100%; (ii) 50 °C 3–12 h, 50–100%; (iii) CF<sub>3</sub>COOH, CH<sub>2</sub>Cl<sub>2</sub>, rt, 0.5–4 h, 80–100%; (iv) <i>i</i>-Pr<sub>2</sub>NEt, IPA, 120 °C, microwave or thermal, 8–14 h, 30–95%.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0010.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00213&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, CuI, Et<sub>3</sub>N, toluene, 80 °C, 3 h, 65–80%; (ii) TBAF, THF; (iii) Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, CuI, Et<sub>3</sub>N, DMF, 90 °C, 3 h, 60–80%.</p></p></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Aldehyde oxidase mediated metabolism of <b>18</b> to its M + 16 metabolite <b>21</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00213&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. 2.85 Å X-ray crystal structure of <b>32</b> bound in the PI3Kδ ATP-binding site (PDB accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5I6U">5I6U</a>). In addition to the classic hinge binding interactions, the pyrazole ring forms hydrogen bonds to Lys779, Asp911, and Asp787 in the affinity pocket.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00213&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Aldehyde oxidase mediated metabolism of <b>31</b> to its metabolite <b>M1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00213&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. 2.4 Å X-ray crystal structure of <b>34</b> in PI3Kδ illustrates the triaminopyrimidine establishing hydrogen bonds to the hinge residues, Val828 and Glu826. A third hydrogen bond is accomplished between the N2 component of the triaminopyrimidine hinge binder and the carbonyl of Val828 (PDB accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5I4U">5I4U</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00213&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0005.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Concentration–time profiles of <b>52</b> in plasma following a 30 min intravenous infusion at 1 mg/kg and an oral dose at 5 mg/kg in female Lewis rats (mean ± SD, <i>n</i> = 3). The bioavailability of <b>52</b> was 106 ± 24%. The <i>C</i><sub>max</sub> was 2830 ± 942 nM at 1 h, and AUC<sub>inf</sub> was 17000 ± 3930 nM·h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00213&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0006.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Compound <b>52</b> ameliorates ankle swelling in rat established CIA model. Female Lewis rats with CIA were treated, twice daily by oral gavage, for 7 days (study days 10–16) with vehicle, <b>52</b> (0.34, 1.07, 4.6, or 10 mg/kg), or the reference compound dexamethasone (0.03 mg/kg). Caliper measurements of right and left ankle diameters were taken every day beginning on day 9 and continuing through day 16: (∗) <i>p</i> < 0.05 versus arthritis + vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00213&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0007.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Pharmacokinetic profile of <b>52</b> in Lewis rats with established CIA. Blood samples from each dose group animals at indicated time after dosing on days 3 and 7 were analyzed for plasma concentrations of <b>52</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00213&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/medium/jm-2016-002136_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0008.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Analog <b>52</b> ameliorated histopathological disease severity in rats with established CIA. Ankle and knee joint tissue, sections from all animals were examined microscopically and graded on a scale from 0 to 5 for each parameter based on the degree of severity: (∗) <i>p</i> < 0.05 versus arthritis + vehicle. See <a href="/doi/suppl/10.1021/acs.jmedchem.6b00213/suppl_file/jm6b00213_si_001.pdf" class="ext-link">Supporting Information</a> for scoring guidelines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00213/20160414/images/large/jm-2016-002136_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00213&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i86">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35011" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35011" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 20 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Engelman, J. A.</span><span> </span><span class="NLM_article-title">Targeting PI3K signalling in cancer: opportunities, challenges and limitations</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">550</span><span class="NLM_x">–</span> <span class="NLM_lpage">562</span><span class="refDoi"> DOI: 10.1038/nrc2664</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1038%2Fnrc2664" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=19629070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovFylsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=550-562&issue=8&author=J.+A.+Engelman&title=Targeting+PI3K+signalling+in+cancer%3A+opportunities%2C+challenges+and+limitations&doi=10.1038%2Fnrc2664"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting PI3K signalling in cancer: opportunities, challenges and limitations</span></div><div class="casAuthors">Engelman, Jeffrey A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">550-562</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There are ample genetic and lab. studies that suggest the PI3K-Akt pathway is vital to the growth and survival of cancer cells.  Inhibitors targeting this pathway are entering the clinic at a rapid pace.  In this Review, the therapeutic potential of drugs targeting PI3K-Akt signaling for the treatment of cancer is discussed.  I focus on the advantages and drawbacks of different treatment strategies for targeting this pathway, the cancers that might respond best to these therapies and the challenges and limitations that confront their clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCwdUnGEC20LVg90H21EOLACvtfcHk0lgrPh9GCOhzqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovFylsrg%253D&md5=f0d4cc1fabf879e95f8b76e48cc9c1ad</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1038%2Fnrc2664&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2664%26sid%3Dliteratum%253Aachs%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26atitle%3DTargeting%2520PI3K%2520signalling%2520in%2520cancer%253A%2520opportunities%252C%2520challenges%2520and%2520limitations%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26issue%3D8%26spage%3D550%26epage%3D562%26doi%3D10.1038%2Fnrc2664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Witzig, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, M.</span><span> </span><span class="NLM_article-title">Signal transduction inhibitor therapy for lymphoma</span> <span class="citation_source-journal">Hematology A. Soc. Hemato. Educ. Program</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2010</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">270</span><span class="refDoi"> DOI: 10.1182/asheducation-2010.1.265</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1182%2Fasheducation-2010.1.265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=21239804" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2010&publication_year=2010&pages=265-270&author=T.+E.+Witzigauthor=M.+Gupta&title=Signal+transduction+inhibitor+therapy+for+lymphoma&doi=10.1182%2Fasheducation-2010.1.265"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1182%2Fasheducation-2010.1.265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fasheducation-2010.1.265%26sid%3Dliteratum%253Aachs%26aulast%3DWitzig%26aufirst%3DT.%2BE.%26aulast%3DGupta%26aufirst%3DM.%26atitle%3DSignal%2520transduction%2520inhibitor%2520therapy%2520for%2520lymphoma%26jtitle%3DHematology%2520A.%2520Soc.%2520Hemato.%2520Educ.%2520Program%26date%3D2010%26volume%3D2010%26spage%3D265%26epage%3D270%26doi%3D10.1182%2Fasheducation-2010.1.265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lannutti, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meadows, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herman, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashishian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrd, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyner, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loriaux, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deininger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druker, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puri, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulrich, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giese, N. A.</span><span> </span><span class="NLM_article-title">CAL-101, a p110delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">591</span><span class="NLM_x">–</span> <span class="NLM_lpage">594</span><span class="refDoi"> DOI: 10.1182/blood-2010-03-275305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1182%2Fblood-2010-03-275305" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2011&pages=591-594&issue=2&author=B.+J.+Lannuttiauthor=S.+A.+Meadowsauthor=S.+E.+Hermanauthor=A.+Kashishianauthor=B.+Steinerauthor=A.+J.+Johnsonauthor=J.+C.+Byrdauthor=J.+W.+Tynerauthor=M.+M.+Loriauxauthor=M.+Deiningerauthor=B.+J.+Drukerauthor=K.+D.+Puriauthor=R.+G.+Ulrichauthor=N.+A.+Giese&title=CAL-101%2C+a+p110delta+selective+phosphatidylinositol-3-kinase+inhibitor+for+the+treatment+of+B-cell+malignancies%2C+inhibits+PI3K+signaling+and+cellular+viability&doi=10.1182%2Fblood-2010-03-275305"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1182%2Fblood-2010-03-275305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2010-03-275305%26sid%3Dliteratum%253Aachs%26aulast%3DLannutti%26aufirst%3DB.%2BJ.%26aulast%3DMeadows%26aufirst%3DS.%2BA.%26aulast%3DHerman%26aufirst%3DS.%2BE.%26aulast%3DKashishian%26aufirst%3DA.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DJohnson%26aufirst%3DA.%2BJ.%26aulast%3DByrd%26aufirst%3DJ.%2BC.%26aulast%3DTyner%26aufirst%3DJ.%2BW.%26aulast%3DLoriaux%26aufirst%3DM.%2BM.%26aulast%3DDeininger%26aufirst%3DM.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DPuri%26aufirst%3DK.%2BD.%26aulast%3DUlrich%26aufirst%3DR.%2BG.%26aulast%3DGiese%26aufirst%3DN.%2BA.%26atitle%3DCAL-101%252C%2520a%2520p110delta%2520selective%2520phosphatidylinositol-3-kinase%2520inhibitor%2520for%2520the%2520treatment%2520of%2520B-cell%2520malignancies%252C%2520inhibits%2520PI3K%2520signaling%2520and%2520cellular%2520viability%26jtitle%3DBlood%26date%3D2011%26volume%3D117%26issue%3D2%26spage%3D591%26epage%3D594%26doi%3D10.1182%2Fblood-2010-03-275305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Meadows, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashishian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diehl, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Younes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lannutti, B. J.</span><span> </span><span class="NLM_article-title">PI3Kdelta inhibitor, GS-1101 (CAL-101), attenuates pathway signaling, induces apoptosis, and overcomes signals from the microenvironment in cellular models of Hodgkin lymphoma</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1897</span><span class="NLM_x">–</span> <span class="NLM_lpage">1900</span><span class="refDoi"> DOI: 10.1182/blood-2011-10-386763</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1182%2Fblood-2011-10-386763" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2012&pages=1897-1900&issue=8&author=S.+A.+Meadowsauthor=F.+Vegaauthor=A.+Kashishianauthor=D.+Johnsonauthor=V.+Diehlauthor=L.+L.+Millerauthor=A.+Younesauthor=B.+J.+Lannutti&title=PI3Kdelta+inhibitor%2C+GS-1101+%28CAL-101%29%2C+attenuates+pathway+signaling%2C+induces+apoptosis%2C+and+overcomes+signals+from+the+microenvironment+in+cellular+models+of+Hodgkin+lymphoma&doi=10.1182%2Fblood-2011-10-386763"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=10.1182%2Fblood-2011-10-386763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2011-10-386763%26sid%3Dliteratum%253Aachs%26aulast%3DMeadows%26aufirst%3DS.%2BA.%26aulast%3DVega%26aufirst%3DF.%26aulast%3DKashishian%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DD.%26aulast%3DDiehl%26aufirst%3DV.%26aulast%3DMiller%26aufirst%3DL.%2BL.%26aulast%3DYounes%26aufirst%3DA.%26aulast%3DLannutti%26aufirst%3DB.%2BJ.%26atitle%3DPI3Kdelta%2520inhibitor%252C%2520GS-1101%2520%2528CAL-101%2529%252C%2520attenuates%2520pathway%2520signaling%252C%2520induces%2520apoptosis%252C%2520and%2520overcomes%2520signals%2520from%2520the%2520microenvironment%2520in%2520cellular%2520models%2520of%2520Hodgkin%2520lymphoma%26jtitle%3DBlood%26date%3D2012%26volume%3D119%26issue%3D8%26spage%3D1897%26epage%3D1900%26doi%3D10.1182%2Fblood-2011-10-386763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lemmon, M. A.</span><span> </span><span class="NLM_article-title">Membrane recognition by phospholipid-binding domains</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">111</span><span class="refDoi"> DOI: 10.1038/nrm2328</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1038%2Fnrm2328" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=18216767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovFOntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=99-111&issue=2&author=M.+A.+Lemmon&title=Membrane+recognition+by+phospholipid-binding+domains&doi=10.1038%2Fnrm2328"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane recognition by phospholipid-binding domains</span></div><div class="casAuthors">Lemmon, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-111</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Many different globular domains bind to the surfaces of cellular membranes, or to specific phospholipid components in these membranes, and this binding is often tightly regulated.  Examples include pleckstrin homol. and C2 domains, which are among the largest domain families in the human proteome.  Crystal structures, binding studies, and analyses of subcellular localization have provided much insight into how members of this diverse group of domains bind to membranes, what features they recognize and how binding is controlled.  A full appreciation of these processes is crucial for understanding how protein localization and membrane topog. and trafficking are regulated in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM8KKjaRpyL7Vg90H21EOLACvtfcHk0lgC2Q78cucmFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovFOntQ%253D%253D&md5=dd633108d380d534c7af57d31cfb2bd1</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1038%2Fnrm2328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2328%26sid%3Dliteratum%253Aachs%26aulast%3DLemmon%26aufirst%3DM.%2BA.%26atitle%3DMembrane%2520recognition%2520by%2520phospholipid-binding%2520domains%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2008%26volume%3D9%26issue%3D2%26spage%3D99%26epage%3D111%26doi%3D10.1038%2Fnrm2328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bilancio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okkenhaug, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camps, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emery, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruckle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanhaesebroeck, B.</span><span> </span><span class="NLM_article-title">Key role of the p110delta isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110delta function in B cells</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">642</span><span class="NLM_x">–</span> <span class="NLM_lpage">650</span><span class="refDoi"> DOI: 10.1182/blood-2005-07-3041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1182%2Fblood-2005-07-3041" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2006&pages=642-650&issue=2&author=A.+Bilancioauthor=K.+Okkenhaugauthor=M.+Campsauthor=J.+L.+Emeryauthor=T.+Ruckleauthor=C.+Rommelauthor=B.+Vanhaesebroeck&title=Key+role+of+the+p110delta+isoform+of+PI3K+in+B-cell+antigen+and+IL-4+receptor+signaling%3A+comparative+analysis+of+genetic+and+pharmacologic+interference+with+p110delta+function+in+B+cells&doi=10.1182%2Fblood-2005-07-3041"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1182%2Fblood-2005-07-3041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2005-07-3041%26sid%3Dliteratum%253Aachs%26aulast%3DBilancio%26aufirst%3DA.%26aulast%3DOkkenhaug%26aufirst%3DK.%26aulast%3DCamps%26aufirst%3DM.%26aulast%3DEmery%26aufirst%3DJ.%2BL.%26aulast%3DRuckle%26aufirst%3DT.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DVanhaesebroeck%26aufirst%3DB.%26atitle%3DKey%2520role%2520of%2520the%2520p110delta%2520isoform%2520of%2520PI3K%2520in%2520B-cell%2520antigen%2520and%2520IL-4%2520receptor%2520signaling%253A%2520comparative%2520analysis%2520of%2520genetic%2520and%2520pharmacologic%2520interference%2520with%2520p110delta%2520function%2520in%2520B%2520cells%26jtitle%3DBlood%26date%3D2006%26volume%3D107%26issue%3D2%26spage%3D642%26epage%3D650%26doi%3D10.1182%2Fblood-2005-07-3041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Chantry, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vojtek, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashishian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holtzman, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoekstra, M. F.</span><span> </span><span class="NLM_article-title">p110δ, a novel phosphatidylinositol 3-kinase catalytic subunit that associates with p85 and is expressed predominantly in leukocytes</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x"> (</span><span class="NLM_issue">31</span><span class="NLM_x">) </span> <span class="NLM_fpage">19236</span><span class="NLM_x">–</span> <span class="NLM_lpage">19241</span><span class="refDoi"> DOI: 10.1074/jbc.272.31.19236</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1074%2Fjbc.272.31.19236" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=19236-19241&issue=31&author=D.+Chantryauthor=A.+Vojtekauthor=A.+Kashishianauthor=D.+A.+Holtzmanauthor=C.+Woodauthor=P.+W.+Grayauthor=J.+A.+Cooperauthor=M.+F.+Hoekstra&title=p110%CE%B4%2C+a+novel+phosphatidylinositol+3-kinase+catalytic+subunit+that+associates+with+p85+and+is+expressed+predominantly+in+leukocytes&doi=10.1074%2Fjbc.272.31.19236"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.31.19236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.31.19236%26sid%3Dliteratum%253Aachs%26aulast%3DChantry%26aufirst%3DD.%26aulast%3DVojtek%26aufirst%3DA.%26aulast%3DKashishian%26aufirst%3DA.%26aulast%3DHoltzman%26aufirst%3DD.%2BA.%26aulast%3DWood%26aufirst%3DC.%26aulast%3DGray%26aufirst%3DP.%2BW.%26aulast%3DCooper%26aufirst%3DJ.%2BA.%26aulast%3DHoekstra%26aufirst%3DM.%2BF.%26atitle%3Dp110%25CE%25B4%252C%2520a%2520novel%2520phosphatidylinositol%25203-kinase%2520catalytic%2520subunit%2520that%2520associates%2520with%2520p85%2520and%2520is%2520expressed%2520predominantly%2520in%2520leukocytes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26issue%3D31%26spage%3D19236%26epage%3D19241%26doi%3D10.1074%2Fjbc.272.31.19236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Bernal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastore, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asgary, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesarman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liou, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schattner, E. J.</span><span> </span><span class="NLM_article-title">Survival of leukemic B cells promoted by engagement of the antigen receptor</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">3050</span><span class="NLM_x">–</span> <span class="NLM_lpage">3057</span><span class="refDoi"> DOI: 10.1182/blood.V98.10.3050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1182%2Fblood.V98.10.3050" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=3050-3057&issue=10&author=A.+Bernalauthor=R.+D.+Pastoreauthor=Z.+Asgaryauthor=S.+A.+Kellerauthor=E.+Cesarmanauthor=H.+C.+Liouauthor=E.+J.+Schattner&title=Survival+of+leukemic+B+cells+promoted+by+engagement+of+the+antigen+receptor&doi=10.1182%2Fblood.V98.10.3050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1182%2Fblood.V98.10.3050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood.V98.10.3050%26sid%3Dliteratum%253Aachs%26aulast%3DBernal%26aufirst%3DA.%26aulast%3DPastore%26aufirst%3DR.%2BD.%26aulast%3DAsgary%26aufirst%3DZ.%26aulast%3DKeller%26aufirst%3DS.%2BA.%26aulast%3DCesarman%26aufirst%3DE.%26aulast%3DLiou%26aufirst%3DH.%2BC.%26aulast%3DSchattner%26aufirst%3DE.%2BJ.%26atitle%3DSurvival%2520of%2520leukemic%2520B%2520cells%2520promoted%2520by%2520engagement%2520of%2520the%2520antigen%2520receptor%26jtitle%3DBlood%26date%3D2001%26volume%3D98%26issue%3D10%26spage%3D3050%26epage%3D3057%26doi%3D10.1182%2Fblood.V98.10.3050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Bartok, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bugbee, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Firestein, G. S.</span><span> </span><span class="NLM_article-title">PI3 kinase δ is a key regulator of synoviocyte function in rheumatoid arthritis</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">180</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1906</span><span class="NLM_x">–</span> <span class="NLM_lpage">1916</span><span class="refDoi"> DOI: 10.1016/j.ajpath.2012.01.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1016%2Fj.ajpath.2012.01.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=22433439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsF2ksbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2012&pages=1906-1916&issue=5&author=B.+Bartokauthor=D.+L.+Boyleauthor=Y.+Liuauthor=P.+Renauthor=S.+T.+Ballauthor=W.+D.+Bugbeeauthor=C.+Rommelauthor=G.+S.+Firestein&title=PI3+kinase+%CE%B4+is+a+key+regulator+of+synoviocyte+function+in+rheumatoid+arthritis&doi=10.1016%2Fj.ajpath.2012.01.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">PI3 kinase δ is a key regulator of synoviocyte function in rheumatoid arthritis</span></div><div class="casAuthors">Bartok, Beatrix; Boyle, David L.; Liu, Yi; Ren, Pingda; Ball, Scott T.; Bugbee, William D.; Rommel, Christian; Firestein, Gary S.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1906-1916</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Class I phosphoinositide 3 kinase (PI3K) δ is a promising therapeutic target for rheumatoid arthritis (RA) because of its contribution to leukocyte biol.  However, its contribution in fibroblasts has not been studied as a mechanism that contributes to efficacy.  We investigated the expression and function of PI3Kδ in synovium and cultured fibroblast-like synoviocytes (FLS).  Immunohistochem. demonstrated that PI3Kδ is highly expressed in RA synovium, esp. in the synovial lining.  Using quant. PCR and Western blot anal., we found that PI3Kδ mRNA and protein expression is higher in RA than in osteoarthritis (OA) synovium.  PI3Kδ was also expressed in cultured FLS, along with PI3Kα and PI3Kβ, whereas PI3Kγ was not detectable.  PI3Kδ mRNA expression was selectively induced by inflammatory cytokines tumor necrosis factor (TNF) and interleukin-1 (IL-1) but not by growth factors platelet-derived growth factor (PDGF) and transforming growth factor β (TGFβ).  The use of inhibitors that block individual PI3K isoforms, including the novel selective PI3Kδ inhibitor EVK007, showed that PI3Kδ is required for PDGF- and TNF-induced Akt activation.  PI3Kδ inhibition also diminished PDGF-mediated synoviocyte growth and sensitized cells to H2O2-induced apoptosis.  These data are the first documentation of increased PI3Kδ expression in both RA synovium and cultured synoviocytes.  Furthermore, these are the first data demonstrating that PI3Kδ is a major regulator of PDGF-mediated fibroblast growth and survival via Akt.  Thus, targeting PI3Kδ in RA could modulate synoviocyte function via anti-inflammatory and disease-altering mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjfN_H4ikqvrVg90H21EOLACvtfcHk0lgasq-wvJ3SBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsF2ksbs%253D&md5=60cbfbf9ba761bb351eee34612ccf45b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2012.01.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2012.01.030%26sid%3Dliteratum%253Aachs%26aulast%3DBartok%26aufirst%3DB.%26aulast%3DBoyle%26aufirst%3DD.%2BL.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DRen%26aufirst%3DP.%26aulast%3DBall%26aufirst%3DS.%2BT.%26aulast%3DBugbee%26aufirst%3DW.%2BD.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DFirestein%26aufirst%3DG.%2BS.%26atitle%3DPI3%2520kinase%2520%25CE%25B4%2520is%2520a%2520key%2520regulator%2520of%2520synoviocyte%2520function%2520in%2520rheumatoid%2520arthritis%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2012%26volume%3D180%26issue%3D5%26spage%3D1906%26epage%3D1916%26doi%3D10.1016%2Fj.ajpath.2012.01.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Randis, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puri, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diacovo, T. G.</span><span> </span><span class="NLM_article-title">Role of PI3Kδ and PI3Kγ in inflammatory arthritis and tissue localization of neutrophils</span> <span class="citation_source-journal">Eur. J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1215</span><span class="NLM_x">–</span> <span class="NLM_lpage">1224</span><span class="refDoi"> DOI: 10.1002/eji.200838266</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1002%2Feji.200838266" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2008&pages=1215-1224&issue=5&author=T.+M.+Randisauthor=K.+D.+Puriauthor=H.+Zhouauthor=T.+G.+Diacovo&title=Role+of+PI3K%CE%B4+and+PI3K%CE%B3+in+inflammatory+arthritis+and+tissue+localization+of+neutrophils&doi=10.1002%2Feji.200838266"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Feji.200838266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Feji.200838266%26sid%3Dliteratum%253Aachs%26aulast%3DRandis%26aufirst%3DT.%2BM.%26aulast%3DPuri%26aufirst%3DK.%2BD.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DDiacovo%26aufirst%3DT.%2BG.%26atitle%3DRole%2520of%2520PI3K%25CE%25B4%2520and%2520PI3K%25CE%25B3%2520in%2520inflammatory%2520arthritis%2520and%2520tissue%2520localization%2520of%2520neutrophils%26jtitle%3DEur.%2520J.%2520Immunol.%26date%3D2008%26volume%3D38%26issue%3D5%26spage%3D1215%26epage%3D1224%26doi%3D10.1002%2Feji.200838266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Ali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilancio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearce, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilfillan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tkaczyk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuehn, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giddings, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peskett, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruce, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okkenhaug, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanhaesebroeck, B.</span><span> </span><span class="NLM_article-title">Essential role for the p110delta phosphoinositide 3-kinase in the allergic response</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">431</span><span class="NLM_x"> (</span><span class="NLM_issue">7011</span><span class="NLM_x">) </span> <span class="NLM_fpage">1007</span><span class="NLM_x">–</span> <span class="NLM_lpage">1011</span><span class="refDoi"> DOI: 10.1038/nature02991</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1038%2Fnature02991" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=431&publication_year=2004&pages=1007-1011&issue=7011&author=K.+Aliauthor=A.+Bilancioauthor=M.+Thomasauthor=W.+Pearceauthor=A.+M.+Gilfillanauthor=C.+Tkaczykauthor=N.+Kuehnauthor=A.+Grayauthor=J.+Giddingsauthor=E.+Peskettauthor=R.+Foxauthor=I.+Bruceauthor=C.+Walkerauthor=C.+Sawyerauthor=K.+Okkenhaugauthor=P.+Finanauthor=B.+Vanhaesebroeck&title=Essential+role+for+the+p110delta+phosphoinositide+3-kinase+in+the+allergic+response&doi=10.1038%2Fnature02991"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature02991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02991%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DK.%26aulast%3DBilancio%26aufirst%3DA.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DPearce%26aufirst%3DW.%26aulast%3DGilfillan%26aufirst%3DA.%2BM.%26aulast%3DTkaczyk%26aufirst%3DC.%26aulast%3DKuehn%26aufirst%3DN.%26aulast%3DGray%26aufirst%3DA.%26aulast%3DGiddings%26aufirst%3DJ.%26aulast%3DPeskett%26aufirst%3DE.%26aulast%3DFox%26aufirst%3DR.%26aulast%3DBruce%26aufirst%3DI.%26aulast%3DWalker%26aufirst%3DC.%26aulast%3DSawyer%26aufirst%3DC.%26aulast%3DOkkenhaug%26aufirst%3DK.%26aulast%3DFinan%26aufirst%3DP.%26aulast%3DVanhaesebroeck%26aufirst%3DB.%26atitle%3DEssential%2520role%2520for%2520the%2520p110delta%2520phosphoinositide%25203-kinase%2520in%2520the%2520allergic%2520response%26jtitle%3DNature%26date%3D2004%26volume%3D431%26issue%3D7011%26spage%3D1007%26epage%3D1011%26doi%3D10.1038%2Fnature02991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Puri, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doggett, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douangpanya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tino, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clayton, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayflick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diacovo, T. G.</span><span> </span><span class="NLM_article-title">Mechanisms and implications of phosphoinositide 3-kinase delta in promoting neutrophil trafficking into inflamed tissue</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">3448</span><span class="NLM_x">–</span> <span class="NLM_lpage">3456</span><span class="refDoi"> DOI: 10.1182/blood-2003-05-1667</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1182%2Fblood-2003-05-1667" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2004&pages=3448-3456&issue=9&author=K.+D.+Puriauthor=T.+A.+Doggettauthor=J.+Douangpanyaauthor=Y.+Houauthor=W.+T.+Tinoauthor=T.+Wilsonauthor=T.+Grafauthor=E.+Claytonauthor=M.+Turnerauthor=J.+S.+Hayflickauthor=T.+G.+Diacovo&title=Mechanisms+and+implications+of+phosphoinositide+3-kinase+delta+in+promoting+neutrophil+trafficking+into+inflamed+tissue&doi=10.1182%2Fblood-2003-05-1667"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1182%2Fblood-2003-05-1667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2003-05-1667%26sid%3Dliteratum%253Aachs%26aulast%3DPuri%26aufirst%3DK.%2BD.%26aulast%3DDoggett%26aufirst%3DT.%2BA.%26aulast%3DDouangpanya%26aufirst%3DJ.%26aulast%3DHou%26aufirst%3DY.%26aulast%3DTino%26aufirst%3DW.%2BT.%26aulast%3DWilson%26aufirst%3DT.%26aulast%3DGraf%26aufirst%3DT.%26aulast%3DClayton%26aufirst%3DE.%26aulast%3DTurner%26aufirst%3DM.%26aulast%3DHayflick%26aufirst%3DJ.%2BS.%26aulast%3DDiacovo%26aufirst%3DT.%2BG.%26atitle%3DMechanisms%2520and%2520implications%2520of%2520phosphoinositide%25203-kinase%2520delta%2520in%2520promoting%2520neutrophil%2520trafficking%2520into%2520inflamed%2520tissue%26jtitle%3DBlood%26date%3D2004%26volume%3D103%26issue%3D9%26spage%3D3448%26epage%3D3456%26doi%3D10.1182%2Fblood-2003-05-1667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Soond, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjorgo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moltu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dale, V. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patton, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torgersen, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galleway, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Twomey, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaston, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasken, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunyard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okkenhaug, K.</span><span> </span><span class="NLM_article-title">PI3K p110delta regulates T-cell cytokine production during primary and secondary immune responses in mice and humans</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">2203</span><span class="NLM_x">–</span> <span class="NLM_lpage">2213</span><span class="refDoi"> DOI: 10.1182/blood-2009-07-232330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1182%2Fblood-2009-07-232330" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2010&pages=2203-2213&issue=11&author=D.+R.+Soondauthor=E.+Bjorgoauthor=K.+Moltuauthor=V.+Q.+Daleauthor=D.+T.+Pattonauthor=K.+M.+Torgersenauthor=F.+Gallewayauthor=B.+Twomeyauthor=J.+Clarkauthor=J.+S.+Gastonauthor=K.+Taskenauthor=P.+Bunyardauthor=K.+Okkenhaug&title=PI3K+p110delta+regulates+T-cell+cytokine+production+during+primary+and+secondary+immune+responses+in+mice+and+humans&doi=10.1182%2Fblood-2009-07-232330"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1182%2Fblood-2009-07-232330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2009-07-232330%26sid%3Dliteratum%253Aachs%26aulast%3DSoond%26aufirst%3DD.%2BR.%26aulast%3DBjorgo%26aufirst%3DE.%26aulast%3DMoltu%26aufirst%3DK.%26aulast%3DDale%26aufirst%3DV.%2BQ.%26aulast%3DPatton%26aufirst%3DD.%2BT.%26aulast%3DTorgersen%26aufirst%3DK.%2BM.%26aulast%3DGalleway%26aufirst%3DF.%26aulast%3DTwomey%26aufirst%3DB.%26aulast%3DClark%26aufirst%3DJ.%26aulast%3DGaston%26aufirst%3DJ.%2BS.%26aulast%3DTasken%26aufirst%3DK.%26aulast%3DBunyard%26aufirst%3DP.%26aulast%3DOkkenhaug%26aufirst%3DK.%26atitle%3DPI3K%2520p110delta%2520regulates%2520T-cell%2520cytokine%2520production%2520during%2520primary%2520and%2520secondary%2520immune%2520responses%2520in%2520mice%2520and%2520humans%26jtitle%3DBlood%26date%3D2010%26volume%3D115%26issue%3D11%26spage%3D2203%26epage%3D2213%26doi%3D10.1182%2Fblood-2009-07-232330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Somoza, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koditek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villasenor, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novikov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liclican, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagpacan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papalia, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lad, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrath, M. E.</span><span> </span><span class="NLM_article-title">Structural, biochemical, and biophysical characterization of idelalisib binding to phosphoinositide 3-kinase δ</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">8439</span><span class="NLM_x">–</span> <span class="NLM_lpage">8446</span><span class="refDoi"> DOI: 10.1074/jbc.M114.634683</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1074%2Fjbc.M114.634683" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=8439-8446&issue=13&author=J.+R.+Somozaauthor=D.+Koditekauthor=A.+G.+Villasenorauthor=N.+Novikovauthor=M.+H.+Wongauthor=A.+Liclicanauthor=W.+Xingauthor=L.+Lagpacanauthor=R.+Wangauthor=B.+E.+Schultzauthor=G.+A.+Papaliaauthor=D.+Samuelauthor=L.+Ladauthor=M.+E.+McGrath&title=Structural%2C+biochemical%2C+and+biophysical+characterization+of+idelalisib+binding+to+phosphoinositide+3-kinase+%CE%B4&doi=10.1074%2Fjbc.M114.634683"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.634683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.634683%26sid%3Dliteratum%253Aachs%26aulast%3DSomoza%26aufirst%3DJ.%2BR.%26aulast%3DKoditek%26aufirst%3DD.%26aulast%3DVillasenor%26aufirst%3DA.%2BG.%26aulast%3DNovikov%26aufirst%3DN.%26aulast%3DWong%26aufirst%3DM.%2BH.%26aulast%3DLiclican%26aufirst%3DA.%26aulast%3DXing%26aufirst%3DW.%26aulast%3DLagpacan%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DSchultz%26aufirst%3DB.%2BE.%26aulast%3DPapalia%26aufirst%3DG.%2BA.%26aulast%3DSamuel%26aufirst%3DD.%26aulast%3DLad%26aufirst%3DL.%26aulast%3DMcGrath%26aufirst%3DM.%2BE.%26atitle%3DStructural%252C%2520biochemical%252C%2520and%2520biophysical%2520characterization%2520of%2520idelalisib%2520binding%2520to%2520phosphoinositide%25203-kinase%2520%25CE%25B4%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26issue%3D13%26spage%3D8439%26epage%3D8446%26doi%3D10.1074%2Fjbc.M114.634683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Berndt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houseman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacold, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorrec, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hon, W.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaillard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruckle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. L.</span><span> </span><span class="NLM_article-title">The p110δ crystal structure uncovers mechanisms for selectivity and potency of novel PI3K inhibitors</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span><span class="refDoi"> DOI: 10.1038/nchembio.293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1038%2Fnchembio.293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=20081827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvFGrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=117-124&issue=2&author=A.+Berndtauthor=S.+Millerauthor=O.+Williamsauthor=D.+D.+Leauthor=B.+T.+Housemanauthor=J.+I.+Pacoldauthor=F.+Gorrecauthor=W.-C.+Honauthor=Y.+Liuauthor=C.+Rommelauthor=P.+Gaillardauthor=T.+Ruckleauthor=M.+K.+Schwarzauthor=K.+M.+Shokatauthor=J.+P.+Shawauthor=R.+L.+Williams&title=The+p110%CE%B4+crystal+structure+uncovers+mechanisms+for+selectivity+and+potency+of+novel+PI3K+inhibitors&doi=10.1038%2Fnchembio.293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors</span></div><div class="casAuthors">Berndt, Alex; Miller, Simon; Williams, Olusegun; Le, Daniel D.; Houseman, Benjamin T.; Pacold, Joseph I.; Gorrec, Fabrice; Hon, Wai-Ching; Liu, Yi; Rommel, Christian; Gaillard, Pascale; Rueckle, Thomas; Schwarz, Matthias K.; Shokat, Kevan M.; Shaw, Jeffrey P.; Williams, Roger L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">117-124</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Deregulation of the phosphoinositide-3-OH kinase (PI(3)K) pathway has been implicated in numerous pathologies including cancer, diabetes, thrombosis, rheumatoid arthritis, and asthma.  Recently, small-mol. and ATP-competitive PI(3)K inhibitors with a wide range of selectivities have entered clin. development.  To understand the mechanisms underlying the isoform selectivity of these inhibitors, we developed a new expression strategy that enabled us to det. to our knowledge the first crystal structure of the catalytic subunit of the class IA PI(3)K p110δ.  Structures of this enzyme in complex with a broad panel of isoform- and pan-selective class I PI(3)K inhibitors reveal that selectivity toward p110δ can be achieved by exploiting its conformational flexibility and the sequence diversity of active site residues that do not contact ATP.  We have used these observations to rationalize and synthesize highly selective inhibitors for p110δ with greatly improved potencies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL8d01cEl_y7Vg90H21EOLACvtfcHk0ljjgng3QSQW4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvFGrsw%253D%253D&md5=8a0ce73ab8ca88ea9a48a2cb7fdb1975</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.293%26sid%3Dliteratum%253Aachs%26aulast%3DBerndt%26aufirst%3DA.%26aulast%3DMiller%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DO.%26aulast%3DLe%26aufirst%3DD.%2BD.%26aulast%3DHouseman%26aufirst%3DB.%2BT.%26aulast%3DPacold%26aufirst%3DJ.%2BI.%26aulast%3DGorrec%26aufirst%3DF.%26aulast%3DHon%26aufirst%3DW.-C.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DRommel%26aufirst%3DC.%26aulast%3DGaillard%26aufirst%3DP.%26aulast%3DRuckle%26aufirst%3DT.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DShaw%26aufirst%3DJ.%2BP.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26atitle%3DThe%2520p110%25CE%25B4%2520crystal%2520structure%2520uncovers%2520mechanisms%2520for%2520selectivity%2520and%2520potency%2520of%2520novel%2520PI3K%2520inhibitors%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26issue%3D2%26spage%3D117%26epage%3D124%26doi%3D10.1038%2Fnchembio.293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunder, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldenberg, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loewith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokoe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">A pharmacological map of the PI3-K family defines a role for p110α in insulin signaling</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">733</span><span class="NLM_x">–</span> <span class="NLM_lpage">747</span><span class="refDoi"> DOI: 10.1016/j.cell.2006.03.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1016%2Fj.cell.2006.03.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=16647110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=1%3ACAS%3A528%3ADC%252BD28XltlSkt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2006&pages=733-747&issue=4&author=Z.+A.+Knightauthor=B.+Gonzalezauthor=M.+E.+Feldmanauthor=E.+R.+Zunderauthor=D.+D.+Goldenbergauthor=O.+Williamsauthor=R.+Loewithauthor=D.+Stokoeauthor=A.+Ballaauthor=B.+Tothauthor=T.+Ballaauthor=W.+A.+Weissauthor=R.+L.+Williamsauthor=K.+M.+Shokat&title=A+pharmacological+map+of+the+PI3-K+family+defines+a+role+for+p110%CE%B1+in+insulin+signaling&doi=10.1016%2Fj.cell.2006.03.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">A pharmacological map of the PI3-K family defines a role for p110α in insulin signaling</span></div><div class="casAuthors">Knight, Zachary A.; Gonzalez, Beatriz; Feldman, Morri E.; Zunder, Eli R.; Goldenberg, David D.; Williams, Olusegun; Loewith, Robbie; Stokoe, David; Balla, Andras; Toth, Balazs; Balla, Tamas; Weiss, William A.; Williams, Roger L.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">733-747</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Phosphoinositide 3-kinases (PI3-Ks) are an important emerging class of drug targets, but the unique roles of PI3-K isoforms remain poorly defined.  We describe here an approach to pharmacol. interrogate the PI3-K family.  A chem. diverse panel of PI3-K inhibitors was synthesized, and their target selectivity was biochem. enumerated, revealing cryptic homologies across targets and chemotypes.  Crystal structures of three inhibitors bound to p110γ identify a conformationally mobile region that is uniquely exploited by selective compds.  This chem. array was then used to define the PI3-K isoforms required for insulin signaling.  We find that p110α is the primary insulin-responsive PI3-K in cultured cells, whereas p110β is dispensable but sets a phenotypic threshold for p110α activity.  Compds. targeting p110α block the acute effects of insulin treatment in vivo, whereas a p110β inhibitor has no effect.  These results illustrate systematic target validation using a matrix of inhibitors that span a protein family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrozjvOeMXP3bVg90H21EOLACvtfcHk0ljR639iXfCQew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltlSkt7o%253D&md5=b95a8cb433927ff9a75b33fc4ac2c8a0</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.03.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.03.035%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DGonzalez%26aufirst%3DB.%26aulast%3DFeldman%26aufirst%3DM.%2BE.%26aulast%3DZunder%26aufirst%3DE.%2BR.%26aulast%3DGoldenberg%26aufirst%3DD.%2BD.%26aulast%3DWilliams%26aufirst%3DO.%26aulast%3DLoewith%26aufirst%3DR.%26aulast%3DStokoe%26aufirst%3DD.%26aulast%3DBalla%26aufirst%3DA.%26aulast%3DToth%26aufirst%3DB.%26aulast%3DBalla%26aufirst%3DT.%26aulast%3DWeiss%26aufirst%3DW.%2BA.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DA%2520pharmacological%2520map%2520of%2520the%2520PI3-K%2520family%2520defines%2520a%2520role%2520for%2520p110%25CE%25B1%2520in%2520insulin%2520signaling%26jtitle%3DCell%26date%3D2006%26volume%3D125%26issue%3D4%26spage%3D733%26epage%3D747%26doi%3D10.1016%2Fj.cell.2006.03.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Chemically targeting the PI3K family</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">245</span><span class="NLM_x">–</span> <span class="NLM_lpage">249</span><span class="refDoi"> DOI: 10.1042/BST0350245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1042%2FBST0350245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=17371250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjt1Wrsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=245-249&issue=2&author=Z.+A.+Knightauthor=K.+M.+Shokat&title=Chemically+targeting+the+PI3K+family&doi=10.1042%2FBST0350245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">Chemically targeting the PI3K family</span></div><div class="casAuthors">Knight, Z. A.; Shokat, K. M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">245-249</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  PI3K (phosphoinositide 3-kinase) is a key regulator of cell growth, metab., and survival.  The frequent activation of the PI3K pathway in cancer has stimulated widespread interest in identifying potent and selective inhibitors of PI3K isoforms.  The present paper highlights recent progress in identifying such mols. and the challenges that remain for efforts to pharmacol. target the PI3K family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtmivxnuTfQ7Vg90H21EOLACvtfcHk0ljR639iXfCQew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjt1Wrsb4%253D&md5=b7243ad076ba15f65214acc8a3b09d65</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1042%2FBST0350245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0350245%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DChemically%2520targeting%2520the%2520PI3K%2520family%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2007%26volume%3D35%26issue%3D2%26spage%3D245%26epage%3D249%26doi%3D10.1042%2FBST0350245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Flinn, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horwitz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Younes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahl, B.</span><span> </span><span class="NLM_article-title">Clinical safety and activity in a phase 1 trial of IPI-145, a potent inhibitor of phosphoinositide-3-kinase (δ/γ), in patients with advanced hematologic malignancies</span> <span class="citation_source-journal">Blood (ASH Annual Meeting Abstracts)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">3663</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=3663&author=I.+Flinnauthor=S.+Horwitzauthor=M.+Patelauthor=A.+Younesauthor=J.+Porterauthor=J.+Sweeneyauthor=K.+Allenauthor=P.+Kellyauthor=B.+Kahl&title=Clinical+safety+and+activity+in+a+phase+1+trial+of+IPI-145%2C+a+potent+inhibitor+of+phosphoinositide-3-kinase+%28%CE%B4%2F%CE%B3%29%2C+in+patients+with+advanced+hematologic+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFlinn%26aufirst%3DI.%26aulast%3DHorwitz%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DYounes%26aufirst%3DA.%26aulast%3DPorter%26aufirst%3DJ.%26aulast%3DSweeney%26aufirst%3DJ.%26aulast%3DAllen%26aufirst%3DK.%26aulast%3DKelly%26aufirst%3DP.%26aulast%3DKahl%26aufirst%3DB.%26atitle%3DClinical%2520safety%2520and%2520activity%2520in%2520a%2520phase%25201%2520trial%2520of%2520IPI-145%252C%2520a%2520potent%2520inhibitor%2520of%2520phosphoinositide-3-kinase%2520%2528%25CE%25B4%252F%25CE%25B3%2529%252C%2520in%2520patients%2520with%2520advanced%2520hematologic%2520malignancies%26jtitle%3DBlood%2520%2528ASH%2520Annual%2520Meeting%2520Abstracts%2529%26date%3D2012%26volume%3D120%26spage%3D3663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Cushing, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardozo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duquette, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Lopez de Turiso, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henne, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarter, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGee, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">San Miguel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pattaropong, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettus, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichelt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rzasa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seganish, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasker, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wannberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whoriskey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zalameda, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metz, D. P.</span><span> </span><span class="NLM_article-title">Discovery and in Vivo Evaluation of (<i>S</i>)-<i>N</i>-(1-(7-Fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9<i>H</i>-purin-6-amine (AMG319) and Related PI3Kδ Inhibitors for Inflammation and Autoimmune Disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">480</span><span class="NLM_x">–</span> <span class="NLM_lpage">511</span><span class="refDoi"> DOI: 10.1021/jm501624r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501624r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=480-511&issue=1&author=T.+D.+Cushingauthor=X.+Haoauthor=Y.+Shinauthor=K.+Andrewsauthor=M.+Brownauthor=M.+Cardozoauthor=Y.+Chenauthor=J.+Duquetteauthor=B.+Fisherauthor=F.+Gonzalez-Lopez+de+Turisoauthor=X.+Heauthor=K.+R.+Henneauthor=Y.-L.+Huauthor=R.+Hungateauthor=M.+G.+Johnsonauthor=R.+C.+Kellyauthor=B.+Lucasauthor=J.+D.+McCarterauthor=L.+R.+McGeeauthor=J.+C.+Medinaauthor=T.+San+Miguelauthor=D.+Mohnauthor=V.+Pattaropongauthor=L.+H.+Pettusauthor=A.+Reicheltauthor=R.+M.+Rzasaauthor=J.+Seganishauthor=A.+S.+Taskerauthor=R.+C.+Wahlauthor=S.+Wannbergauthor=D.+A.+Whittingtonauthor=J.+Whoriskeyauthor=G.+Yuauthor=L.+Zalamedaauthor=D.+Zhangauthor=D.+P.+Metz&title=Discovery+and+in+Vivo+Evaluation+of+%28S%29-N-%281-%287-Fluoro-2-%28pyridin-2-yl%29quinolin-3-yl%29ethyl%29-9H-purin-6-amine+%28AMG319%29+and+Related+PI3K%CE%B4+Inhibitors+for+Inflammation+and+Autoimmune+Disease&doi=10.1021%2Fjm501624r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm501624r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501624r%26sid%3Dliteratum%253Aachs%26aulast%3DCushing%26aufirst%3DT.%2BD.%26aulast%3DHao%26aufirst%3DX.%26aulast%3DShin%26aufirst%3DY.%26aulast%3DAndrews%26aufirst%3DK.%26aulast%3DBrown%26aufirst%3DM.%26aulast%3DCardozo%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DDuquette%26aufirst%3DJ.%26aulast%3DFisher%26aufirst%3DB.%26aulast%3DGonzalez-Lopez%2Bde%2BTuriso%26aufirst%3DF.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DHenne%26aufirst%3DK.%2BR.%26aulast%3DHu%26aufirst%3DY.-L.%26aulast%3DHungate%26aufirst%3DR.%26aulast%3DJohnson%26aufirst%3DM.%2BG.%26aulast%3DKelly%26aufirst%3DR.%2BC.%26aulast%3DLucas%26aufirst%3DB.%26aulast%3DMcCarter%26aufirst%3DJ.%2BD.%26aulast%3DMcGee%26aufirst%3DL.%2BR.%26aulast%3DMedina%26aufirst%3DJ.%2BC.%26aulast%3DSan%2BMiguel%26aufirst%3DT.%26aulast%3DMohn%26aufirst%3DD.%26aulast%3DPattaropong%26aufirst%3DV.%26aulast%3DPettus%26aufirst%3DL.%2BH.%26aulast%3DReichelt%26aufirst%3DA.%26aulast%3DRzasa%26aufirst%3DR.%2BM.%26aulast%3DSeganish%26aufirst%3DJ.%26aulast%3DTasker%26aufirst%3DA.%2BS.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWannberg%26aufirst%3DS.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DWhoriskey%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DG.%26aulast%3DZalameda%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DMetz%26aufirst%3DD.%2BP.%26atitle%3DDiscovery%2520and%2520in%2520Vivo%2520Evaluation%2520of%2520%2528S%2529-N-%25281-%25287-Fluoro-2-%2528pyridin-2-yl%2529quinolin-3-yl%2529ethyl%2529-9H-purin-6-amine%2520%2528AMG319%2529%2520and%2520Related%2520PI3K%25CE%25B4%2520Inhibitors%2520for%2520Inflammation%2520and%2520Autoimmune%2520Disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D1%26spage%3D480%26epage%3D511%26doi%3D10.1021%2Fjm501624r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Currie, K. S.</span><span> </span><span class="NLM_article-title">Targeting the B-cell receptor pathway in hematological malignancies</span> <span class="citation_source-journal">Med. Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">230</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2015&pages=230-231&author=K.+S.+Currie&title=Targeting+the+B-cell+receptor+pathway+in+hematological+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCurrie%26aufirst%3DK.%2BS.%26atitle%3DTargeting%2520the%2520B-cell%2520receptor%2520pathway%2520in%2520hematological%2520malignancies%26jtitle%3DMed.%2520Chem.%2520Rev.%26date%3D2015%26volume%3D50%26spage%3D230%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Johnson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcus, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebsworth, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sablan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dairaghi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonn, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schall, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J.</span><span> </span><span class="NLM_article-title">Discovery and optimization of a series of quinazolinone-derived antagonists of CXCR3</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">3339</span><span class="NLM_x">–</span> <span class="NLM_lpage">3343</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.03.106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1016%2Fj.bmcl.2007.03.106" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3339-3343&issue=12&author=M.+Johnsonauthor=A.-R.+Liauthor=J.+Liuauthor=Z.+Fuauthor=L.+Zhuauthor=S.+Miaoauthor=X.+Wangauthor=Q.+Xuauthor=A.+Huangauthor=A.+Marcusauthor=F.+Xuauthor=K.+Ebsworthauthor=E.+Sablanauthor=J.+Danaoauthor=J.+Kumerauthor=D.+Dairaghiauthor=C.+Lawrenceauthor=T.+Sullivanauthor=G.+Tonnauthor=T.+Schallauthor=T.+Collinsauthor=J.+Medina&title=Discovery+and+optimization+of+a+series+of+quinazolinone-derived+antagonists+of+CXCR3&doi=10.1016%2Fj.bmcl.2007.03.106"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.03.106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.03.106%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DA.-R.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DMiao%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DHuang%26aufirst%3DA.%26aulast%3DMarcus%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DF.%26aulast%3DEbsworth%26aufirst%3DK.%26aulast%3DSablan%26aufirst%3DE.%26aulast%3DDanao%26aufirst%3DJ.%26aulast%3DKumer%26aufirst%3DJ.%26aulast%3DDairaghi%26aufirst%3DD.%26aulast%3DLawrence%26aufirst%3DC.%26aulast%3DSullivan%26aufirst%3DT.%26aulast%3DTonn%26aufirst%3DG.%26aulast%3DSchall%26aufirst%3DT.%26aulast%3DCollins%26aufirst%3DT.%26aulast%3DMedina%26aufirst%3DJ.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520a%2520series%2520of%2520quinazolinone-derived%2520antagonists%2520of%2520CXCR3%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26issue%3D12%26spage%3D3339%26epage%3D3343%26doi%3D10.1016%2Fj.bmcl.2007.03.106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robeson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilbert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramanathan, S.</span><span> </span><span class="NLM_article-title">Clinical drug interaction profile of idelalisib in healthy subjects</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">919</span><span class="refDoi"> DOI: 10.1002/jcph.495</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1002%2Fjcph.495" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=25760671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFCru7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2015&pages=909-919&issue=8&author=F.+Jinauthor=M.+Robesonauthor=H.+Zhouauthor=C.+Moyerauthor=S.+Wilbertauthor=B.+Murrayauthor=S.+Ramanathan&title=Clinical+drug+interaction+profile+of+idelalisib+in+healthy+subjects&doi=10.1002%2Fjcph.495"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical drug interaction profile of idelalisib in healthy subjects</span></div><div class="casAuthors">Jin, Feng; Robeson, Michelle; Zhou, Huafeng; Moyer, Candra; Wilbert, Sibylle; Murray, Bernard; Ramanathan, Srini</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">909-919</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Idelalisib, a potent phosphatidylinositol-3-kinase delta (PI3Kδ) inhibitor, is metabolized primarily by aldehyde oxidase to form GS-563117 and to a lesser extent by cytochrome P 450 (CYP) 3A and uridine 5'-diphospho-glucuronosyltransferase 1A4.  In vitro, idelalisib inhibits P-glycoprotein (P-gp) and org. anion transporting polypeptides 1B1 and 1B3, and GS-563117 is a time-dependent CYP3A inhibitor.  This study enrolled 24 healthy subjects and evaluated (1) the effect of idelalisib on the pharmacokinetics (PK) of digoxin, a P-gp probe substrate, rosuvastatin, a breast cancer resistance protein, and OATP1B1/OATP1B3 substrate, and midazolam, a CYP3A substrate; and (2) the effect of a strong inducer, rifampin, on idelalisib PK.  On treatment, the most common clin. adverse events (AEs) were headache and pyrexia.  Grade 3 transaminase increases were obsd. in 5 of 24 subjects and were reversible.  Two subjects had serious AEs after treatment completion (grade 3 pyrexia and/or drug-induced liver injury).  Idelalisib coadministration did not affect digoxin and rosuvastatin PK.  Coadministration with idelalisib increased plasma exposures of midazolam (138% and 437% for max. obsd. plasma concn. [Cmax] and area under the plasma concn.-time curve from time 0 extrapolated to infinity [AUCinf], resp.), consistent with the in vitro finding of CYP3A inhibition by GS-563117.  Rifampin caused a substantial decrease in idelalisib (58% and 75%, Cmax and AUCinf, resp.) and GS-563117 exposures, indicating an enhanced contribution of CYP3A to idelalisib metab. under a strongly induced state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnGy4bARtgkLVg90H21EOLACvtfcHk0ljv1CL2xVWteA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFCru7%252FM&md5=b4e8bb97a51561cecda3ecd0c7a16372</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1002%2Fjcph.495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcph.495%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DF.%26aulast%3DRobeson%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DMoyer%26aufirst%3DC.%26aulast%3DWilbert%26aufirst%3DS.%26aulast%3DMurray%26aufirst%3DB.%26aulast%3DRamanathan%26aufirst%3DS.%26atitle%3DClinical%2520drug%2520interaction%2520profile%2520of%2520idelalisib%2520in%2520healthy%2520subjects%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2015%26volume%3D55%26issue%3D8%26spage%3D909%26epage%3D919%26doi%3D10.1002%2Fjcph.495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ramanathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kearney, B. P.</span><span> </span><span class="NLM_article-title">Clinical pharmacokinetic and pharmacodynamic profile of idelalisib</span> <span class="citation_source-journal">Clin. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span><span class="refDoi"> DOI: 10.1007/s40262-015-0304-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1007%2Fs40262-015-0304-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=26242379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlSit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=33-45&author=S.+Ramanathanauthor=F.+Jinauthor=S.+Sharmaauthor=B.+P.+Kearney&title=Clinical+pharmacokinetic+and+pharmacodynamic+profile+of+idelalisib&doi=10.1007%2Fs40262-015-0304-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical Pharmacokinetic and Pharmacodynamic Profile of Idelalisib</span></div><div class="casAuthors">Ramanathan, Srinivasan; Jin, Feng; Sharma, Shringi; Kearney, Brian P.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-45</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Idelalisib is a potent and selective phosphatidylinositol 3-kinase-δ inhibitor, which is a first-in-class agent to be approved for the treatment of relapsed chronic lymphocytic leukemia, follicular B cell non-Hodgkin's lymphoma and small lymphocytic lymphoma.  In dose-ranging studies, idelalisib exposure increased in a less than dose-proportional manner, likely because of soly.-limited absorption.  The approved starting dose of 150 mg twice daily was supported by extensive exposure-response evaluations, with dose redn. to 100 mg twice daily being allowed for specific toxicities.  Idelalisib may be administered without regard to food on the basis of the absence of clin. relevant food effects, and was accordingly dosed in primary efficacy/safety studies.  Idelalisib is metabolized primarily via aldehyde oxidase (AO) and, to a lesser extent, via cytochrome P 450 (CYP) 3A.  Coadministration with the strong CYP3A inhibitor ketoconazole 400 mg once daily resulted in a ∼79 % increase in the idelalisib area under the plasma concn.-time curve (AUC).  Administration with the potent inducer rifampin resulted in a 75 % decrease in idelalisib exposure (AUC) and, as such, coadministration with strong inducers should be avoided.  GS-563117 is an inactive primary circulating metabolite of idelalisib formed mainly via AO.  Unlike idelalisib, GS-563117 is a mechanism-based inhibitor of CYP3A.  Accordingly, idelalisib 150 mg twice-daily dosing increases the midazolam AUC 5.4-fold.  Clin., idelalisib is not an inhibitor of the transporters P-glycoprotein, breast cancer resistance protein, org. anion-transporting polypeptide (OATP) 1B1 or OAPT1B3.  In a population pharmacokinetic model, no meaningful impact on idelalisib pharmacokinetics was noted for any of the covariates tested.  Idelalisib exposure was ∼60 % higher with moderate/severe hepatic impairment; no relevant changes were obsd. with severe renal impairment.  This article reviews a comprehensive pharmacol. program, including drug-drug interaction studies and mechanistic and special population studies, which has allowed a thorough understanding of idelalisib clin. pharmacokinetics and their impact on clin. safety and efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprSL8hV_Gha7Vg90H21EOLACvtfcHk0ljHJMyR07wSCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlSit7o%253D&md5=df1082fcbb0e1a9aa941769ade9fe962</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1007%2Fs40262-015-0304-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40262-015-0304-0%26sid%3Dliteratum%253Aachs%26aulast%3DRamanathan%26aufirst%3DS.%26aulast%3DJin%26aufirst%3DF.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DKearney%26aufirst%3DB.%2BP.%26atitle%3DClinical%2520pharmacokinetic%2520and%2520pharmacodynamic%2520profile%2520of%2520idelalisib%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2016%26volume%3D55%26spage%3D33%26epage%3D45%26doi%3D10.1007%2Fs40262-015-0304-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hall, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krenitsky, T. A.</span><span> </span><span class="NLM_article-title">Aldehyde oxidase from rabbit liver: specificity toward purines and their analogs</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">251</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">36</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span><span class="refDoi"> DOI: 10.1016/0003-9861(86)90048-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1016%2F0003-9861%2886%2990048-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=1986&pages=36-46&issue=1&author=W.+W.+Hallauthor=T.+A.+Krenitsky&title=Aldehyde+oxidase+from+rabbit+liver%3A+specificity+toward+purines+and+their+analogs&doi=10.1016%2F0003-9861%2886%2990048-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1016%2F0003-9861%2886%2990048-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-9861%252886%252990048-2%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DW.%2BW.%26aulast%3DKrenitsky%26aufirst%3DT.%2BA.%26atitle%3DAldehyde%2520oxidase%2520from%2520rabbit%2520liver%253A%2520specificity%2520toward%2520purines%2520and%2520their%2520analogs%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1986%26volume%3D251%26issue%3D1%26spage%3D36%26epage%3D46%26doi%3D10.1016%2F0003-9861%2886%2990048-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Torres, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korzekwa, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMasters, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. P.</span><span> </span><span class="NLM_article-title">Use of density functional calculations to predict the regioselectivity of drugs and molecules metabolized by aldehyde oxidase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">4642</span><span class="NLM_x">–</span> <span class="NLM_lpage">4647</span><span class="refDoi"> DOI: 10.1021/jm0703690</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0703690" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsVKnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4642-4647&issue=19&author=R.+A.+Torresauthor=K.+R.+Korzekwaauthor=D.+R.+McMastersauthor=C.+M.+Fandozziauthor=J.+P.+Jones&title=Use+of+density+functional+calculations+to+predict+the+regioselectivity+of+drugs+and+molecules+metabolized+by+aldehyde+oxidase&doi=10.1021%2Fjm0703690"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Use of Density Functional Calculations To Predict the Regioselectivity of Drugs and Molecules Metabolized by Aldehyde Oxidase</span></div><div class="casAuthors">Torres, Rhonda A.; Korzekwa, Kenneth R.; McMasters, Daniel R.; Fandozzi, Christine M.; Jones, Jeffrey P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4642-4647</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aldehyde oxidase is a molybdenum hydroxylase that catalyzes the oxidn. of aldehydes and nitrogen-contg. heterocycles.  The enzyme plays a dual role in the metab. of physiol. important endogenous compds. and the biotransformation of xenobiotics.  Using d. functional theory methods, geometry optimization of tetrahedral intermediates of drugs and druglike compds. was examd. to predict the likely metabolites of aldehyde oxidase.  The calcns. suggest that the lowest energy tetrahedral intermediate resulting from the initial substrate corresponds to the obsd. metabolite ≥90% of the time.  Addnl. calcns. were performed on a series of heterocyclic compds. where the products resulting from metab. by xanthine oxidase and aldehyde oxidase differ in many instances.  Again, the lowest energy tetrahedral intermediate corresponded to the obsd. product of aldehyde oxidase metab. ≥90% for the compds. examd., while the obsd. products of xanthine oxidase were not well predicted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmnIR2Ha4_oLVg90H21EOLACvtfcHk0ljHJMyR07wSCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsVKnsb4%253D&md5=514ee5703f306287a3b7315fc5cea434</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1021%2Fjm0703690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0703690%26sid%3Dliteratum%253Aachs%26aulast%3DTorres%26aufirst%3DR.%2BA.%26aulast%3DKorzekwa%26aufirst%3DK.%2BR.%26aulast%3DMcMasters%26aufirst%3DD.%2BR.%26aulast%3DFandozzi%26aufirst%3DC.%2BM.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26atitle%3DUse%2520of%2520density%2520functional%2520calculations%2520to%2520predict%2520the%2520regioselectivity%2520of%2520drugs%2520and%2520molecules%2520metabolized%2520by%2520aldehyde%2520oxidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D19%26spage%3D4642%26epage%3D4647%26doi%3D10.1021%2Fjm0703690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Linton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ornelas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kephart, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pairish, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, C.</span><span> </span><span class="NLM_article-title">Systematic structure modifications of imidazo[1,2-a]pyrimidine to reduce metabolism mediated by aldehyde oxidase (AO)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">7705</span><span class="NLM_x">–</span> <span class="NLM_lpage">7712</span><span class="refDoi"> DOI: 10.1021/jm2010942</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2010942" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1ynu7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7705-7712&issue=21&author=A.+Lintonauthor=P.+Kangauthor=M.+Ornelasauthor=S.+Kephartauthor=Q.+Huauthor=M.+Pairishauthor=Y.+Jiangauthor=C.+Guo&title=Systematic+structure+modifications+of+imidazo%5B1%2C2-a%5Dpyrimidine+to+reduce+metabolism+mediated+by+aldehyde+oxidase+%28AO%29&doi=10.1021%2Fjm2010942"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17cR"><div class="casContent"><span class="casTitleNuber">17c</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic Structure Modifications of Imidazo[1,2-a]pyrimidine to Reduce Metabolism Mediated by Aldehyde Oxidase (AO)</span></div><div class="casAuthors">Linton, Angelica; Kang, Ping; Ornelas, Martha; Kephart, Susan; Hu, Qiyue; Pairish, Mason; Jiang, Ying; Guo, Chuangxing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7705-7712</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-{trans-3-[(5-Cyano-6-methylpyridin-2-yl)oxy]-2,2,4,4-tetramethylcyclobutyl}imidazo[1,2-a]pyrimidine-3-carboxamide (I) was recently identified as a full antagonist of the androgen receptor, demonstrating excellent in vivo tumor growth inhibition in castration-resistant prostate cancer (CRPC).  However, the imidazo[1,2-a]pyrimidine moiety is rapidly metabolized by aldehyde oxidase (AO).  The present paper describes a no. of medicinal chem. strategies taken to avoid the AO-mediated oxidn. of this particular system.  Guided by an AO protein structure-based model, the investigation revealed the most probable site of AO oxidn. and the observation that altering the heterocycle or blocking the reactive site are two of the more effective strategies for reducing AO metab.  These strategies may be useful for other drug discovery programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQMDVJxz6g_bVg90H21EOLACvtfcHk0ljHJMyR07wSCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1ynu7bL&md5=b6da895d38c71f90eb4f83716f1060f0</span></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=10.1021%2Fjm2010942&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2010942%26sid%3Dliteratum%253Aachs%26aulast%3DLinton%26aufirst%3DA.%26aulast%3DKang%26aufirst%3DP.%26aulast%3DOrnelas%26aufirst%3DM.%26aulast%3DKephart%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DPairish%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DC.%26atitle%3DSystematic%2520structure%2520modifications%2520of%2520imidazo%255B1%252C2-a%255Dpyrimidine%2520to%2520reduce%2520metabolism%2520mediated%2520by%2520aldehyde%2520oxidase%2520%2528AO%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D21%26spage%3D7705%26epage%3D7712%26doi%3D10.1021%2Fjm2010942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Pryde, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.-D.</span><span> </span><span class="NLM_article-title">Aldehyde oxidase: an enzyme of emerging importance in drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">8441</span><span class="NLM_x">–</span> <span class="NLM_lpage">8460</span><span class="refDoi"> DOI: 10.1021/jm100888d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100888d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFygt73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8441-8460&issue=24&author=D.+C.+Prydeauthor=D.+Dalvieauthor=Q.+Huauthor=P.+Jonesauthor=R.+S.+Obachauthor=T.-D.+Tran&title=Aldehyde+oxidase%3A+an+enzyme+of+emerging+importance+in+drug+discovery&doi=10.1021%2Fjm100888d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17dR"><div class="casContent"><span class="casTitleNuber">17d</span><div class="casTitle"><span class="NLM_cas:atitle">Aldehyde Oxidase: An Enzyme of Emerging Importance in Drug Discovery</span></div><div class="casAuthors">Pryde, David C.; Dalvie, Deepak; Hu, Qiyue; Jones, Peter; Obach, R. Scott; Tran, Thien-Duc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8441-8460</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Aldehyde oxidase has for many years been recognized as a metabolizing enzyme contained within the cytosolic compartment of many tissues and in many species.  The first literature ref. to AO dates from the 1930s, but literature citations to this enzyme have been steadily growing ever since, esp. in the past decade.  It has been increasingly recognized in this past decade that AO, through its unique structure, distribution, and substrate recognition, has an important role to play in the metab. of drugs.  In this timely Perspective, we present the current knowledge of the enzyme's expression, its structure, and its distribution across species.  We offer an anal. of substrates recognized by AO and highlight clin. examples where metab. by this enzyme has had significant clin. impact or led to the termination of a drug development program.  Finally, through anal. of the structure of known substrates, we present data to suggest the significant impact AO could play on future drug discovery programs along with strategies that could be employed to mitigate this.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqALwFS70G6tLVg90H21EOLACvtfcHk0lgdfVzspF9VJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFygt73N&md5=972eb9862a7dc7bff024b530ab40de7f</span></div><a href="/servlet/linkout?suffix=cit17d&amp;dbid=16384&amp;doi=10.1021%2Fjm100888d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100888d%26sid%3Dliteratum%253Aachs%26aulast%3DPryde%26aufirst%3DD.%2BC.%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DTran%26aufirst%3DT.-D.%26atitle%3DAldehyde%2520oxidase%253A%2520an%2520enzyme%2520of%2520emerging%2520importance%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D24%26spage%3D8441%26epage%3D8460%26doi%3D10.1021%2Fjm100888d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Rashidi, M.-R.; Pashaei-Asl, R.</span><span> </span><span class="NLM_article-title">Role of aldehyde oxidase and xanthine oxidase in the metabolism of purine-related drugs</span>.  <span class="citation_source-book">Readings in Advanced Pharmacokinetics. Theory, Methods and Applications</span>, <span class="NLM_edition">1</span>st ed.; <span class="NLM_contrib-group">Noreddin, A.</span>, Ed.; <span class="NLM_publisher-name">InTech</span>: <span class="NLM_publisher-loc">Rijeka, Croatia</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">285</span><span class="NLM_x">–</span> <span class="NLM_lpage">314</span>, DOI: <span class="refDoi"> DOI: 10.5772/33202</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.5772%2F33202" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=285-314&author=M.-R.+Rashidi&author=R.+Pashaei-Aslauthor=A.+Noreddin&title=Readings+in+Advanced+Pharmacokinetics.+Theory%2C+Methods+and+Applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17e&amp;dbid=16384&amp;doi=10.5772%2F33202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.5772%252F33202%26sid%3Dliteratum%253Aachs%26aulast%3DRashidi%26aufirst%3DM.-R.%26atitle%3DRole%2520of%2520aldehyde%2520oxidase%2520and%2520xanthine%2520oxidase%2520in%2520the%2520metabolism%2520of%2520purine-related%2520drugs%26btitle%3DReadings%2520in%2520Advanced%2520Pharmacokinetics.%2520Theory%252C%2520Methods%2520and%2520Applications%26aulast%3DNoreddin%26aufirst%3DA.%26pub%3DInTech%26date%3D2012%26spage%3D285%26epage%3D314%26doi%3D10.5772%2F33202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Zientek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span> </span><span class="NLM_article-title">In vitro-in vivo correlation for intrinsic clearance for drugs metabolized by human aldehyde oxidase</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1322</span><span class="NLM_x">–</span> <span class="NLM_lpage">1327</span><span class="refDoi"> DOI: 10.1124/dmd.110.033555</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1124%2Fdmd.110.033555" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=20444863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVWktrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=1322-1327&issue=8&author=M.+Zientekauthor=Y.+Jiangauthor=K.+Youdimauthor=R.+S.+Obach&title=In+vitro-in+vivo+correlation+for+intrinsic+clearance+for+drugs+metabolized+by+human+aldehyde+oxidase&doi=10.1124%2Fdmd.110.033555"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro-in vivo correlation for intrinsic clearance for drugs metabolized by human aldehyde oxidase</span></div><div class="casAuthors">Zientek, Michael; Jiang, Ying; Youdim, Kuresh; Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1322-1327</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The ability to predict in vivo clearance from in vitro intrinsic clearance for compds. metabolized by aldehyde oxidase has not been demonstrated.  To date, there is no established scaling method for predicting aldehyde oxidase-mediated clearance using in vitro or animal data.  This challenge is exacerbated by the fact that rats and dogs, two of the lab. animal species commonly used to develop in vitro-in vivo correlations of clearance, differ from humans with regard to expression of aldehyde oxidase.  The objective of this investigation was to develop an in vitro-in vivo correlation of intrinsic clearance for aldehyde oxidase, using 11 drugs known to be metabolized by this enzyme.  The set consisted of methotrexate, XK-469, (±-4-(4-cyanoanilino)-5,6-dihydro-7-hydroxy-7H-cyclopenta[d]pyrimidine (RS-8359), zaleplon, 6-deoxypenciclovir, zoniporide, O6-benzylguanine, N-[(2'-dimethylamino)ethyl]acridine-4-carboxamide (DACA), carbazeran, PF-4217903, and PF-945863.  These compds. were assayed using two in vitro systems (pooled human liver cytosol and liver S-9 fractions) to calc. scaled unbound intrinsic clearance, and they were then compared with calcd. in vivo unbound intrinsic clearance.  The investigation provided a relative scale that can be used for in vitro-in vivo correlation of aldehyde oxidase clearance and suggests limits as to when a potential new drug candidate that is metabolized by this enzyme will possess acceptable human clearance, or when structural modification is required to reduce aldehyde oxidase catalyzed metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFkx3d5zxrd7Vg90H21EOLACvtfcHk0lgdfVzspF9VJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVWktrjJ&md5=296ee366707d82b416e70eb8161f923b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1124%2Fdmd.110.033555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.110.033555%26sid%3Dliteratum%253Aachs%26aulast%3DZientek%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DYoudim%26aufirst%3DK.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DIn%2520vitro-in%2520vivo%2520correlation%2520for%2520intrinsic%2520clearance%2520for%2520drugs%2520metabolized%2520by%2520human%2520aldehyde%2520oxidase%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26issue%3D8%26spage%3D1322%26epage%3D1327%26doi%3D10.1124%2Fdmd.110.033555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Pryde, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duckworth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyland, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenham, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span> </span><span class="NLM_article-title">Medicinal chemistry approaches to avoid aldehyde oxidase metabolism</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">2856</span><span class="NLM_x">–</span> <span class="NLM_lpage">2860</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.02.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1016%2Fj.bmcl.2012.02.069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=22429467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=1%3ACAS%3A528%3ADC%252BC38XktFSitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2856-2860&issue=8&author=D.+C.+Prydeauthor=T.-D.+Tranauthor=P.+Jonesauthor=J.+Duckworthauthor=M.+Howardauthor=I.+Gardnerauthor=R.+Hylandauthor=R.+Websterauthor=T.+Wenhamauthor=S.+Bagalauthor=K.+Omotoauthor=R.+P.+Schneiderauthor=J.+Lin&title=Medicinal+chemistry+approaches+to+avoid+aldehyde+oxidase+metabolism&doi=10.1016%2Fj.bmcl.2012.02.069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry approaches to avoid aldehyde oxidase metabolism</span></div><div class="casAuthors">Pryde, David C.; Tran, Thien-Duc; Jones, Peter; Duckworth, Jonathan; Howard, Martin; Gardner, Iain; Hyland, Ruth; Webster, Rob; Wenham, Tracey; Bagal, Sharan; Omoto, Kiyoyuki; Schneider, Richard P.; Lin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2856-2860</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aldehyde oxidase (AO) is a molybdenum-contg. enzyme distributed throughout the animal kingdom and capable of metabolising a wide range of aldehydes and N-heterocyclic compds.  Although metab. by this enzyme in man is recognized to have significant clin. impact where human AO activity was not predicted by screening in preclin. species, there is very little reported literature offering real examples where drug discoverers have successfully designed away from AO oxidn.  This article reports on some strategies adopted in the Pfizer TLR7 agonist program to successfully switch off AO metab. that was seen principally in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZKVEe9ZUzMbVg90H21EOLACvtfcHk0lgH_iJ-1iybiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktFSitbs%253D&md5=4c4c68b64f1c7013ad978408add0b09a</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.069%26sid%3Dliteratum%253Aachs%26aulast%3DPryde%26aufirst%3DD.%2BC.%26aulast%3DTran%26aufirst%3DT.-D.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DDuckworth%26aufirst%3DJ.%26aulast%3DHoward%26aufirst%3DM.%26aulast%3DGardner%26aufirst%3DI.%26aulast%3DHyland%26aufirst%3DR.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DWenham%26aufirst%3DT.%26aulast%3DBagal%26aufirst%3DS.%26aulast%3DOmoto%26aufirst%3DK.%26aulast%3DSchneider%26aufirst%3DR.%2BP.%26aulast%3DLin%26aufirst%3DJ.%26atitle%3DMedicinal%2520chemistry%2520approaches%2520to%2520avoid%2520aldehyde%2520oxidase%2520metabolism%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26issue%3D8%26spage%3D2856%26epage%3D2860%26doi%3D10.1016%2Fj.bmcl.2012.02.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bendele, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McComb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gould, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAbee, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sennello, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chlipala, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guy, M.</span><span> </span><span class="NLM_article-title">Animal models of arthritis: relevance to human disease</span> <span class="citation_source-journal">Toxicol. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">134</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span><span class="refDoi"> DOI: 10.1177/019262339902700125</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1177%2F019262339902700125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10367688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=1%3ACAS%3A280%3ADyaK1M3psVWjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1999&pages=134-42&issue=1&author=A.+Bendeleauthor=J.+McCombauthor=T.+Gouldauthor=T.+McAbeeauthor=G.+Sennelloauthor=E.+Chlipalaauthor=M.+Guy&title=Animal+models+of+arthritis%3A+relevance+to+human+disease&doi=10.1177%2F019262339902700125"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">Animal models of arthritis: relevance to human disease</span></div><div class="casAuthors">Bendele A; McComb J; Gould T; McAbee T; Sennello G; Chlipala E; Guy M</div><div class="citationInfo"><span class="NLM_cas:title">Toxicologic pathology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">134-42</span>
        ISSN:<span class="NLM_cas:issn">0192-6233</span>.
    </div><div class="casAbstract">Animal models of arthritis are used to evaluate potential antiarthritis drugs for clinical use.  Therefore capacity of the model to predict efficacy in human disease is one of the most important criteria in model selection.  Animal models of rheumatoid arthritis (RA) with a proven track record of predictability include rat adjuvant arthritis, rat type II collagen arthritis, mouse type II collagen arthritis, and antigen-induced arthritis in several species.  Agents currently in clinical use (or trials) that are active in these models include corticosteroids, methotrexate, nonsteroidal anti-inflammatory drugs, cyclosporin A, leflunomide, interleukin-1 receptor antagonist, and soluble tumor necrosis factor receptors.  For some of these agents, the models also predict that toxicities seen at higher doses for prolonged periods would preclude dosing in humans at levels that might provide disease-modifying effects.  Animal models of osteoarthritis (OA) include mouse and guinea pig spontaneous OA, meniscectomy and ligament transection in guinea pigs, meniscectomy in rabbits, and meniscectomy and cruciate transection in dogs.  None of these models have a proven track record of predictability in human disease because there are no agents that have been proven to provide anything other than symptomatic relief in human OA.  Efficacy data and features of the various models of RA and OA are discussed with emphasis on their proven relevance to human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSl_Wv0PotC6OkdrW1FkXG-fW6udTcc2eZTfo6uJb7_Kbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M3psVWjug%253D%253D&md5=1b6484ca61fd10dbb07f090d376730a4</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1177%2F019262339902700125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F019262339902700125%26sid%3Dliteratum%253Aachs%26aulast%3DBendele%26aufirst%3DA.%26aulast%3DMcComb%26aufirst%3DJ.%26aulast%3DGould%26aufirst%3DT.%26aulast%3DMcAbee%26aufirst%3DT.%26aulast%3DSennello%26aufirst%3DG.%26aulast%3DChlipala%26aufirst%3DE.%26aulast%3DGuy%26aufirst%3DM.%26atitle%3DAnimal%2520models%2520of%2520arthritis%253A%2520relevance%2520to%2520human%2520disease%26jtitle%3DToxicol.%2520Pathol.%26date%3D1999%26volume%3D27%26issue%3D1%26spage%3D134%26epage%3D42%26doi%3D10.1177%2F019262339902700125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bendele, A. M.</span><span> </span><span class="NLM_article-title">Animal models of rheumatoid arthritis</span> <span class="citation_source-journal">J. Musculoskeletal Neuronal Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">377</span><span class="NLM_x">–</span> <span class="NLM_lpage">385</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=15758488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltVOhu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=377-385&issue=4&author=A.+M.+Bendele&title=Animal+models+of+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Animal models of rheumatoid arthritis</span></div><div class="casAuthors">Bendele, A. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Musculoskeletal & Neuronal Interactions</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">377-385</span>CODEN:
                <span class="NLM_cas:coden">JMNIB3</span>;
        ISSN:<span class="NLM_cas:issn">1108-7161</span>.
    
            (<span class="NLM_cas:orgname">Journal of Musculoskeletal and Neuronal Interactions</span>)
        </div><div class="casAbstract">A review.  Animal models of arthritis are used to study pathogenesis of disease and to evaluate potential anti-arthritic drugs for clin. use.  Therefore morphol. similarities to human disease and capacity of the model to predict efficacy in humans are important criteria in model selection.  Animal models of rheumatoid arthritis (RA) with a proven track record of predictability for efficacy in humans include: rat adjuvant arthritis, rat type II collagen arthritis, mouse type II collagen arthritis and antigen-induced arthritis in several species.  Agents currently in clin. use (or trials) that are active in these models include: corticosteroids, methotrexate, nonsteroidal anti-inflammatory drugs, cyclosporin A, leflunomide interleukin-1 receptor antagonist (IL-1ra) and sol. TNF receptors.  For some of these agents, the models also predict that toxicities seen at higher doses for prolonged dosing periods would preclude dosing in humans at levels that might provide disease modifying effects.  Data, conduct and features of the various models of these commonly utilized models of RA as well as some transgenic mouse models and less commonly utilized rodent models will be discussed with emphasis on their similarities to human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwhtLWBEJFcbVg90H21EOLACvtfcHk0lgH_iJ-1iybiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltVOhu7o%253D&md5=21f16894bcfdad981a6b7d32773431cf</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBendele%26aufirst%3DA.%2BM.%26atitle%3DAnimal%2520models%2520of%2520rheumatoid%2520arthritis%26jtitle%3DJ.%2520Musculoskeletal%2520Neuronal%2520Interact.%26date%3D2001%26volume%3D1%26issue%3D4%26spage%3D377%26epage%3D385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Trentham, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townes, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, A. H.</span><span> </span><span class="NLM_article-title">Autoimmunity to type II collagen an experimental model of arthritis</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">146</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">857</span><span class="NLM_x">–</span> <span class="NLM_lpage">868</span><span class="refDoi"> DOI: 10.1084/jem.146.3.857</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;key=10.1084%2Fjem.146.3.857" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=1977&pages=857-868&issue=3&author=D.+E.+Trenthamauthor=A.+S.+Townesauthor=A.+H.+Kang&title=Autoimmunity+to+type+II+collagen+an+experimental+model+of+arthritis&doi=10.1084%2Fjem.146.3.857"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20c&amp;dbid=16384&amp;doi=10.1084%2Fjem.146.3.857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.146.3.857%26sid%3Dliteratum%253Aachs%26aulast%3DTrentham%26aufirst%3DD.%2BE.%26aulast%3DTownes%26aufirst%3DA.%2BS.%26aulast%3DKang%26aufirst%3DA.%2BH.%26atitle%3DAutoimmunity%2520to%2520type%2520II%2520collagen%2520an%2520experimental%2520model%2520of%2520arthritis%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1977%26volume%3D146%26issue%3D3%26spage%3D857%26epage%3D868%26doi%3D10.1084%2Fjem.146.3.857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4XE0" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4XE0','PDB','4XE0'); return false;">PDB: 4XE0</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5I6U" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5I6U','PDB','5I6U'); return false;">PDB: 5I6U</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5I4U" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5I4U','PDB','5I4U'); return false;">PDB: 5I4U</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i79"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00213">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_80751"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b00213">10.1021/acs.jmedchem.6b00213</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Histopathology scoring criteria for rat CIA model, DiscoveRx primary screen data and selectivity scores for <b>52</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00213/suppl_file/jm6b00213_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00213/suppl_file/jm6b00213_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00213/suppl_file/jm6b00213_si_001.pdf">jm6b00213_si_001.pdf (144.6 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00213/suppl_file/jm6b00213_si_002.csv">jm6b00213_si_002.csv (3.63 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB code for idelalisib is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4XE0">4XE0</a>. PDB code for compound <b>32</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5I6U">5I6U</a>. PDB code for compound <b>34</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5I4U">5I4U</a>.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00213&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00213%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-7%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00213" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799298f0dd73c82","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
